primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Asthma,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blindness,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood cholesterol increased,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood pressure increased,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood pressure systolic increased,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Bronchospasm,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Cervical spinal stenosis,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Eye disorder,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Eye pain,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Forced expiratory volume decreased,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Gastroenteritis,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Heart rate increased,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Lung disorder,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Middle insomnia,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Muscle spasms,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Musculoskeletal stiffness,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Myalgia,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Nasal congestion,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Nasal discharge discolouration,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Nerve compression,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Nerve injury,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Nervous system disorder,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Neuritis,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Optic nerve disorder,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Paranasal sinus discomfort,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Periarthritis,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Rales,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Sinusitis,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Sputum discoloured,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Visual field defect,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Visual impairment,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
1177931125,11779311,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Wheezing,,2021,Q1,25,F,20120306.0,20210303.0,20151125,20210310,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20210310.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q1,Adult
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Agitation,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Amnesia,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Arthralgia,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Asthenia,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Autoinflammatory disease,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Blood pressure systolic increased,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Bronchitis,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Conjunctivitis,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Cryopyrin associated periodic syndrome,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Deafness neurosensory,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Decreased appetite,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Delirium,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Dementia,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Drug ineffective,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Drug intolerance,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Eye inflammation,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Eye pain,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Fatigue,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Gene mutation,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Glaucoma,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Hypertension,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Illness,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Joint swelling,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Lethargy,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Mood swings,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Muscular weakness,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Ocular hyperaemia,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Paranoia,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Pyrexia,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Serum amyloid A protein increased,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Skin disorder,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Treatment failure,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Upper respiratory tract infection,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Urticaria,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Vascular cognitive impairment,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
167224899,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q1,Weight decreased,,2021,Q1,9,F,201903.0,20210112.0,20190820,20210119,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210119.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Alopecia,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Anxiety,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Apraxia,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Atrophic vulvovaginitis,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Balance disorder,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Bite,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blindness,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood chloride decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood creatinine increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood glucose decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood iron decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood parathyroid hormone increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood phosphorus increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood potassium increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood pressure decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood pressure fluctuation,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood pressure increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood pressure systolic increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood sodium increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Blood urea increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Cholelithiasis,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Chronic kidney disease,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Dry skin,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Erythema,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Faeces discoloured,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Fall,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Gait disturbance,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Haematocrit decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Haemoglobin decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Head injury,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Headache,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Heart rate irregular,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hepatic steatosis,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Hypophagia,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Insulin-like growth factor decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Joint swelling,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Lethargy,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Light chain analysis increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Limb discomfort,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Lymphocyte count decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Memory impairment,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Muscle spasms,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Nerve injury,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Neuropathy peripheral,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Nocturia,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Osteoporosis,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Paraesthesia,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Peripheral swelling,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Protein urine present,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Pruritus,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Pulmonary mass,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Rash erythematous,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Red blood cell count decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Skin discolouration,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Sleep apnoea syndrome,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Sleep disorder,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Urethral caruncle,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Urinary incontinence,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Urine calcium/creatinine ratio increased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Vitamin B12 decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
170962882,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q1,White blood cell count decreased,,2021,Q1,2,F,,20210315.0,20191202,20210326,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210326.0,,CN,CA,CA,2021,Q1,Elderly
172068053,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q1,Blood creatine phosphokinase increased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q1,Malaise,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q1,Weight decreased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q1,Blood creatine phosphokinase increased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q1,Malaise,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
172068053,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q1,Weight decreased,,2021,Q1,3,F,,20210118.0,20191227,20210127,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210127.0,,CN,CA,CA,2021,Q1,Adult
181009467,18100946,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3 MG, QD",66.0,MG,Y,,,,213051.0,3.0,MG,TABLET,QD,2021,Q1,Cholelithiasis,,2021,Q1,7,F,20200118.0,20210308.0,20200731,20210317,EXP,,TR-NOVOPROD-711991,NOVO NORDISK,,63.0,YR,,M,Y,70.0,KG,20210317.0,,MD,TR,TR,2021,Q1,Adult
181009467,18100946,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3 MG, QD",66.0,MG,Y,,,,213051.0,3.0,MG,TABLET,QD,2021,Q1,Obstructive pancreatitis,,2021,Q1,7,F,20200118.0,20210308.0,20200731,20210317,EXP,,TR-NOVOPROD-711991,NOVO NORDISK,,63.0,YR,,M,Y,70.0,KG,20210317.0,,MD,TR,TR,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Angina pectoris,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Appetite disorder,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Asthma,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Chest discomfort,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Chest pain,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Cough,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Depressed mood,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Depressive symptom,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Dyspnoea,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Dyspnoea exertional,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Fall,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Flank pain,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Heart sounds,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Influenza,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Injury,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Insomnia,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Loss of personal independence in daily activities,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Lower respiratory tract infection,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Malaise,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Nasal congestion,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Nasopharyngitis,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Productive cough,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Prolonged expiration,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Pyrexia,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Rales,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Respiration abnormal,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Rhinorrhoea,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Sleep disorder due to a general medical condition,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Stress,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Upper respiratory tract infection,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Weight decreased,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181601213,18160121,39,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,SOLUTION,/wk,2021,Q1,Wheezing,,2021,Q1,3,F,,20210311.0,20200818,20210324,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20210324.0,,CN,CA,CA,2021,Q1,Adult
181821724,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Drug hypersensitivity,,2021,Q1,4,F,20180801.0,20210308.0,20200821,20210315,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210315.0,,HP,CA,CA,2021,Q1,Elderly
181821724,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Incorrect dose administered,,2021,Q1,4,F,20180801.0,20210308.0,20200821,20210315,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210315.0,,HP,CA,CA,2021,Q1,Elderly
181821724,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Metastases to bone,,2021,Q1,4,F,20180801.0,20210308.0,20200821,20210315,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210315.0,,HP,CA,CA,2021,Q1,Elderly
181821724,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Oedema peripheral,,2021,Q1,4,F,20180801.0,20210308.0,20200821,20210315,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210315.0,,HP,CA,CA,2021,Q1,Elderly
181821724,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Off label use,,2021,Q1,4,F,20180801.0,20210308.0,20200821,20210315,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210315.0,,HP,CA,CA,2021,Q1,Elderly
181821724,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q1,Weight decreased,,2021,Q1,4,F,20180801.0,20210308.0,20200821,20210315,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210315.0,,HP,CA,CA,2021,Q1,Elderly
1821482011,18214820,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,,"3 MG, QD",3934.0,MG,Y,N,,,213051.0,3.0,MG,TABLET,QD,2021,Q1,Gastric ulcer haemorrhage,,2021,Q1,11,F,20200715.0,20210303.0,20200831,20210311,EXP,,RU-NOVOPROD-749874,NOVO NORDISK,,61.0,YR,,M,Y,86.0,KG,20210311.0,,MD,RU,RU,2021,Q1,Adult
1821482011,18214820,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",3934.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Gastric ulcer haemorrhage,,2021,Q1,11,F,20200715.0,20210303.0,20200831,20210311,EXP,,RU-NOVOPROD-749874,NOVO NORDISK,,61.0,YR,,M,Y,86.0,KG,20210311.0,,MD,RU,RU,2021,Q1,Adult
182591893,18259189,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 MILLIGRAM,,,U,,,,,9.0,MG,,,2021,Q1,Myasthenia gravis,,2021,Q1,3,F,20200826.0,20210329.0,20200911,20210331,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,99.0,KG,20210331.0,,HP,DK,DK,2021,Q1,Elderly
182591893,18259189,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 MILLIGRAM,,,U,,,,,9.0,MG,,,2021,Q1,Myocarditis,,2021,Q1,3,F,20200826.0,20210329.0,20200911,20210331,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,99.0,KG,20210331.0,,HP,DK,DK,2021,Q1,Elderly
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Blood pressure fluctuation,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Cystitis,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Ear pain,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Hypertension,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Intentional product use issue,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Lower respiratory tract infection,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Oropharyngeal pain,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Product use issue,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Red blood cell count increased,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Red blood cell sedimentation rate increased,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183092692,18309269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,2,F,,20210201.0,20200925,20210211,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20210211.0,,HP,CA,CA,2021,Q1,Adult
183522557,18352255,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Bile duct stone,,2021,Q1,7,F,20200916.0,20210112.0,20201006,20210121,EXP,,JP-NOVOPROD-756490,NOVO NORDISK,,85.0,YR,,M,Y,69.0,KG,20210121.0,,MD,JP,JP,2021,Q1,Elderly
183770974,18377097,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,UNKNOWN,,2021,Q1,Cataract nuclear,,2021,Q1,4,F,,20210201.0,20201013,20210203,EXP,,CH-JNJFOC-20201006584,JOHNSON AND JOHNSON,,57.0,YR,A,F,Y,63.0,KG,20210203.0,,MD,CH,CH,2021,Q1,Adult
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Acute kidney injury,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Anaemia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Asthenia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Cardiomyopathy,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Chronic kidney disease,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Cough,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Diarrhoea,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Diverticulum,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Drug level increased,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Duodenal ulcer,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Dyspnoea,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Gastrointestinal haemorrhage,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Hydronephrosis,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Hyperkalaemia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Hyperphosphataemia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Hypoalbuminaemia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Hypocalcaemia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Lung hernia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Lymphoma,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Mass,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Metabolic acidosis,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Myocardial infarction,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Nephrolithiasis,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Product substitution issue,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Streptococcal sepsis,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Thrombocytopenia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Tricuspid valve incompetence,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Ulcer haemorrhage,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Vasculitis,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Ventricular extrasystoles,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Ventricular tachycardia,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Vitamin D deficiency,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184737923,18473792,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Vomiting,,2021,Q1,3,F,201808.0,20201228.0,20201106,20210104,EXP,,NVSC2020BE291001,NOVARTIS,,68.0,YR,,M,Y,120.9,KG,20210104.0,,HP,BE,BE,2021,Q1,Elderly
184795856,18479585,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.25,MG,ONCE PER WEEK",,,,,,,209637.0,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Cholangitis acute,,2021,Q1,6,F,20201004.0,20210216.0,20201109,20210226,EXP,,JP-NOVOPROD-763484,NOVO NORDISK,,78.0,YR,,M,Y,75.0,KG,20210226.0,,MD,JP,JP,2021,Q1,Elderly
184795856,18479585,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.25,MG,ONCE PER WEEK",,,,,,,209637.0,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Cholelithiasis,,2021,Q1,6,F,20201004.0,20210216.0,20201109,20210226,EXP,,JP-NOVOPROD-763484,NOVO NORDISK,,78.0,YR,,M,Y,75.0,KG,20210226.0,,MD,JP,JP,2021,Q1,Elderly
184975883,18497588,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,938.0,MG,Y,,,,213051.0,,,TABLET,,2021,Q1,Cholelithiasis,,2021,Q1,3,F,20200215.0,20210210.0,20201112,20210219,EXP,,IL-NOVOPROD-714606,NOVO NORDISK,,68.0,YR,,M,Y,88.0,KG,20210219.0,,MD,IL,IL,2021,Q1,Elderly
184975883,18497588,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,938.0,MG,Y,,,,213051.0,,,TABLET,,2021,Q1,Obstructive pancreatitis,,2021,Q1,3,F,20200215.0,20210210.0,20201112,20210219,EXP,,IL-NOVOPROD-714606,NOVO NORDISK,,68.0,YR,,M,Y,88.0,KG,20210219.0,,MD,IL,IL,2021,Q1,Elderly
184975883,18497588,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,938.0,MG,Y,,,,213051.0,,,TABLET,,2021,Q1,Cholelithiasis,,2021,Q1,3,F,20200215.0,20210210.0,20201112,20210219,EXP,,IL-NOVOPROD-714606,NOVO NORDISK,,68.0,YR,,M,Y,88.0,KG,20210219.0,,MD,IL,IL,2021,Q1,Elderly
184975883,18497588,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,938.0,MG,Y,,,,213051.0,,,TABLET,,2021,Q1,Obstructive pancreatitis,,2021,Q1,3,F,20200215.0,20210210.0,20201112,20210219,EXP,,IL-NOVOPROD-714606,NOVO NORDISK,,68.0,YR,,M,Y,88.0,KG,20210219.0,,MD,IL,IL,2021,Q1,Elderly
184975883,18497588,3,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",938.0,MG,Y,,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Cholelithiasis,,2021,Q1,3,F,20200215.0,20210210.0,20201112,20210219,EXP,,IL-NOVOPROD-714606,NOVO NORDISK,,68.0,YR,,M,Y,88.0,KG,20210219.0,,MD,IL,IL,2021,Q1,Elderly
184975883,18497588,3,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",938.0,MG,Y,,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Obstructive pancreatitis,,2021,Q1,3,F,20200215.0,20210210.0,20201112,20210219,EXP,,IL-NOVOPROD-714606,NOVO NORDISK,,68.0,YR,,M,Y,88.0,KG,20210219.0,,MD,IL,IL,2021,Q1,Elderly
186086834,18608683,1,PS,Semaglutide 7 mg,SEMAGLUTIDE,1,Oral,",MG,ONCE PER DAY",,,,,,,213051.0,,,TABLET,,2021,Q1,Cholecystitis acute,,2021,Q1,4,F,20201102.0,20201218.0,20201213,20210317,EXP,,UA-NOVOPROD-771731,NOVO NORDISK,,66.0,YR,,F,Y,82.0,KG,20210317.0,,MD,UA,UA,2021,Q1,Elderly
186086834,18608683,1,PS,Semaglutide 7 mg,SEMAGLUTIDE,1,Oral,",MG,ONCE PER DAY",,,,,,,213051.0,,,TABLET,,2021,Q1,Cholelithiasis,,2021,Q1,4,F,20201102.0,20201218.0,20201213,20210317,EXP,,UA-NOVOPROD-771731,NOVO NORDISK,,66.0,YR,,F,Y,82.0,KG,20210317.0,,MD,UA,UA,2021,Q1,Elderly
186584002,18658400,1,PS,Semaglutide 7 mg,SEMAGLUTIDE,1,Oral,"7 MG, QD",266.0,MG,Y,,,,,7.0,MG,TABLET,QD,2021,Q1,Escherichia sepsis,,2021,Q1,2,F,20201213.0,20210310.0,20201223,20210323,EXP,,IT-NOVOPROD-774648,NOVO NORDISK,,73.0,YR,,F,Y,53.0,KG,20210322.0,,MD,IT,IT,2021,Q1,Elderly
186846166,18684616,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",,,,,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Diabetic retinopathy,,2021,Q1,6,F,20200914.0,20210304.0,20201230,20210316,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20210316.0,,MD,US,US,2021,Q1,Adult
186846166,18684616,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",,,,,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Vitreous haemorrhage,,2021,Q1,6,F,20200914.0,20210304.0,20201230,20210316,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20210316.0,,MD,US,US,2021,Q1,Adult
187022441,18702244,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,, UNKNOWN,,,25.0,MG,UNKNOWN,,2021,Q1,Circulatory collapse,,2021,Q1,1,I,20201127.0,20201228.0,20210105,20210105,EXP,FR-AFSSAPS-AM20201392,FR-FRESENIUS KABI-FK202014109,FRESENIUS KABI,,39.0,YR,,F,Y,86.0,KG,20210105.0,,HP,NL,FR,2021,Q1,Adult
187022441,18702244,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,, UNKNOWN,,,25.0,MG,UNKNOWN,,2021,Q1,Syncope,,2021,Q1,1,I,20201127.0,20201228.0,20210105,20210105,EXP,FR-AFSSAPS-AM20201392,FR-FRESENIUS KABI-FK202014109,FRESENIUS KABI,,39.0,YR,,F,Y,86.0,KG,20210105.0,,HP,NL,FR,2021,Q1,Adult
187065191,18706519,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q1,Dyspnoea,,2021,Q1,1,I,20201216.0,,20210105,20210105,DIR,,,FDA-CTU,,72.0,YR,,M,N,243.0,KG,20201217.0,N,PH,US,US,2021,Q1,Elderly
187065191,18706519,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q1,Respiratory depression,,2021,Q1,1,I,20201216.0,,20210105,20210105,DIR,,,FDA-CTU,,72.0,YR,,M,N,243.0,KG,20201217.0,N,PH,US,US,2021,Q1,Elderly
187245501,18724550,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.5,MG,,QW,2021,Q1,Constipation,,2021,Q1,1,I,20201123.0,,20210111,20210111,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20201201.0,N,PH,US,US,2021,Q1,Elderly
187261781,18726178,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210105.0,20210111,20210111,EXP,,US-JNJFOC-20210111938,JOHNSON AND JOHNSON,"CURANAJ F.M., SELEY J.,  EUGLYCEMIC DKA IN A PATIENT WITH TYPE 2 DIABETES ON AN SGLT2 INHIBITOR: IS IT A ZEBRA? ENDOCRINE PRACTICE 2020 26 142",29.0,YR,A,F,Y,,,20210111.0,,HP,US,US,2021,Q1,Young Adult
187300714,18730071,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",,,,,,,213051.0,3.0,MG,TABLET,QD,2021,Q1,Bacteraemia,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",,,,,,,213051.0,3.0,MG,TABLET,QD,2021,Q1,Cholecystitis acute,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",,,,,,,213051.0,3.0,MG,TABLET,QD,2021,Q1,Postoperative abscess,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q1,Bacteraemia,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q1,Cholecystitis acute,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q1,Postoperative abscess,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q1,Bacteraemia,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q1,Cholecystitis acute,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187300714,18730071,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q1,Postoperative abscess,,2021,Q1,4,F,20201229.0,20210211.0,20210112,20210218,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210218.0,,MD,CA,CA,2021,Q1,Elderly
187301141,18730114,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D, UNKNOWN,,,1.0,MG,,QW,2021,Q1,Pancreatitis,,2021,Q1,1,I,20201212.0,,20210112,20210112,DIR,,,FDA-CTU,,49.0,YR,,M,N,103.05,KG,20210112.0,Y,PH,US,US,2021,Q1,Adult
187399791,18739979,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q1,Chest pain,,2021,Q1,1,I,20201230.0,,20210113,20210113,DIR,,,FDA-CTU,,69.0,YR,,M,N,124.0,KG,20210111.0,N,PH,US,US,2021,Q1,Elderly
187399791,18739979,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q1,Pancreatitis,,2021,Q1,1,I,20201230.0,,20210113,20210113,DIR,,,FDA-CTU,,69.0,YR,,M,N,124.0,KG,20210111.0,N,PH,US,US,2021,Q1,Elderly
187485622,18748562,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14.0,MG,ONCE PER DAY",5726.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Cholecystitis acute,,2021,Q1,2,F,20201113.0,20210118.0,20210115,20210128,EXP,,CA-NOVOPROD-778944,NOVO NORDISK,,76.0,YR,,M,Y,72.0,KG,20210128.0,,MD,CA,CA,2021,Q1,Elderly
187485622,18748562,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",5726.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Cholecystitis acute,,2021,Q1,2,F,20201113.0,20210118.0,20210115,20210128,EXP,,CA-NOVOPROD-778944,NOVO NORDISK,,76.0,YR,,M,Y,72.0,KG,20210128.0,,MD,CA,CA,2021,Q1,Elderly
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Angina pectoris,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Appetite disorder,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Asthma,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Chest discomfort,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Chest pain,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Cough,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Depressed mood,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Depressive symptom,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Dyspnoea exertional,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Fall,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Flank pain,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Heart sounds,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Influenza,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Injury,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Insomnia,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Loss of personal independence in daily activities,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Lower respiratory tract infection,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Malaise,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Nasal congestion,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Nasopharyngitis,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Productive cough,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Prolonged expiration,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Pyrexia,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Rales,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Respiration abnormal,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Rhinorrhoea,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Sleep disorder due to a general medical condition,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Stress,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Upper respiratory tract infection,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187538311,18753831,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.25,MG,CUTANEOUS SOLUTION,,2021,Q1,Wheezing,,2021,Q1,1,I,,20210105.0,20210119,20210119,EXP,,"CA-ALLEGIS PHARMACEUTICALS, LLC-APL202101-000002",ALLEGIS PHARMACEUTICALS,,61.0,YR,A,F,Y,,,20210119.0,,HP,CA,CA,2021,Q1,Adult
187550661,18755066,9,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,1,I,20210111.0,,20210115,20210115,DIR,,,FDA-CTU,,61.0,YR,,M,N,89.6,KG,20210115.0,Y,PH,US,US,2021,Q1,Adult
187550661,18755066,9,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q1,Malaise,,2021,Q1,1,I,20210111.0,,20210115,20210115,DIR,,,FDA-CTU,,61.0,YR,,M,N,89.6,KG,20210115.0,Y,PH,US,US,2021,Q1,Adult
187550661,18755066,9,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210111.0,,20210115,20210115,DIR,,,FDA-CTU,,61.0,YR,,M,N,89.6,KG,20210115.0,Y,PH,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Breast tenderness,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Device breakage,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Device issue,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Device physical property issue,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Insomnia,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Product adhesion issue,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
187961351,18796135,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q1,Therapeutic product ineffective,,2021,Q1,1,I,202011.0,20210104.0,20210127,20210127,PER,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210127.0,,CN,US,US,2021,Q1,Adult
188000931,18800093,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q1,Diarrhoea,,2021,Q1,1,I,20190514.0,,20210128,20210128,DIR,,,FDA-CTU,,73.0,YR,,M,N,97.0,KG,20200116.0,N,PH,US,US,2021,Q1,Elderly
188001812,18800181,19,C,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,UNKNOWN,,2021,Q1,Rash,,2021,Q1,2,F,20201219.0,20210203.0,20210128,20210211,PER,,US-CELGENEUS-USA-20210105963,CELGENE,,75.0,YR,,M,Y,,,20210211.0,,MD,US,US,2021,Q1,Elderly
188068011,18806801,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,1.0,MG,,QW,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,20200904.0,,20210128,20210128,DIR,,,FDA-CTU,,62.0,YR,,M,N,129.0,KG,20201028.0,N,PH,US,US,2021,Q1,Adult
188068011,18806801,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,1.0,MG,,QW,2021,Q1,Nausea,,2021,Q1,1,I,20200904.0,,20210128,20210128,DIR,,,FDA-CTU,,62.0,YR,,M,N,129.0,KG,20201028.0,N,PH,US,US,2021,Q1,Adult
188068011,18806801,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,1.0,MG,,QW,2021,Q1,Vomiting,,2021,Q1,1,I,20200904.0,,20210128,20210128,DIR,,,FDA-CTU,,62.0,YR,,M,N,129.0,KG,20201028.0,N,PH,US,US,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Gout,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Oxygen consumption increased,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Product use in unapproved indication,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Pulmonary arterial hypertension,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Pulmonary oedema,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Pulmonary veno-occlusive disease,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Right ventricular failure,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Right-to-left cardiac shunt,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188491313,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Ulcer haemorrhage,,2021,Q1,3,F,2020.0,20210302.0,20210204,20210311,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20210311.0,,MD,CA,CA,2021,Q1,Adult
188681892,18868189,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Bile duct stone,,2021,Q1,2,F,20210104.0,20210208.0,20210209,20210218,EXP,,SK-NOVOPROD-784303,NOVO NORDISK,,73.0,YR,,F,Y,100.0,KG,20210218.0,,MD,SK,SK,2021,Q1,Elderly
188703181,18870318,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201231.0,20210128.0,20210209,20210209,EXP,GB-MHRA-EYC 00238957,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-079384",BOEHRINGER INGELHEIM,,48.0,YR,A,F,Y,,,20210210.0,,PH,GB,GB,2021,Q1,Adult
188711131,18871113,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Drug titration error,,2021,Q1,1,I,,20210204.0,20210210,20210210,EXP,,CA-APOTEX-2021AP002574,APOTEX,,54.0,YR,,F,Y,141.0,KG,20210210.0,,CN,CA,CA,2021,Q1,Adult
188711131,18871113,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Facial paralysis,,2021,Q1,1,I,,20210204.0,20210210,20210210,EXP,,CA-APOTEX-2021AP002574,APOTEX,,54.0,YR,,F,Y,141.0,KG,20210210.0,,CN,CA,CA,2021,Q1,Adult
188711131,18871113,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Food craving,,2021,Q1,1,I,,20210204.0,20210210,20210210,EXP,,CA-APOTEX-2021AP002574,APOTEX,,54.0,YR,,F,Y,141.0,KG,20210210.0,,CN,CA,CA,2021,Q1,Adult
188711131,18871113,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Meniere's disease,,2021,Q1,1,I,,20210204.0,20210210,20210210,EXP,,CA-APOTEX-2021AP002574,APOTEX,,54.0,YR,,F,Y,141.0,KG,20210210.0,,CN,CA,CA,2021,Q1,Adult
188711131,18871113,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Nausea,,2021,Q1,1,I,,20210204.0,20210210,20210210,EXP,,CA-APOTEX-2021AP002574,APOTEX,,54.0,YR,,F,Y,141.0,KG,20210210.0,,CN,CA,CA,2021,Q1,Adult
188711131,18871113,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Synovial cyst,,2021,Q1,1,I,,20210204.0,20210210,20210210,EXP,,CA-APOTEX-2021AP002574,APOTEX,,54.0,YR,,F,Y,141.0,KG,20210210.0,,CN,CA,CA,2021,Q1,Adult
188711131,18871113,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Urticaria,,2021,Q1,1,I,,20210204.0,20210210,20210210,EXP,,CA-APOTEX-2021AP002574,APOTEX,,54.0,YR,,F,Y,141.0,KG,20210210.0,,CN,CA,CA,2021,Q1,Adult
188826852,18882685,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",,,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q1,Cholecystitis acute,,2021,Q1,2,F,20210128.0,20210307.0,20210211,20210317,EXP,,CZ-NOVOPROD-785390,NOVO NORDISK,,73.0,YR,,M,Y,91.0,KG,20210317.0,,MD,CZ,CZ,2021,Q1,Elderly
188837421,18883742,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20210207.0,20210208.0,20210211,20210211,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-081889",BOEHRINGER INGELHEIM,,55.0,YR,A,M,Y,91.0,KG,20210211.0,,MD,DE,DE,2021,Q1,Adult
188837421,18883742,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q1,Diabetic nephropathy,,2021,Q1,1,I,20210207.0,20210208.0,20210211,20210211,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-081889",BOEHRINGER INGELHEIM,,55.0,YR,A,M,Y,91.0,KG,20210211.0,,MD,DE,DE,2021,Q1,Adult
188837421,18883742,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,20210207.0,20210208.0,20210211,20210211,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-081889",BOEHRINGER INGELHEIM,,55.0,YR,A,M,Y,91.0,KG,20210211.0,,MD,DE,DE,2021,Q1,Adult
188837421,18883742,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q1,Vomiting,,2021,Q1,1,I,20210207.0,20210208.0,20210211,20210211,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-081889",BOEHRINGER INGELHEIM,,55.0,YR,A,M,Y,91.0,KG,20210211.0,,MD,DE,DE,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Asthma,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Chronic kidney disease,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Hyperlipidaemia,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Hypertension,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Lower respiratory tract infection,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Nasal congestion,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Nasopharyngitis,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Pharyngitis,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Productive cough,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Sleep apnoea syndrome,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
188998051,18899805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Urinary incontinence,,2021,Q1,1,I,,20210209.0,20210216,20210216,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082386",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210216.0,,MD,CA,CA,2021,Q1,Adult
189081481,18908148,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,4.8,MG,,,,,,2.4,MG,,/wk,2021,Q1,Lymphoedema,,2021,Q1,1,I,20200916.0,20210202.0,20210218,20210218,EXP,,IT-ASTRAZENECA-2021A027485,ASTRAZENECA,,64.0,YR,,M,Y,90.0,KG,20210217.0,,HP,IT,IT,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Asthma,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Chronic kidney disease,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Hyperlipidaemia,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Hypertension,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Lower respiratory tract infection,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Nasal congestion,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Nasopharyngitis,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Pharyngitis,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Productive cough,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Sleep apnoea syndrome,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189119152,18911915,12,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q1,Urinary incontinence,,2021,Q1,2,F,,20210308.0,20210219,20210317,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210317.0,,CN,CA,CA,2021,Q1,Adult
189180141,18918014,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,20210202.0,20210211.0,20210219,20210219,EXP,GB-MHRA-EYC 00240219,GB-NOVOPROD-787716,NOVO NORDISK,,72.0,YR,,F,Y,70.0,KG,20210219.0,,HP,GB,GB,2021,Q1,Elderly
189180141,18918014,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,20210202.0,20210211.0,20210219,20210219,EXP,GB-MHRA-EYC 00240219,GB-NOVOPROD-787716,NOVO NORDISK,,72.0,YR,,F,Y,70.0,KG,20210219.0,,HP,GB,GB,2021,Q1,Elderly
189180141,18918014,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210202.0,20210211.0,20210219,20210219,EXP,GB-MHRA-EYC 00240219,GB-NOVOPROD-787716,NOVO NORDISK,,72.0,YR,,F,Y,70.0,KG,20210219.0,,HP,GB,GB,2021,Q1,Elderly
189180141,18918014,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hyperhidrosis,,2021,Q1,1,I,20210202.0,20210211.0,20210219,20210219,EXP,GB-MHRA-EYC 00240219,GB-NOVOPROD-787716,NOVO NORDISK,,72.0,YR,,F,Y,70.0,KG,20210219.0,,HP,GB,GB,2021,Q1,Elderly
189180141,18918014,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Sneezing,,2021,Q1,1,I,20210202.0,20210211.0,20210219,20210219,EXP,GB-MHRA-EYC 00240219,GB-NOVOPROD-787716,NOVO NORDISK,,72.0,YR,,F,Y,70.0,KG,20210219.0,,HP,GB,GB,2021,Q1,Elderly
189312531,18931253,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 MILLIGRAM/DOSE,,,,,,,,1.0,MG,,,2021,Q1,COVID-19,,2021,Q1,1,I,202012.0,20210212.0,20210223,20210223,EXP,,US-BEH-2021128421,CSL BEHRING,,73.0,YR,E,M,Y,,,20210223.0,,HP,US,US,2021,Q1,Elderly
189349611,18934961,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210217.0,20210224,20210224,EXP,,US-MYLANLABS-2021M1011477,MYLAN,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. P?M?R 2020?NULL:NULL.",19.0,YR,,M,Y,,,20210224.0,,MD,US,US,2021,Q1,Youth
189349611,18934961,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Gait inability,,2021,Q1,1,I,,20210217.0,20210224,20210224,EXP,,US-MYLANLABS-2021M1011477,MYLAN,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. P?M?R 2020?NULL:NULL.",19.0,YR,,M,Y,,,20210224.0,,MD,US,US,2021,Q1,Youth
189349611,18934961,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q1,Vitamin B12 deficiency,,2021,Q1,1,I,,20210217.0,20210224,20210224,EXP,,US-MYLANLABS-2021M1011477,MYLAN,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. P?M?R 2020?NULL:NULL.",19.0,YR,,M,Y,,,20210224.0,,MD,US,US,2021,Q1,Youth
189378411,18937841,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q1,Blood creatine phosphokinase increased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q1,Malaise,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q1,Blood creatine phosphokinase increased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q1,Malaise,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189378411,18937841,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210216.0,20210224,20210224,EXP,,CA-BAUSCH-BL-2021-006042,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210224.0,,MD,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Asthma,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Chronic kidney disease,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Hyperlipidaemia,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Hypertension,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Lower respiratory tract infection,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Nasal congestion,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Nasopharyngitis,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Pharyngitis,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Productive cough,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Sleep apnoea syndrome,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189476231,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q1,Urinary incontinence,,2021,Q1,1,I,,20210219.0,20210226,20210226,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210226.0,,CN,CA,CA,2021,Q1,Adult
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Ankle fracture,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Atrial fibrillation,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Coronary artery disease,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Hypercholesterolaemia,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Hypertension,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Lower limb fracture,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Obesity,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189480012,18948001,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 MG ONCE A WEEK,,,U,N,,,,,,,,2021,Q1,Peripheral arterial occlusive disease,,2021,Q1,2,F,201602.0,20210222.0,20210226,20210303,EXP,,DE-ANIPHARMA-2021-DE-000027,ANI,,73.0,YR,,M,Y,87.0,KG,20210303.0,,MD,DE,DE,2021,Q1,Elderly
189527301,18952730,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Neuropathy vitamin B12 deficiency,,2021,Q1,1,I,,20210217.0,20210301,20210301,EXP,,US-APOTEX-2021AP003714,APOTEX,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12 (1):S137?S138",19.0,YR,,M,Y,,,20210301.0,,HP,US,US,2021,Q1,Youth
189534061,18953406,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Disease progression,,2021,Q1,1,I,,20210217.0,20210301,20210301,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-02494,LUPIN,,19.0,YR,,M,Y,,,20210301.0,,MD,US,US,2021,Q1,Youth
189534061,18953406,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Gait inability,,2021,Q1,1,I,,20210217.0,20210301,20210301,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-02494,LUPIN,,19.0,YR,,M,Y,,,20210301.0,,MD,US,US,2021,Q1,Youth
189534061,18953406,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Vitamin B12 deficiency,,2021,Q1,1,I,,20210217.0,20210301,20210301,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-02494,LUPIN,,19.0,YR,,M,Y,,,20210301.0,,MD,US,US,2021,Q1,Youth
189587891,18958789,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/wk,2021,Q1,Euglycaemic diabetic ketoacidosis,,2021,Q1,1,I,,20210221.0,20210302,20210302,EXP,,US-ASTRAZENECA-2021A081675,ASTRAZENECA,,71.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Elderly
189591201,18959120,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNK,,,,,,,2021,Q1,Areflexia,,2021,Q1,1,I,,20210218.0,20210302,20210302,EXP,,US-ALSI-2021000053,AIRGAS,"MEDICAL LITERATURE BY THE EMA MLM SERVICE FROM DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8 ON 17?FEB?2021.?THE ABOVE CITATION IS FROM A CONFERENCE ABSTRACT.",19.0,YR,,M,Y,,,20210302.0,,HP,US,US,2021,Q1,Youth
189591201,18959120,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNK,,,,,,,2021,Q1,Decreased vibratory sense,,2021,Q1,1,I,,20210218.0,20210302,20210302,EXP,,US-ALSI-2021000053,AIRGAS,"MEDICAL LITERATURE BY THE EMA MLM SERVICE FROM DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8 ON 17?FEB?2021.?THE ABOVE CITATION IS FROM A CONFERENCE ABSTRACT.",19.0,YR,,M,Y,,,20210302.0,,HP,US,US,2021,Q1,Youth
189591201,18959120,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNK,,,,,,,2021,Q1,Exercise tolerance decreased,,2021,Q1,1,I,,20210218.0,20210302,20210302,EXP,,US-ALSI-2021000053,AIRGAS,"MEDICAL LITERATURE BY THE EMA MLM SERVICE FROM DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8 ON 17?FEB?2021.?THE ABOVE CITATION IS FROM A CONFERENCE ABSTRACT.",19.0,YR,,M,Y,,,20210302.0,,HP,US,US,2021,Q1,Youth
189591201,18959120,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNK,,,,,,,2021,Q1,Gait inability,,2021,Q1,1,I,,20210218.0,20210302,20210302,EXP,,US-ALSI-2021000053,AIRGAS,"MEDICAL LITERATURE BY THE EMA MLM SERVICE FROM DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8 ON 17?FEB?2021.?THE ABOVE CITATION IS FROM A CONFERENCE ABSTRACT.",19.0,YR,,M,Y,,,20210302.0,,HP,US,US,2021,Q1,Youth
189591201,18959120,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNK,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,1,I,,20210218.0,20210302,20210302,EXP,,US-ALSI-2021000053,AIRGAS,"MEDICAL LITERATURE BY THE EMA MLM SERVICE FROM DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8 ON 17?FEB?2021.?THE ABOVE CITATION IS FROM A CONFERENCE ABSTRACT.",19.0,YR,,M,Y,,,20210302.0,,HP,US,US,2021,Q1,Youth
189591201,18959120,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNK,,,,,,,2021,Q1,Neuropathy vitamin B12 deficiency,,2021,Q1,1,I,,20210218.0,20210302,20210302,EXP,,US-ALSI-2021000053,AIRGAS,"MEDICAL LITERATURE BY THE EMA MLM SERVICE FROM DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8 ON 17?FEB?2021.?THE ABOVE CITATION IS FROM A CONFERENCE ABSTRACT.",19.0,YR,,M,Y,,,20210302.0,,HP,US,US,2021,Q1,Youth
189591201,18959120,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNK,,,,,,,2021,Q1,Substance use,,2021,Q1,1,I,,20210218.0,20210302,20210302,EXP,,US-ALSI-2021000053,AIRGAS,"MEDICAL LITERATURE BY THE EMA MLM SERVICE FROM DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8 ON 17?FEB?2021.?THE ABOVE CITATION IS FROM A CONFERENCE ABSTRACT.",19.0,YR,,M,Y,,,20210302.0,,HP,US,US,2021,Q1,Youth
189630172,18963017,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood pressure inadequately controlled,,2021,Q1,2,F,,20210324.0,20210303,20210331,PER,,NVSC2021US048349,NOVARTIS,,66.0,YR,,M,Y,,,20210331.0,,MD,US,US,2021,Q1,Elderly
189630172,18963017,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,2,F,,20210324.0,20210303,20210331,PER,,NVSC2021US048349,NOVARTIS,,66.0,YR,,M,Y,,,20210331.0,,MD,US,US,2021,Q1,Elderly
189664311,18966431,3,C,semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210217.0,20210304,20210304,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-283468,RANBAXY,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. P M R. 2020?1?2",19.0,YR,,M,Y,,,20210304.0,,MD,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Areflexia,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Decreased vibratory sense,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Drug abuse,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Exercise tolerance decreased,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Gait inability,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Neuropathy vitamin B12 deficiency,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189674861,18967486,3,C,Semaglutide,SEMAGLUTIDE,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Substance use,,2021,Q1,1,I,,20210224.0,20210304,20210304,EXP,US-MLMSERVICE-20210218-2733934-1,US-TILLOMED LABORATORIES LTD.-2021-EPL-000626,EMCURE,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12",19.0,YR,,M,Y,,,20210304.0,,HP,US,US,2021,Q1,Youth
189694421,18969442,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,1,I,202001.0,20200909.0,20210304,20210304,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR004967,AEGERION,,60.0,YR,,F,Y,,,20210304.0,,HP,US,US,2021,Q1,Adult
189694421,18969442,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,,,2021,Q1,Diarrhoea,,2021,Q1,1,I,202001.0,20200909.0,20210304,20210304,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR004967,AEGERION,,60.0,YR,,F,Y,,,20210304.0,,HP,US,US,2021,Q1,Adult
189694421,18969442,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,,,2021,Q1,Rhinorrhoea,,2021,Q1,1,I,202001.0,20200909.0,20210304,20210304,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR004967,AEGERION,,60.0,YR,,F,Y,,,20210304.0,,HP,US,US,2021,Q1,Adult
189694421,18969442,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,,,2021,Q1,Sinus disorder,,2021,Q1,1,I,202001.0,20200909.0,20210304,20210304,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR004967,AEGERION,,60.0,YR,,F,Y,,,20210304.0,,HP,US,US,2021,Q1,Adult
189694421,18969442,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,1,I,202001.0,20200909.0,20210304,20210304,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR004967,AEGERION,,60.0,YR,,F,Y,,,20210304.0,,HP,US,US,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Asthma,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Chronic kidney disease,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Hyperlipidaemia,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Hypertension,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Lower respiratory tract infection,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Nasal congestion,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Nasopharyngitis,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Pharyngitis,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Productive cough,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Sleep apnoea syndrome,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189705731,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Urinary incontinence,,2021,Q1,1,I,,20210222.0,20210304,20210304,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Asthma,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Chronic kidney disease,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Hyperlipidaemia,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Hypertension,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Lower respiratory tract infection,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Nasal congestion,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Nasopharyngitis,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Pharyngitis,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Productive cough,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Sleep apnoea syndrome,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189707482,18970748,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q1,Urinary incontinence,,2021,Q1,2,F,,20210228.0,20210304,20210304,EXP,,CA-ASTRAZENECA-2021A099095,ASTRAZENECA,,51.0,YR,,F,Y,,,20210304.0,,CN,CA,CA,2021,Q1,Adult
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Areflexia,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Decreased vibratory sense,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Drug abuse,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Exercise tolerance decreased,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Gait inability,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Neuropathy vitamin B12 deficiency,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189715252,18971525,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Substance use,,2021,Q1,2,F,,20210301.0,20210304,20210311,EXP,,US-AUROBINDO-AUR-APL-2021-008338,AUROBINDO,,19.0,YR,,M,Y,,,20210311.0,,MD,US,US,2021,Q1,Youth
189742061,18974206,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4 MG, QW",,,,,,,209637.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Cholecystitis,,2021,Q1,1,I,20210218.0,20210222.0,20210305,20210305,EXP,,BE-NOVOPROD-790214,NOVO NORDISK,,70.0,YR,,M,Y,113.0,KG,20210305.0,,MD,BE,BE,2021,Q1,Elderly
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Areflexia,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Decreased vibratory sense,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Drug abuse,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Exercise tolerance decreased,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Gait inability,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Neuropathy vitamin B12 deficiency,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189793301,18979330,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,, UNKNOWN,,,,,,,2021,Q1,Substance use,,2021,Q1,1,I,,20210224.0,20210308,20210308,EXP,,US-DRREDDYS-USA/USA/21/0132619,DR REDDYS,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1)SUPPL:S137?8. DOI:10.1002/PMRJ.12519",19.0,YR,A,M,Y,,,20210308.0,,HP,US,US,2021,Q1,Youth
189859471,18985947,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210224.0,20210309,20210309,EXP,,US-BAUSCH-BL-2021-006800,BAUSCH AND LOMB,"DAVIS S, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1):S137?S138. DOI:10.1002/PMRJ.12519",19.0,YR,,M,Y,,,20210309.0,,HP,US,US,2021,Q1,Youth
189859471,18985947,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q1,Neuropathy vitamin B12 deficiency,,2021,Q1,1,I,,20210224.0,20210309,20210309,EXP,,US-BAUSCH-BL-2021-006800,BAUSCH AND LOMB,"DAVIS S, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. PM AND R. 2020?12(1):S137?S138. DOI:10.1002/PMRJ.12519",19.0,YR,,M,Y,,,20210309.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Areflexia,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Decreased vibratory sense,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug abuse,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Exercise tolerance decreased,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Gait inability,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Muscular weakness,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Neuropathy vitamin B12 deficiency,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
189934801,18993480,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Substance use,,2021,Q1,1,I,,20210224.0,20210310,20210310,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK052685,GLENMARK,"DAVIS SM, LIN K, BEDELL K.. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT.. PM AND R.. 2020?12(1):S137?8",19.0,YR,,M,Y,,,20210311.0,,HP,US,US,2021,Q1,Youth
190085451,19008545,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Gait inability,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,US-TEVA-2021-US-1887721,TEVA,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. P?M?R 2020?:.",19.0,YR,A,M,Y,,,20210315.0,,MD,US,US,2021,Q1,Youth
190085451,19008545,3,C,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q1,Vitamin B12 deficiency,,2021,Q1,1,I,,20210301.0,20210315,20210315,EXP,,US-TEVA-2021-US-1887721,TEVA,"DAVIS SM, LIN K, BEDELL K. PROLONGED RECOVERY FROM NITROUS OXIDE?INDUCED B12 NEUROPATHY: A CASE REPORT. P?M?R 2020?:.",19.0,YR,A,M,Y,,,20210315.0,,MD,US,US,2021,Q1,Youth
190093922,19009392,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",81.152,MG,N,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q1,Cholecystitis acute,,2021,Q1,2,F,20210226.0,20210317.0,20210315,20210325,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210325.0,,MD,GB,GB,2021,Q1,Adult
190093922,19009392,2,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q1,Cholecystitis acute,,2021,Q1,2,F,20210226.0,20210317.0,20210315,20210325,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210325.0,,MD,GB,GB,2021,Q1,Adult
190093922,19009392,3,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q1,Cholecystitis acute,,2021,Q1,2,F,20210226.0,20210317.0,20210315,20210325,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210325.0,,MD,GB,GB,2021,Q1,Adult
190203572,19020357,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",770.0,MG,Y,,,,213051.0,14.0,MG,TABLET,QD,2021,Q1,Cholecystitis,,2021,Q1,2,F,20210126.0,20210317.0,20210317,20210325,EXP,,IN-NOVOPROD-788369,NOVO NORDISK,,55.0,YR,,M,Y,73.0,KG,20210325.0,,MD,IN,IN,2021,Q1,Adult
190594841,19059484,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.4 MILLIGRAM,,,U,,,,,1.4,MG,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,,20210315.0,20210326,20210326,EXP,,CA-APOTEX-2021AP006869,APOTEX,,55.0,YR,,M,Y,,,20210326.0,,CN,CA,CA,2021,Q1,Adult
190594841,19059484,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.4 MILLIGRAM,,,U,,,,,1.4,MG,,,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210315.0,20210326,20210326,EXP,,CA-APOTEX-2021AP006869,APOTEX,,55.0,YR,,M,Y,,,20210326.0,,CN,CA,CA,2021,Q1,Adult
190675711,19067571,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN, PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,, KP50791,20221031.0,,0.5,MG,,QW,2021,Q1,Dizziness,,2021,Q1,1,I,20200903.0,,20210326,20210326,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200910.0,N,PH,US,US,2021,Q1,Adult
190675711,19067571,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN, PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,, KP50791,20221031.0,,0.5,MG,,QW,2021,Q1,Weight decreased,,2021,Q1,1,I,20200903.0,,20210326,20210326,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200910.0,N,PH,US,US,2021,Q1,Adult
190676651,19067665,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q1,Diarrhoea,,2021,Q1,1,I,20200806.0,,20210326,20210326,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20200817.0,N,PH,US,US,2021,Q1,Elderly
190702501,19070250,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2021,Q1,Hepatic enzyme increased,,2021,Q1,1,I,20210305.0,20210305.0,20210329,20210329,PER,,US-009507513-2103USA002044,MERCK,,53.0,YR,,M,Y,,,20210329.0,,HP,US,US,2021,Q1,Adult
190709201,19070920,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q1,Blood potassium decreased,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q1,Cardiac dysfunction,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug interaction,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190709201,19070920,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,1,I,,20210323.0,20210330,20210330,EXP,,CA-ROCHE-2796181,ROCHE,,65.0,YR,,F,Y,98.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Elderly
190725931,19072593,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MLG/0.375ML INJ, SOLN, PEN,1.5MLP",SEMAGLUTIDE,1,Subcutaneous,,,,Y,, KP50572,20220930.0,,0.5,MG,,QW,2021,Q1,Diarrhoea,,2021,Q1,1,I,20200806.0,,20210326,20210326,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20200817.0,N,PH,US,US,2021,Q1,Elderly
190730331,19073033,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,"?          OTHER STRENGTH:0.5MG/0.375ML,1.5M;?",,,Y,, KP50791,20221031.0,,0.5,MG,,QW,2021,Q1,Dizziness,,2021,Q1,1,I,20200903.0,,20210326,20210326,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200910.0,N,PH,US,US,2021,Q1,Adult
190730331,19073033,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,"?          OTHER STRENGTH:0.5MG/0.375ML,1.5M;?",,,Y,, KP50791,20221031.0,,0.5,MG,,QW,2021,Q1,Weight decreased,,2021,Q1,1,I,20200903.0,,20210326,20210326,DIR,,,FDA-CTU,,55.0,YR,,M,N,,,20200910.0,N,PH,US,US,2021,Q1,Adult
190819271,19081927,1,PS,semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,Y,,,,0.25,MG,,QW,2021,Q1,Haematuria,,2021,Q1,1,I,20210201.0,,20210331,20210331,DIR,,,FDA-CTU,,74.0,YR,,M,N,101.25,KG,20210331.0,N,MD,US,US,2021,Q1,Elderly
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Amnesia,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Anaemia,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Asthenia,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Balance disorder,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Blood glucose abnormal,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Blood lactic acid increased,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Cataract,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Cognitive disorder,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Colonoscopy,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Condition aggravated,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Decreased appetite,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Disturbance in attention,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Dizziness,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Eating disorder,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Fall,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Gastrooesophageal reflux disease,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Haematemesis,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Headache,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Hiatus hernia,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Hypoglycaemia,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Hypotension,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Impaired gastric emptying,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Incision site complication,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Infusion site pain,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Lid sulcus deepened,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Multiple sclerosis relapse,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Muscle atrophy,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Nausea,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Nervousness,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Peroneal nerve palsy,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Psychomotor hyperactivity,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Surgery,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Syncope,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Thrombosis,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Urinary bladder suspension,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Vaginoplasty,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Vomiting,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1525613010,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q2,Weight decreased,,2021,Q2,10,F,2017.0,20210603.0,20180808,20210614,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210614.0,,HP,CA,CA,2021,Q2,Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Abdominal pain upper,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Acne cystic,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Allergy to chemicals,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Alopecia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Anaphylactic shock,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Anxiety,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Arthropod bite,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Arthropod sting,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Asthma,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Back pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Balance disorder,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Blood pressure increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,C-reactive protein increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chest discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chest pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chills,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Choking,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Claustrophobia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Cough,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Diarrhoea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Diplopia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Dizziness,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Dyspnoea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Electrocardiogram T wave abnormal,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Eye pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Fatigue,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Fibromyalgia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Food allergy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Gastrointestinal motility disorder,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Haemoptysis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Headache,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Heart rate increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Hypersensitivity,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Illness,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Infection,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Influenza,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Injection site discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Injection site pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Insomnia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lethargy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract infection,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lymphadenopathy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Malaise,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Muscle spasms,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Myalgia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nasal congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nausea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oedema peripheral,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Optic neuritis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oropharyngeal pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oxygen saturation decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pain in extremity,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Paranasal sinus discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Platelet count increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Product dose omission issue,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Productive cough,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pruritus,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Psoriasis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pyrexia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Rash,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Red cell distribution width increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Respiratory tract congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Sinusitis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Swelling,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Throat irritation,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Vision blurred,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Vomiting,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Weight decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,59,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25MG/0.5MG WEEKLY X 4 WEEKS),,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Wheezing,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Abdominal pain upper,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Acne cystic,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Allergy to chemicals,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Alopecia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Anaphylactic shock,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Anxiety,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Arthropod bite,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Arthropod sting,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Asthma,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Back pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Balance disorder,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Blood pressure increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,C-reactive protein increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chest discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chest pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chills,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Choking,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Claustrophobia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Cough,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Diarrhoea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Diplopia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Dizziness,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Dyspnoea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Electrocardiogram T wave abnormal,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Eye pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Fatigue,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Fibromyalgia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Food allergy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Gastrointestinal motility disorder,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Haemoptysis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Headache,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Heart rate increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Hypersensitivity,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Illness,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Infection,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Influenza,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Injection site discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Injection site pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Insomnia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lethargy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract infection,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lymphadenopathy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Malaise,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Muscle spasms,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Myalgia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nasal congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nausea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oedema peripheral,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Optic neuritis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oropharyngeal pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oxygen saturation decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pain in extremity,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Paranasal sinus discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Platelet count increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Product dose omission issue,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Productive cough,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pruritus,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Psoriasis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pyrexia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Rash,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Red cell distribution width increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Respiratory tract congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Sinusitis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Swelling,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Throat irritation,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Vision blurred,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Vomiting,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Weight decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,60,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Wheezing,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Abdominal pain upper,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Acne cystic,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Allergy to chemicals,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Alopecia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Anaphylactic shock,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Anxiety,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Arthropod bite,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Arthropod sting,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Asthma,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Back pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Balance disorder,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Blood pressure increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,C-reactive protein increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chest discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chest pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Chills,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Choking,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Claustrophobia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Cough,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Diarrhoea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Diplopia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Dizziness,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Dyspnoea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Electrocardiogram T wave abnormal,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Eye pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Fatigue,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Fibromyalgia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Food allergy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Gastrointestinal motility disorder,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Haemoptysis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Headache,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Heart rate increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Hypersensitivity,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Illness,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Infection,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Influenza,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Injection site discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Injection site pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Insomnia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lethargy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract infection,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Lymphadenopathy,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Malaise,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Muscle spasms,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Myalgia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nasal congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Nausea,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oedema peripheral,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Optic neuritis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oropharyngeal pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Oxygen saturation decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pain,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pain in extremity,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Paranasal sinus discomfort,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Platelet count increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Product dose omission issue,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Productive cough,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pruritus,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Psoriasis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Pyrexia,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Rash,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Red cell distribution width increased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Respiratory tract congestion,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Sinusitis,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Swelling,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Throat irritation,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Vision blurred,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Vomiting,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Weight decreased,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1670401315,16704013,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1MG/0.5MG X 4?6 WEEKS)",,,,, UNKNOWN,,,1.0,DF,,/wk,2021,Q2,Wheezing,,2021,Q2,15,F,20170215.0,20210604.0,20190814,20210616,EXP,,CA-ROCHE-2374570,ROCHE,,31.0,YR,,F,Y,,,20210616.0,,MD,CA,CA,2021,Q2,Young Adult
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Agitation,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Amnesia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Arthralgia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Asthenia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Autoinflammatory disease,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Blood pressure systolic increased,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Bronchitis,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Conjunctivitis,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Cryopyrin associated periodic syndrome,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Deafness neurosensory,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Decreased appetite,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Delirium,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Dementia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Drug ineffective,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Drug intolerance,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Dyspnoea,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Eye inflammation,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Eye pain,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Fatigue,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Gene mutation,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Glaucoma,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Hypertension,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Illness,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Joint swelling,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Lethargy,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Mood swings,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Muscular weakness,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Ocular hyperaemia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Paranoia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Pneumonia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Pyrexia,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Serum amyloid A protein increased,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Skin disorder,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Treatment failure,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Upper respiratory tract infection,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Urticaria,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Vascular cognitive impairment,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
1672248911,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (BRAND NAME: OZEMPIC)",,,U,,,,,,,,/wk,2021,Q2,Weight decreased,,2021,Q2,11,F,201903.0,20210527.0,20190820,20210603,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20210603.0,,CN,CA,CA,2021,Q2,Elderly
171413352,17141335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,,12.148809,MG,Y,,,,,1.0,MG,,/wk,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20191101.0,20210611.0,20191211,20210621,EXP,GB-MHRA-EYC 00212940,GB-EMD SERONO-E2B_90073106,EMD SERONO INC,,64.0,YR,A,M,Y,158.0,KG,20210621.0,,HP,GB,GB,2021,Q2,Adult
171413352,17141335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,,12.148809,MG,Y,,,,,1.0,MG,,/wk,2021,Q2,Nausea,,2021,Q2,2,F,20191101.0,20210611.0,20191211,20210621,EXP,GB-MHRA-EYC 00212940,GB-EMD SERONO-E2B_90073106,EMD SERONO INC,,64.0,YR,A,M,Y,158.0,KG,20210621.0,,HP,GB,GB,2021,Q2,Adult
171413352,17141335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,,12.148809,MG,Y,,,,,1.0,MG,,/wk,2021,Q2,Vomiting,,2021,Q2,2,F,20191101.0,20210611.0,20191211,20210621,EXP,GB-MHRA-EYC 00212940,GB-EMD SERONO-E2B_90073106,EMD SERONO INC,,64.0,YR,A,M,Y,158.0,KG,20210621.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,"1 MILLIGRAM, 1 DOSE PER 1W",12.149,MG,Y,, UNK,,,1.0,MG,,/wk,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,"1 MILLIGRAM, 1 DOSE PER 1W",12.149,MG,Y,, UNK,,,1.0,MG,,/wk,2021,Q2,Nausea,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,"1 MILLIGRAM, 1 DOSE PER 1W",12.149,MG,Y,, UNK,,,1.0,MG,,/wk,2021,Q2,Vomiting,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,12.149,MG,Y,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,12.149,MG,Y,,,,,,,,,2021,Q2,Nausea,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,12.149,MG,Y,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,12.149,MG,Y,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,12.149,MG,Y,,,,,,,,,2021,Q2,Nausea,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171494862,17149486,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,12.149,MG,Y,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,2,F,20191101.0,20210611.0,20191213,20210618,EXP,GB-MHRA-ADR 24453753,GB-EMCURE PHARMACEUTICALS LTD-2019-EPL-1185,EMCURE,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Anhedonia,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Anxiety,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Emotional distress,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Glomerulonephritis membranous,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Nephrotic syndrome,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Renal failure,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
171627934,17162793,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Tooth loss,,2021,Q2,4,F,2016.0,20210614.0,20191217,20210616,EXP,,US-GILEAD-2019-0442869,GILEAD,,54.0,YR,A,M,Y,92.98,KG,20210616.0,,LW,US,US,2021,Q2,Adult
172068054,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Alanine aminotransferase increased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Aspartate aminotransferase increased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Malaise,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Alanine aminotransferase increased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Aspartate aminotransferase increased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Malaise,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
172068054,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,4,F,,20210520.0,20191227,20210601,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210601.0,,CN,CA,CA,2021,Q2,Adult
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Alopecia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Anxiety,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Apraxia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Atrophic vulvovaginitis,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Balance disorder,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Bite,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blindness,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood chloride decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood iron decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood parathyroid hormone increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood phosphorus increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood potassium increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure fluctuation,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure systolic increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood sodium increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood urea increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cholelithiasis,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Dry skin,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Erythema,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Faeces discoloured,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Fall,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Haematocrit decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Head injury,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Headache,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Heart rate irregular,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hepatic steatosis,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypophagia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Insulin-like growth factor decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Light chain analysis increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Limb discomfort,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Lymphocyte count decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Memory impairment,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Muscle spasms,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Nerve injury,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Neuropathy peripheral,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Nocturia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Osteoporosis,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Paraesthesia,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Protein urine present,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pruritus,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pulmonary mass,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Rash erythematous,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Red blood cell count decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Skin discolouration,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Sleep apnoea syndrome,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Sleep disorder,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Urethral caruncle,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Urinary incontinence,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Urine calcium/creatinine ratio increased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Vitamin B12 decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
173509823,17350982,30,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,White blood cell count decreased,,2021,Q2,3,F,,20210414.0,20200130,20210423,EXP,,CA-AUROBINDO-AUR-APL-2020-003959,AUROBINDO,,75.0,YR,,F,Y,40.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Elderly
174736462,17473646,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,"1 MG, QW",12.149,MG,Y,,,,,1.0,MG,,/wk,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20191101.0,20210611.0,20200228,20210618,EXP,GB-MHRA-EYC 00212940,NVSC2020GB050150,NOVARTIS,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
174736462,17473646,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,"1 MG, QW",12.149,MG,Y,,,,,1.0,MG,,/wk,2021,Q2,Nausea,,2021,Q2,2,F,20191101.0,20210611.0,20200228,20210618,EXP,GB-MHRA-EYC 00212940,NVSC2020GB050150,NOVARTIS,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
174736462,17473646,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Parenteral,"1 MG, QW",12.149,MG,Y,,,,,1.0,MG,,/wk,2021,Q2,Vomiting,,2021,Q2,2,F,20191101.0,20210611.0,20200228,20210618,EXP,GB-MHRA-EYC 00212940,NVSC2020GB050150,NOVARTIS,,64.0,YR,,M,Y,158.4,KG,20210618.0,,HP,GB,GB,2021,Q2,Adult
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Alopecia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Anxiety,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Apraxia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Atrophic vulvovaginitis,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Balance disorder,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Bite,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blindness,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood chloride decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood iron decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood parathyroid hormone increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood phosphorus increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood potassium increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure fluctuation,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure systolic increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood sodium increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood urea increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Cholelithiasis,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Dry skin,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Erythema,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Faeces discoloured,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Haematocrit decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Head injury,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Heart rate irregular,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Hepatic steatosis,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypophagia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Insulin-like growth factor decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Light chain analysis increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Limb discomfort,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Lymphocyte count decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Memory impairment,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Muscle spasms,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Nerve injury,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Neuropathy peripheral,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Nocturia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Osteoporosis,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Paraesthesia,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Protein urine present,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Pruritus,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Pulmonary mass,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Rash erythematous,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Red blood cell count decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Skin discolouration,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Sleep apnoea syndrome,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Sleep disorder,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Urethral caruncle,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Urinary incontinence,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Urine calcium/creatinine ratio increased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Vitamin B12 decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
180115993,18011599,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,White blood cell count decreased,,2021,Q2,3,F,,20210428.0,20200713,20210508,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-033790",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,40.0,KG,20210508.0,,MD,CA,CA,2021,Q2,Elderly
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Angina pectoris,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Appetite disorder,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Asthma,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Chest discomfort,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Chest pain,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Cough,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Depressed mood,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Depressive symptom,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Dyspnoea,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Dyspnoea exertional,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Fall,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Flank pain,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Heart sounds,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Influenza,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Injury,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Insomnia,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Loss of personal independence in daily activities,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Lower respiratory tract infection,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Malaise,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Nasal congestion,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Productive cough,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Prolonged expiration,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Pyrexia,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Rales,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Respiration abnormal,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Rhinorrhoea,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Stress,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Upper respiratory tract infection,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Weight decreased,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
183019474,18301947,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Wheezing,,2021,Q2,4,F,,20210511.0,20200923,20210521,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210521.0,,CN,CA,CA,2021,Q2,Adult
1830354913,18303549,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"3 MG, QD",3892.0,MG,Y,N,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Bile duct stone,,2021,Q2,13,F,20200828.0,20210429.0,20200923,20210510,EXP,,GB-NOVOPROD-753194,NOVO NORDISK,,75.0,YR,,F,Y,105.0,KG,20210510.0,,MD,GB,GB,2021,Q2,Elderly
1830354913,18303549,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"3 MG, QD",3892.0,MG,Y,N,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Liver function test abnormal,,2021,Q2,13,F,20200828.0,20210429.0,20200923,20210510,EXP,,GB-NOVOPROD-753194,NOVO NORDISK,,75.0,YR,,F,Y,105.0,KG,20210510.0,,MD,GB,GB,2021,Q2,Elderly
1830354913,18303549,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",3892.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q2,Bile duct stone,,2021,Q2,13,F,20200828.0,20210429.0,20200923,20210510,EXP,,GB-NOVOPROD-753194,NOVO NORDISK,,75.0,YR,,F,Y,105.0,KG,20210510.0,,MD,GB,GB,2021,Q2,Elderly
1830354913,18303549,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",3892.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q2,Liver function test abnormal,,2021,Q2,13,F,20200828.0,20210429.0,20200923,20210510,EXP,,GB-NOVOPROD-753194,NOVO NORDISK,,75.0,YR,,F,Y,105.0,KG,20210510.0,,MD,GB,GB,2021,Q2,Elderly
1830354913,18303549,3,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,3892.0,MG,Y,N,,,213051.0,,,TABLET,,2021,Q2,Bile duct stone,,2021,Q2,13,F,20200828.0,20210429.0,20200923,20210510,EXP,,GB-NOVOPROD-753194,NOVO NORDISK,,75.0,YR,,F,Y,105.0,KG,20210510.0,,MD,GB,GB,2021,Q2,Elderly
1830354913,18303549,3,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,3892.0,MG,Y,N,,,213051.0,,,TABLET,,2021,Q2,Liver function test abnormal,,2021,Q2,13,F,20200828.0,20210429.0,20200923,20210510,EXP,,GB-NOVOPROD-753194,NOVO NORDISK,,75.0,YR,,F,Y,105.0,KG,20210510.0,,MD,GB,GB,2021,Q2,Elderly
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Asthma,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Chronic kidney disease,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Hyperlipidaemia,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Hypertension,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Lower respiratory tract infection,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Nasal congestion,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Nasopharyngitis,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Oropharyngeal pain,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Pharyngitis,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Productive cough,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Sleep apnoea syndrome,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
183089515,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q2,Urinary incontinence,,2021,Q2,5,F,,20210407.0,20200924,20210419,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210419.0,,CN,CA,CA,2021,Q2,Adult
184845452,18484545,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,2016.0,20210527.0,20201110,20210604,EXP,,US-ASTRAZENECA-2020SF44399,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20210604.0,,,US,US,2021,Q2,Adult
184845452,18484545,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,2,F,2016.0,20210527.0,20201110,20210604,EXP,,US-ASTRAZENECA-2020SF44399,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20210604.0,,,US,US,2021,Q2,Adult
184845452,18484545,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Gastrooesophageal reflux disease,,2021,Q2,2,F,2016.0,20210527.0,20201110,20210604,EXP,,US-ASTRAZENECA-2020SF44399,ASTRAZENECA,,46.0,YR,,F,Y,98.0,KG,20210604.0,,,US,US,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Abdominal discomfort,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Abdominal pain,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Acne,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Adverse drug reaction,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Anogenital warts,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Back pain,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Cellulitis,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Condition aggravated,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Constipation,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Cyst,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Diabetes mellitus,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Diarrhoea,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Eating disorder,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Fibromyalgia,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Herpes zoster,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Illness,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Immune system disorder,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Impetigo,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Joint range of motion decreased,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Mass,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Memory impairment,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Rosacea,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Skin lesion,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Speech disorder,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
185546775,18554677,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG; 2 MG /1.5 ML INJECTABLE PEN,,,,,,,,,,INJECTION,/wk,2021,Q2,Unevaluable event,,2021,Q2,5,F,2019.0,20210415.0,20201127,20210423,EXP,,CA-ABBVIE-20K-028-3664566-00,ABBVIE,,51.0,YR,,F,Y,96.0,KG,20210423.0,,MD,CA,CA,2021,Q2,Adult
186620484,18662048,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q2,Cholecystitis,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q2,Cholelithiasis,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q2,Pleural effusion,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q2,Cholecystitis,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q2,Cholelithiasis,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q2,Pleural effusion,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",570.0,MG,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Cholecystitis,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",570.0,MG,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Cholelithiasis,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
186620484,18662048,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",570.0,MG,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Pleural effusion,,2021,Q2,4,F,20201217.0,20210324.0,20201224,20210401,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210401.0,,MD,DK,DK,2021,Q2,Elderly
187300715,18730071,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",,,,,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Bacteraemia,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",,,,,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Cholecystitis acute,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",,,,,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Postoperative abscess,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Bacteraemia,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Cholecystitis acute,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Postoperative abscess,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Bacteraemia,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Cholecystitis acute,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187300715,18730071,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Postoperative abscess,,2021,Q2,5,F,20201229.0,20210615.0,20210112,20210625,EXP,,CA-NOVOPROD-778439,NOVO NORDISK,,67.0,YR,,M,Y,90.0,KG,20210625.0,,MD,CA,CA,2021,Q2,Elderly
187325532,18732553,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Flank pain,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Pyuria,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Unresponsive to stimuli,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187938043,18793804,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,3,F,20210111.0,20210331.0,20210127,20210407,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007222,ELI LILLY AND CO,,61.0,YR,,M,Y,89.6,KG,20210407.0,,PH,US,US,2021,Q2,Adult
188681895,18868189,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Bile duct stone,,2021,Q2,5,F,20210104.0,20210604.0,20210209,20210615,EXP,,SK-NOVOPROD-784303,NOVO NORDISK,,73.0,YR,,F,Y,100.0,KG,20210615.0,,MD,SK,SK,2021,Q2,Elderly
188826854,18882685,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",60.0,MG,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q2,Cholecystitis acute,,2021,Q2,4,F,20210127.0,20210429.0,20210211,20210510,EXP,,CZ-NOVOPROD-785390,NOVO NORDISK,,73.0,YR,,M,Y,91.0,KG,20210510.0,,MD,CZ,CZ,2021,Q2,Elderly
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Asthma,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Chronic kidney disease,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Hyperlipidaemia,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Hypertension,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Lower respiratory tract infection,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Nasal congestion,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Nasopharyngitis,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Oropharyngeal pain,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Pharyngitis,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Productive cough,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Sleep apnoea syndrome,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
189119153,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q2,Urinary incontinence,,2021,Q2,3,F,,20210614.0,20210219,20210624,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Adult
190093923,19009392,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",81.152,MG,N,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Cholecystitis acute,,2021,Q2,3,F,20210226.0,20210607.0,20210315,20210617,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210617.0,,MD,GB,GB,2021,Q2,Adult
190093923,19009392,2,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q2,Cholecystitis acute,,2021,Q2,3,F,20210226.0,20210607.0,20210315,20210617,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210617.0,,MD,GB,GB,2021,Q2,Adult
190093923,19009392,3,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q2,Cholecystitis acute,,2021,Q2,3,F,20210226.0,20210607.0,20210315,20210617,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210617.0,,MD,GB,GB,2021,Q2,Adult
190093923,19009392,4,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",81.152,MG,N,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Cholecystitis acute,,2021,Q2,3,F,20210226.0,20210607.0,20210315,20210617,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210617.0,,MD,GB,GB,2021,Q2,Adult
190813184,19081318,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.5,MG,ONCE PER WEEK",3.0,MG,D,,,,209637.0,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Hyperkalaemia,,2021,Q2,4,F,20210318.0,20210610.0,20210401,20210618,EXP,,JP-NOVOPROD-797828,NOVO NORDISK,,73.0,YR,,M,Y,67.0,KG,20210618.0,,MD,JP,JP,2021,Q2,Elderly
190831671,19083167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Arthritis,,2021,Q2,1,I,,20210325.0,20210401,20210401,EXP,,CA-PFIZER INC-2021334874,PFIZER,,61.0,YR,,F,Y,,,20210401.0,,HP,CA,CA,2021,Q2,Adult
190831671,19083167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hepatic enzyme increased,,2021,Q2,1,I,,20210325.0,20210401,20210401,EXP,,CA-PFIZER INC-2021334874,PFIZER,,61.0,YR,,F,Y,,,20210401.0,,HP,CA,CA,2021,Q2,Adult
190831671,19083167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,,20210325.0,20210401,20210401,EXP,,CA-PFIZER INC-2021334874,PFIZER,,61.0,YR,,F,Y,,,20210401.0,,HP,CA,CA,2021,Q2,Adult
190864741,19086474,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Arthritis,,2021,Q2,1,I,,20210325.0,20210402,20210402,EXP,,CA-ORION CORPORATION ORION PHARMA-21_00013874,ORION,,61.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Adult
190864741,19086474,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hepatic enzyme increased,,2021,Q2,1,I,,20210325.0,20210402,20210402,EXP,,CA-ORION CORPORATION ORION PHARMA-21_00013874,ORION,,61.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Adult
190864741,19086474,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,,20210325.0,20210402,20210402,EXP,,CA-ORION CORPORATION ORION PHARMA-21_00013874,ORION,,61.0,YR,,F,Y,,,20210402.0,,HP,CA,CA,2021,Q2,Adult
190868731,19086873,2,SS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,N,,,,0.25,MG,,QW,2021,Q2,Abdominal pain,,2021,Q2,1,I,20201217.0,,20210401,20210401,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.0,KG,20210218.0,N,HP,US,US,2021,Q2,Adult
190868731,19086873,2,SS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,N,,,,0.25,MG,,QW,2021,Q2,Asthenia,,2021,Q2,1,I,20201217.0,,20210401,20210401,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.0,KG,20210218.0,N,HP,US,US,2021,Q2,Adult
190868731,19086873,2,SS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,N,,,,0.25,MG,,QW,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20201217.0,,20210401,20210401,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.0,KG,20210218.0,N,HP,US,US,2021,Q2,Adult
190868731,19086873,2,SS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,N,,,,0.25,MG,,QW,2021,Q2,Lactic acidosis,,2021,Q2,1,I,20201217.0,,20210401,20210401,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.0,KG,20210218.0,N,HP,US,US,2021,Q2,Adult
190868731,19086873,2,SS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,N,,,,0.25,MG,,QW,2021,Q2,Pancreatitis,,2021,Q2,1,I,20201217.0,,20210401,20210401,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.0,KG,20210218.0,N,HP,US,US,2021,Q2,Adult
190868731,19086873,2,SS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,N,,,,0.25,MG,,QW,2021,Q2,Polyuria,,2021,Q2,1,I,20201217.0,,20210401,20210401,DIR,,,FDA-CTU,,60.0,YR,,F,N,86.0,KG,20210218.0,N,HP,US,US,2021,Q2,Adult
190918501,19091850,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q2,Cholecystitis,,2021,Q2,1,I,20200911.0,,20210405,20210405,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
190918501,19091850,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q2,Gastrointestinal haemorrhage,,2021,Q2,1,I,20200911.0,,20210405,20210405,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
190918501,19091850,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q2,Pancreatic mass,,2021,Q2,1,I,20200911.0,,20210405,20210405,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
190964643,19096464,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Frequent bowel movements,,2021,Q2,3,F,20210325.0,20210601.0,20210406,20210610,EXP,,RS-NOVOPROD-799398,NOVO NORDISK,,73.0,YR,,M,Y,92.0,KG,20210610.0,,MD,RS,RS,2021,Q2,Elderly
190964643,19096464,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,TABLET,,2021,Q2,Frequent bowel movements,,2021,Q2,3,F,20210325.0,20210601.0,20210406,20210610,EXP,,RS-NOVOPROD-799398,NOVO NORDISK,,73.0,YR,,M,Y,92.0,KG,20210610.0,,MD,RS,RS,2021,Q2,Elderly
190964643,19096464,3,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",,,,,,,213051.0,14.0,MG,TABLET,QD,2021,Q2,Frequent bowel movements,,2021,Q2,3,F,20210325.0,20210601.0,20210406,20210610,EXP,,RS-NOVOPROD-799398,NOVO NORDISK,,73.0,YR,,M,Y,92.0,KG,20210610.0,,MD,RS,RS,2021,Q2,Elderly
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Anxiety,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Constipation,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Feeling jittery,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Food craving,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Headache,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Hormone level abnormal,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Nervousness,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Vaginal infection,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,19,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1.5 MILLIGRAM,,,,,,,,1.5,MG,SOLUTION,,2021,Q2,Vulvovaginal dryness,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Anxiety,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Constipation,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Feeling jittery,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Food craving,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Headache,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Hormone level abnormal,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Nervousness,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Vaginal infection,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191056491,19105649,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,1 MILLIGRAM,,,,,,,,1.0,MG,SOLUTION,,2021,Q2,Vulvovaginal dryness,,2021,Q2,1,I,,20210330.0,20210408,20210408,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20210408.0,,HP,CA,CA,2021,Q2,Adult
191093431,19109343,2,C,BLINDED SEMAGLUTIDE,,2,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Anaphylactic reaction,,2021,Q2,1,I,20201125.0,20210329.0,20210408,20210408,EXP,,US-JNJFOC-20210403777,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,136.0,KG,20210408.0,,HP,US,US,2021,Q2,Adult
191093431,19109343,2,C,BLINDED SEMAGLUTIDE,,2,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Drug hypersensitivity,,2021,Q2,1,I,20201125.0,20210329.0,20210408,20210408,EXP,,US-JNJFOC-20210403777,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,136.0,KG,20210408.0,,HP,US,US,2021,Q2,Adult
191093431,19109343,2,C,BLINDED SEMAGLUTIDE,,2,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Hypotension,,2021,Q2,1,I,20201125.0,20210329.0,20210408,20210408,EXP,,US-JNJFOC-20210403777,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,136.0,KG,20210408.0,,HP,US,US,2021,Q2,Adult
191227861,19122786,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,,,,,,2021,Q2,Abdominal discomfort,,2021,Q2,1,I,202006.0,20200608.0,20210412,20210412,PER,,US-CORCEPT THERAPEUTICS INC.-US-2020CRT000702,CORCEPT,,46.0,YR,,F,Y,84.81,KG,20210410.0,,CN,US,US,2021,Q2,Adult
191227861,19122786,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,,,,,,2021,Q2,Blood magnesium decreased,,2021,Q2,1,I,202006.0,20200608.0,20210412,20210412,PER,,US-CORCEPT THERAPEUTICS INC.-US-2020CRT000702,CORCEPT,,46.0,YR,,F,Y,84.81,KG,20210410.0,,CN,US,US,2021,Q2,Adult
191227861,19122786,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,,,,,,2021,Q2,Blood potassium decreased,,2021,Q2,1,I,202006.0,20200608.0,20210412,20210412,PER,,US-CORCEPT THERAPEUTICS INC.-US-2020CRT000702,CORCEPT,,46.0,YR,,F,Y,84.81,KG,20210410.0,,CN,US,US,2021,Q2,Adult
191227861,19122786,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,,,,,,2021,Q2,Flatulence,,2021,Q2,1,I,202006.0,20200608.0,20210412,20210412,PER,,US-CORCEPT THERAPEUTICS INC.-US-2020CRT000702,CORCEPT,,46.0,YR,,F,Y,84.81,KG,20210410.0,,CN,US,US,2021,Q2,Adult
191227861,19122786,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,,,,,,2021,Q2,Malaise,,2021,Q2,1,I,202006.0,20200608.0,20210412,20210412,PER,,US-CORCEPT THERAPEUTICS INC.-US-2020CRT000702,CORCEPT,,46.0,YR,,F,Y,84.81,KG,20210410.0,,CN,US,US,2021,Q2,Adult
191227861,19122786,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,202006.0,20200608.0,20210412,20210412,PER,,US-CORCEPT THERAPEUTICS INC.-US-2020CRT000702,CORCEPT,,46.0,YR,,F,Y,84.81,KG,20210410.0,,CN,US,US,2021,Q2,Adult
191227861,19122786,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,202006.0,20200608.0,20210412,20210412,PER,,US-CORCEPT THERAPEUTICS INC.-US-2020CRT000702,CORCEPT,,46.0,YR,,F,Y,84.81,KG,20210410.0,,CN,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Chest discomfort,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Chest pain,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Troponin T increased,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191322582,19132258,3,SS,BLINDED SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0MG/ML UNKNOWN,,,,,,,,,,,,2021,Q2,Vision blurred,,2021,Q2,2,F,2020.0,20210405.0,20210414,20210419,EXP,,US-ASTRAZENECA-2021A283247,ASTRAZENECA,,63.0,YR,,F,Y,129.0,KG,20210419.0,,HP,US,US,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Asthma,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Depression,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Hypoacusis,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Loss of personal independence in daily activities,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191402621,19140262,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Wheezing,,2021,Q2,1,I,,20210401.0,20210415,20210415,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20210415.0,,CN,CA,CA,2021,Q2,Adult
191475821,19147582,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q2,Alanine aminotransferase increased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q2,Aspartate aminotransferase increased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q2,Malaise,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.5 MILLIGRAM DAILY;,,,U,,,,,0.5,MG,,QD,2021,Q2,Alanine aminotransferase increased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.5 MILLIGRAM DAILY;,,,U,,,,,0.5,MG,,QD,2021,Q2,Aspartate aminotransferase increased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.5 MILLIGRAM DAILY;,,,U,,,,,0.5,MG,,QD,2021,Q2,Blood creatine phosphokinase increased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.5 MILLIGRAM DAILY;,,,U,,,,,0.5,MG,,QD,2021,Q2,Malaise,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191475821,19147582,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,.5 MILLIGRAM DAILY;,,,U,,,,,0.5,MG,,QD,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210408.0,20210416,20210416,EXP,,CA-TEVA-2021-CA-1900972,TEVA,,59.0,YR,A,F,Y,,,20210416.0,,MD,CA,CA,2021,Q2,Adult
191579791,19157979,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,SOLUTION,/wk,2021,Q2,Asthma,,2021,Q2,1,I,,20210412.0,20210420,20210420,EXP,,CA-BAUSCH-BL-2021-013368,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20210420.0,,MD,CA,CA,2021,Q2,Elderly
191579791,19157979,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,SOLUTION,/wk,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,,20210412.0,20210420,20210420,EXP,,CA-BAUSCH-BL-2021-013368,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20210420.0,,MD,CA,CA,2021,Q2,Elderly
191579791,19157979,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,SOLUTION,/wk,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210412.0,20210420,20210420,EXP,,CA-BAUSCH-BL-2021-013368,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20210420.0,,MD,CA,CA,2021,Q2,Elderly
191579791,19157979,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,SOLUTION,/wk,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210412.0,20210420,20210420,EXP,,CA-BAUSCH-BL-2021-013368,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20210420.0,,MD,CA,CA,2021,Q2,Elderly
191579791,19157979,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,SOLUTION,/wk,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210412.0,20210420,20210420,EXP,,CA-BAUSCH-BL-2021-013368,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20210420.0,,MD,CA,CA,2021,Q2,Elderly
191579791,19157979,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,SOLUTION,/wk,2021,Q2,Wheezing,,2021,Q2,1,I,,20210412.0,20210420,20210420,EXP,,CA-BAUSCH-BL-2021-013368,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20210420.0,,MD,CA,CA,2021,Q2,Elderly
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood corticotrophin increased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood potassium decreased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Thyroid disorder,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Blood corticotrophin increased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Blood potassium decreased,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Renal impairment,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191616071,19161607,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,DOSE INCREASED,,,,,,,,,,,,2021,Q2,Thyroid disorder,,2021,Q2,1,I,2020.0,20210412.0,20210421,20210421,EXP,,US-EMD SERONO-9232366,EMD SERONO INC,,60.0,YR,A,F,Y,76.0,KG,20210421.0,,CN,US,US,2021,Q2,Adult
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Extremity contracture,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Gait disturbance,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Limb discomfort,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Listless,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Pain in extremity,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Poor quality sleep,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191637272,19163727,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW",,,U,,,,,,,,/wk,2021,Q2,Sciatica,,2021,Q2,2,F,202103.0,20210528.0,20210421,20210604,EXP,,NVSC2021ES084456,NOVARTIS,,79.0,YR,,F,Y,52.6,KG,20210604.0,,HP,ES,ES,2021,Q2,Elderly
191643871,19164387,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,, UNK,,,1.0,MG,,/wk,2021,Q2,Anxiety,,2021,Q2,1,I,,20210420.0,20210421,20210421,EXP,,CA-FRESENIUS KABI-FK202104002,FRESENIUS KABI,,40.0,YR,,F,Y,,,20210421.0,,PH,CA,CA,2021,Q2,Adult
191643871,19164387,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,, UNK,,,1.0,MG,,/wk,2021,Q2,Blood thyroid stimulating hormone decreased,,2021,Q2,1,I,,20210420.0,20210421,20210421,EXP,,CA-FRESENIUS KABI-FK202104002,FRESENIUS KABI,,40.0,YR,,F,Y,,,20210421.0,,PH,CA,CA,2021,Q2,Adult
191643871,19164387,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,, UNK,,,1.0,MG,,/wk,2021,Q2,Irritability,,2021,Q2,1,I,,20210420.0,20210421,20210421,EXP,,CA-FRESENIUS KABI-FK202104002,FRESENIUS KABI,,40.0,YR,,F,Y,,,20210421.0,,PH,CA,CA,2021,Q2,Adult
191643871,19164387,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,, UNK,,,1.0,MG,,/wk,2021,Q2,Palpitations,,2021,Q2,1,I,,20210420.0,20210421,20210421,EXP,,CA-FRESENIUS KABI-FK202104002,FRESENIUS KABI,,40.0,YR,,F,Y,,,20210421.0,,PH,CA,CA,2021,Q2,Adult
191643871,19164387,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,, UNK,,,1.0,MG,,/wk,2021,Q2,Potentiating drug interaction,,2021,Q2,1,I,,20210420.0,20210421,20210421,EXP,,CA-FRESENIUS KABI-FK202104002,FRESENIUS KABI,,40.0,YR,,F,Y,,,20210421.0,,PH,CA,CA,2021,Q2,Adult
191643871,19164387,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,, UNK,,,1.0,MG,,/wk,2021,Q2,Product label issue,,2021,Q2,1,I,,20210420.0,20210421,20210421,EXP,,CA-FRESENIUS KABI-FK202104002,FRESENIUS KABI,,40.0,YR,,F,Y,,,20210421.0,,PH,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Anxiety,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Constipation,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Fatigue,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Feeling jittery,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Food craving,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Headache,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Hormone level abnormal,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Nervousness,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Urinary tract infection,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Vaginal infection,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,SOLUTION FOR INJECTION/INFUSION,QD,2021,Q2,Vulvovaginal dryness,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Anxiety,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Constipation,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Fatigue,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Feeling jittery,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Food craving,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Headache,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Hormone level abnormal,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Nervousness,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Urinary tract infection,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Vaginal infection,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191691421,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,QD,2021,Q2,Vulvovaginal dryness,,2021,Q2,1,I,,20210414.0,20210422,20210422,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20210422.0,,CN,CA,CA,2021,Q2,Adult
191713111,19171311,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,TABLET,,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,CA-JNJFOC-20210443526,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,69.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Adult
191713111,19171311,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,TABLET,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,CA-JNJFOC-20210443526,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,69.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Adult
191713111,19171311,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,TABLET,,2021,Q2,Off label use,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,CA-JNJFOC-20210443526,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,69.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Adult
191713111,19171311,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,TABLET,,2021,Q2,Product use issue,,2021,Q2,1,I,,20210419.0,20210423,20210423,EXP,,CA-JNJFOC-20210443526,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,69.0,KG,20210423.0,,HP,CA,CA,2021,Q2,Adult
191715461,19171546,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D, 00169413212,,,0.5,MG,,QW,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210328.0,,20210422,20210422,DIR,,,FDA-CTU,,74.0,YR,,M,N,83.0,KG,20210421.0,N,PH,US,US,2021,Q2,Elderly
191715461,19171546,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D, 00169413212,,,0.5,MG,,QW,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,20210328.0,,20210422,20210422,DIR,,,FDA-CTU,,74.0,YR,,M,N,83.0,KG,20210421.0,N,PH,US,US,2021,Q2,Elderly
191715461,19171546,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D, 00169413212,,,0.5,MG,,QW,2021,Q2,Hypophagia,,2021,Q2,1,I,20210328.0,,20210422,20210422,DIR,,,FDA-CTU,,74.0,YR,,M,N,83.0,KG,20210421.0,N,PH,US,US,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Alopecia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Anxiety,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Apraxia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Atrophic vulvovaginitis,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Bite,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blindness,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood chloride decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood iron decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood parathyroid hormone increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood phosphorus increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood potassium increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood pressure fluctuation,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood pressure systolic increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood sodium increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Blood urea increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Cholelithiasis,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Dry skin,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Erythema,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Faeces discoloured,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Haematocrit decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Head injury,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Headache,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Heart rate irregular,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Hepatic steatosis,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Hypophagia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Insulin-like growth factor decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Light chain analysis increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Limb discomfort,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Lymphocyte count decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Memory impairment,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Muscle spasms,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Nerve injury,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Neuropathy peripheral,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Nocturia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Osteoporosis,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Paraesthesia,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Protein urine present,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Pruritus,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Pulmonary mass,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Rash erythematous,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Red blood cell count decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Skin discolouration,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Sleep apnoea syndrome,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Sleep disorder,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Urethral caruncle,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Urinary incontinence,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Urine calcium/creatinine ratio increased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Vitamin B12 decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191817531,19181753,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q2,White blood cell count decreased,,2021,Q2,1,I,,20210413.0,20210426,20210426,EXP,,NVSC2021CA084408,NOVARTIS,,75.0,YR,,F,Y,40.0,KG,20210426.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
191860081,19186008,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW (ANNEE)",1.0,DF,Y,,,,,1.0,DF,,/wk,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210321.0,20210426.0,20210427,20210427,EXP,FR-AFSSAPS-AM20211043,NVSC2021FR094127,NOVARTIS,,61.0,YR,,F,Y,96.0,KG,20210427.0,,HP,FR,FR,2021,Q2,Adult
191860081,19186008,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW (ANNEE)",1.0,DF,Y,,,,,1.0,DF,,/wk,2021,Q2,Lactic acidosis,,2021,Q2,1,I,20210321.0,20210426.0,20210427,20210427,EXP,FR-AFSSAPS-AM20211043,NVSC2021FR094127,NOVARTIS,,61.0,YR,,F,Y,96.0,KG,20210427.0,,HP,FR,FR,2021,Q2,Adult
191860081,19186008,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW (ANNEE)",1.0,DF,Y,,,,,1.0,DF,,/wk,2021,Q2,Renal failure,,2021,Q2,1,I,20210321.0,20210426.0,20210427,20210427,EXP,FR-AFSSAPS-AM20211043,NVSC2021FR094127,NOVARTIS,,61.0,YR,,F,Y,96.0,KG,20210427.0,,HP,FR,FR,2021,Q2,Adult
191915441,19191544,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210420.0,20210429,20210429,EXP,,CA-AUROBINDO-AUR-APL-2021-016908,AUROBINDO,,71.0,YR,,M,Y,,,20210429.0,,CN,CA,CA,2021,Q2,Elderly
191950471,19195047,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,", 0.25 MILLIGRAM.",,,U,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q2,Asthma,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-099410",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20210429.0,,MD,CA,CA,2021,Q2,Elderly
191950471,19195047,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,", 0.25 MILLIGRAM.",,,U,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q2,Diabetes mellitus,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-099410",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20210429.0,,MD,CA,CA,2021,Q2,Elderly
191950471,19195047,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,", 0.25 MILLIGRAM.",,,U,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-099410",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20210429.0,,MD,CA,CA,2021,Q2,Elderly
191950471,19195047,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,", 0.25 MILLIGRAM.",,,U,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q2,Sleep disorder due to a general medical condition,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-099410",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20210429.0,,MD,CA,CA,2021,Q2,Elderly
191950471,19195047,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,", 0.25 MILLIGRAM.",,,U,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-099410",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20210429.0,,MD,CA,CA,2021,Q2,Elderly
191950471,19195047,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,", 0.25 MILLIGRAM.",,,U,U, UNKNOWN,,,0.25,MG,,/wk,2021,Q2,Wheezing,,2021,Q2,1,I,,20210421.0,20210429,20210429,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-099410",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20210429.0,,MD,CA,CA,2021,Q2,Elderly
191964855,19196485,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,5572.0,MG,Y,,,,213051.0,,,TABLET,,2021,Q2,Bile duct stone,,2021,Q2,5,F,20210420.0,20210614.0,20210429,20210624,EXP,,JP-NOVOPROD-805489,NOVO NORDISK,,51.0,YR,,M,Y,98.0,KG,20210624.0,,MD,JP,JP,2021,Q2,Adult
191964855,19196485,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,5572.0,MG,Y,,,,213051.0,,,TABLET,,2021,Q2,Bile duct stone,,2021,Q2,5,F,20210420.0,20210614.0,20210429,20210624,EXP,,JP-NOVOPROD-805489,NOVO NORDISK,,51.0,YR,,M,Y,98.0,KG,20210624.0,,MD,JP,JP,2021,Q2,Adult
191964855,19196485,3,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",5572.0,MG,Y,,,,213051.0,14.0,MG,TABLET,QD,2021,Q2,Bile duct stone,,2021,Q2,5,F,20210420.0,20210614.0,20210429,20210624,EXP,,JP-NOVOPROD-805489,NOVO NORDISK,,51.0,YR,,M,Y,98.0,KG,20210624.0,,MD,JP,JP,2021,Q2,Adult
191964855,19196485,4,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,,UNK,5572.0,MG,Y,,,,213051.0,,,TABLET,,2021,Q2,Bile duct stone,,2021,Q2,5,F,20210420.0,20210614.0,20210429,20210624,EXP,,JP-NOVOPROD-805489,NOVO NORDISK,,51.0,YR,,M,Y,98.0,KG,20210624.0,,MD,JP,JP,2021,Q2,Adult
191964855,19196485,5,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",5572.0,MG,Y,,,,213051.0,14.0,MG,TABLET,QD,2021,Q2,Bile duct stone,,2021,Q2,5,F,20210420.0,20210614.0,20210429,20210624,EXP,,JP-NOVOPROD-805489,NOVO NORDISK,,51.0,YR,,M,Y,98.0,KG,20210624.0,,MD,JP,JP,2021,Q2,Adult
192019341,19201934,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,COVID-19 pneumonia,,2021,Q2,1,I,202103.0,20210421.0,20210430,20210430,EXP,,HR-JNJFOC-20210455871,JOHNSON AND JOHNSON,,76.0,YR,E,,Y,,,20210430.0,,MD,HR,HR,2021,Q2,Elderly
192186472,19218647,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Hypotension,,2021,Q2,2,F,20210307.0,20210507.0,20210505,20210512,EXP,,CH-ANIPHARMA-2021-CH-000022,ANI,,73.0,YR,,F,Y,,,20210512.0,,HP,CH,CH,2021,Q2,Elderly
192186472,19218647,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Malaise,,2021,Q2,2,F,20210307.0,20210507.0,20210505,20210512,EXP,,CH-ANIPHARMA-2021-CH-000022,ANI,,73.0,YR,,F,Y,,,20210512.0,,HP,CH,CH,2021,Q2,Elderly
192186472,19218647,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,2,F,20210307.0,20210507.0,20210505,20210512,EXP,,CH-ANIPHARMA-2021-CH-000022,ANI,,73.0,YR,,F,Y,,,20210512.0,,HP,CH,CH,2021,Q2,Elderly
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Anxiety,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Constipation,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Feeling jittery,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Food craving,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Headache,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Hormone level abnormal,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Nervousness,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Vaginal infection,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 MG,,,,,,,,1.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Vulvovaginal dryness,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Anxiety,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Constipation,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Feeling jittery,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Food craving,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Headache,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Hormone level abnormal,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Nervousness,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Urinary tract infection,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Vaginal infection,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192221791,19222179,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG,,,,,,,,1.0,MG,SOLUTION FOR INJECTION,,2021,Q2,Vulvovaginal dryness,,2021,Q2,1,I,,20210427.0,20210506,20210506,EXP,,CA-PFIZER INC-2021476019,PFIZER,,43.0,YR,,F,Y,178.0,KG,20210506.0,,HP,CA,CA,2021,Q2,Adult
192337813,19233781,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",2604.0,MG,N,,,,213051.0,14.0,MG,TABLET,QD,2021,Q2,Gallbladder empyema,,2021,Q2,3,F,20201220.0,20210618.0,20210507,20210623,EXP,,RS-NOVOPROD-777560,NOVO NORDISK,,80.0,YR,,M,Y,70.0,KG,20210623.0,,MD,RS,RS,2021,Q2,Elderly
192351001,19235100,16,C,semaglutide,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Asthenia,,2021,Q2,1,I,20200916.0,20210428.0,20210509,20210509,PER,,US-CELGENEUS-USA-20210407858,CELGENE,,60.0,YR,,F,Y,101.5,KG,20210509.0,,PH,US,US,2021,Q2,Adult
192351001,19235100,16,C,semaglutide,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20200916.0,20210428.0,20210509,20210509,PER,,US-CELGENEUS-USA-20210407858,CELGENE,,60.0,YR,,F,Y,101.5,KG,20210509.0,,PH,US,US,2021,Q2,Adult
192351001,19235100,16,C,semaglutide,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Fatigue,,2021,Q2,1,I,20200916.0,20210428.0,20210509,20210509,PER,,US-CELGENEUS-USA-20210407858,CELGENE,,60.0,YR,,F,Y,101.5,KG,20210509.0,,PH,US,US,2021,Q2,Adult
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Alopecia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Anxiety,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Apraxia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Atrophic vulvovaginitis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Bite,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blindness,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood chloride decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood iron decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood parathyroid hormone increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood phosphorus increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood potassium increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood pressure fluctuation,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood pressure systolic increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood sodium increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Blood urea increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Cholelithiasis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Dry skin,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Erythema,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Faeces discoloured,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Haematocrit decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Head injury,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Heart rate irregular,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Hepatic steatosis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Hypophagia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Insulin-like growth factor decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Light chain analysis increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Limb discomfort,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Lymphocyte count decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Memory impairment,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Muscle spasms,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Nerve injury,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Neuropathy peripheral,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Nocturia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Osteoporosis,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Paraesthesia,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Protein urine present,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Pruritus,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Pulmonary mass,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Rash erythematous,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Red blood cell count decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Skin discolouration,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Sleep apnoea syndrome,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Sleep disorder,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Urethral caruncle,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Urinary incontinence,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Urine calcium/creatinine ratio increased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Vitamin B12 decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192429031,19242903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,White blood cell count decreased,,2021,Q2,1,I,,20210426.0,20210510,20210510,EXP,,CA-BAUSCH-BL-2021-014983,BAUSCH AND LOMB,,75.0,YR,,F,Y,40.0,KG,20210511.0,,CN,CA,CA,2021,Q2,Elderly
192431161,19243116,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210426.0,20210505.0,20210511,20210511,EXP,GB-MHRA-EYC 00248995,GB-MYLANLABS-2021M1027056,MYLAN,,54.0,YR,,F,Y,120.0,KG,20210511.0,,PH,GB,GB,2021,Q2,Adult
192431161,19243116,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210426.0,20210505.0,20210511,20210511,EXP,GB-MHRA-EYC 00248995,GB-MYLANLABS-2021M1027056,MYLAN,,54.0,YR,,F,Y,120.0,KG,20210511.0,,PH,GB,GB,2021,Q2,Adult
192431161,19243116,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,20210426.0,20210505.0,20210511,20210511,EXP,GB-MHRA-EYC 00248995,GB-MYLANLABS-2021M1027056,MYLAN,,54.0,YR,,F,Y,120.0,KG,20210511.0,,PH,GB,GB,2021,Q2,Adult
192431161,19243116,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Malaise,,2021,Q2,1,I,20210426.0,20210505.0,20210511,20210511,EXP,GB-MHRA-EYC 00248995,GB-MYLANLABS-2021M1027056,MYLAN,,54.0,YR,,F,Y,120.0,KG,20210511.0,,PH,GB,GB,2021,Q2,Adult
192431161,19243116,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,20210426.0,20210505.0,20210511,20210511,EXP,GB-MHRA-EYC 00248995,GB-MYLANLABS-2021M1027056,MYLAN,,54.0,YR,,F,Y,120.0,KG,20210511.0,,PH,GB,GB,2021,Q2,Adult
192431161,19243116,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210426.0,20210505.0,20210511,20210511,EXP,GB-MHRA-EYC 00248995,GB-MYLANLABS-2021M1027056,MYLAN,,54.0,YR,,F,Y,120.0,KG,20210511.0,,PH,GB,GB,2021,Q2,Adult
192453841,19245384,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192453841,19245384,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192453841,19245384,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192453841,19245384,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192453841,19245384,20,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192462601,19246260,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,GB-MHRA-EYC 00248995,GB-TEVA-2021-GB-1909749,TEVA,,54.0,YR,A,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192462601,19246260,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,GB-MHRA-EYC 00248995,GB-TEVA-2021-GB-1909749,TEVA,,54.0,YR,A,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192462601,19246260,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,GB-MHRA-EYC 00248995,GB-TEVA-2021-GB-1909749,TEVA,,54.0,YR,A,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192462601,19246260,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,GB-MHRA-EYC 00248995,GB-TEVA-2021-GB-1909749,TEVA,,54.0,YR,A,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192462601,19246260,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,GB-MHRA-EYC 00248995,GB-TEVA-2021-GB-1909749,TEVA,,54.0,YR,A,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192517161,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192517161,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192517161,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192517161,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192517161,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210426.0,20210505.0,20210512,20210512,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210512.0,,PH,GB,GB,2021,Q2,Adult
192589841,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210426.0,20210505.0,20210514,20210514,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210514.0,,HP,GB,GB,2021,Q2,Adult
192589841,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210426.0,20210505.0,20210514,20210514,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210514.0,,HP,GB,GB,2021,Q2,Adult
192589841,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Drug interaction,,2021,Q2,1,I,20210426.0,20210505.0,20210514,20210514,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210514.0,,HP,GB,GB,2021,Q2,Adult
192589841,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,20210426.0,20210505.0,20210514,20210514,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210514.0,,HP,GB,GB,2021,Q2,Adult
192589841,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210426.0,20210505.0,20210514,20210514,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210514.0,,HP,GB,GB,2021,Q2,Adult
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Adenocarcinoma,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Cholecystitis,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Gastrointestinal haemorrhage,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Hepatic enzyme increased,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Hyperbilirubinaemia,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Jaundice,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Nausea,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Pancreatic mass,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193651431,19365143,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,1.0,MG,,QW,2021,Q2,Vomiting,,2021,Q2,1,I,20200911.0,,20210603,20210603,DIR,,,FDA-CTU,,71.0,YR,,M,N,147.0,KG,20210304.0,N,PH,US,US,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Eyelid pain,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Lacrimation increased,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Ocular hyperaemia,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Photophobia,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Swelling face,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Swelling of eyelid,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Uveitis,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193795902,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Vision blurred,,2021,Q2,2,F,20210510.0,20210615.0,20210607,20210623,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210623.0,,HP,CA,CA,2021,Q2,Elderly
193799251,19379925,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Abdominal pain,,2021,Q2,1,I,20210225.0,,20210604,20210604,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210528.0,N,PH,US,US,2021,Q2,Elderly
193799251,19379925,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210225.0,,20210604,20210604,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210528.0,N,PH,US,US,2021,Q2,Elderly
193799251,19379925,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Nausea,,2021,Q2,1,I,20210225.0,,20210604,20210604,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210528.0,N,PH,US,US,2021,Q2,Elderly
193799251,19379925,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Pancreatic duct dilatation,,2021,Q2,1,I,20210225.0,,20210604,20210604,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210528.0,N,PH,US,US,2021,Q2,Elderly
193799251,19379925,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Pancreatitis,,2021,Q2,1,I,20210225.0,,20210604,20210604,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210528.0,N,PH,US,US,2021,Q2,Elderly
193799251,19379925,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Vomiting,,2021,Q2,1,I,20210225.0,,20210604,20210604,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210528.0,N,PH,US,US,2021,Q2,Elderly
193801981,19380198,4,C,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM (WEEKLY, SOLUTION FOR INJECTION / INFUSION)",,,,,,,,0.5,MG,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,,DE-AUROBINDO-AUR-APL-2021-022997,AUROBINDO,,65.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193801981,19380198,4,C,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM (WEEKLY, SOLUTION FOR INJECTION / INFUSION)",,,,,,,,0.5,MG,,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,,DE-AUROBINDO-AUR-APL-2021-022997,AUROBINDO,,65.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193801981,19380198,4,C,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM (WEEKLY, SOLUTION FOR INJECTION / INFUSION)",,,,,,,,0.5,MG,,,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210527.0,20210607,20210607,EXP,,DE-AUROBINDO-AUR-APL-2021-022997,AUROBINDO,,65.0,YR,,M,Y,,,20210607.0,,PH,DE,DE,2021,Q2,Elderly
193826241,19382624,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG WEEKLY,,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-05986-01,NVSC2021DE123237,NOVARTIS,,65.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193826241,19382624,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG WEEKLY,,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-05986-01,NVSC2021DE123237,NOVARTIS,,65.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193826241,19382624,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG WEEKLY,,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-ADRED-05986-01,NVSC2021DE123237,NOVARTIS,,65.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193896722,19389672,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 MG, WITH DOSE TITRATION",,,,,,,,,,,,2021,Q2,COVID-19 pneumonia,,2021,Q2,2,F,2016.0,20210610.0,20210608,20210618,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-106354",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,103.0,KG,20210618.0,,MD,HU,HU,2021,Q2,Elderly
193896722,19389672,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 MG, WITH DOSE TITRATION",,,,,,,,,,,,2021,Q2,Carbohydrate metabolism disorder,,2021,Q2,2,F,2016.0,20210610.0,20210608,20210618,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-106354",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,103.0,KG,20210618.0,,MD,HU,HU,2021,Q2,Elderly
193896722,19389672,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 MG, WITH DOSE TITRATION",,,,,,,,,,,,2021,Q2,Humerus fracture,,2021,Q2,2,F,2016.0,20210610.0,20210608,20210618,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-106354",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,103.0,KG,20210618.0,,MD,HU,HU,2021,Q2,Elderly
193896722,19389672,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 MG, WITH DOSE TITRATION",,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,2016.0,20210610.0,20210608,20210618,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-106354",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,103.0,KG,20210618.0,,MD,HU,HU,2021,Q2,Elderly
193896722,19389672,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 MG, WITH DOSE TITRATION",,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,2,F,2016.0,20210610.0,20210608,20210618,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-106354",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,103.0,KG,20210618.0,,MD,HU,HU,2021,Q2,Elderly
193896722,19389672,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 MG, WITH DOSE TITRATION",,,,,,,,,,,,2021,Q2,Sleep apnoea syndrome,,2021,Q2,2,F,2016.0,20210610.0,20210608,20210618,EXP,,"HU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-106354",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,103.0,KG,20210618.0,,MD,HU,HU,2021,Q2,Elderly
193955471,19395547,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Fournier's gangrene,,2021,Q2,1,I,20210529.0,20210602.0,20210609,20210609,EXP,GB-MHRA-EYC 00252163,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-107231",BOEHRINGER INGELHEIM,,63.0,YR,A,M,Y,,,20210609.0,,HP,GB,GB,2021,Q2,Adult
193989751,19398975,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Drug use disorder,,2021,Q2,1,I,,20210528.0,20210610,20210610,EXP,,CA-PFIZER INC-2021634002,PFIZER,,44.0,YR,,M,Y,,,20210610.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Drug use disorder,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Emotional distress,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Impaired quality of life,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Intentional product use issue,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Joint injury,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194033841,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q2,Somatic symptom disorder,,2021,Q2,1,I,,20210528.0,20210611,20210611,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20210611.0,,HP,CA,CA,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Abdominal distension,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Dyspepsia,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Flatulence,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Hunger,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Injection site pruritus,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Injection site urticaria,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194120641,19412064,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,20200328.0,20200601.0,20210614,20210614,PER,,US-COVIS PHARMA GMBH-2020COV00253,COVIS,,63.0,YR,,M,Y,88.89,KG,20210420.0,,CN,SE,US,2021,Q2,Adult
194188391,19418839,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, UNKNOWN",,,N,U,,,,0.5,MG,,,2021,Q2,Adverse food reaction,,2021,Q2,1,I,20180401.0,20210603.0,20210615,20210615,EXP,GB-MHRA-EYC 00252107,GB-ELI_LILLY_AND_COMPANY-GB202106002081,ELI LILLY AND CO,,56.0,YR,,M,Y,75.0,KG,20210615.0,,MD,GB,GB,2021,Q2,Adult
194188391,19418839,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, UNKNOWN",,,N,U,,,,0.5,MG,,,2021,Q2,Asthenia,,2021,Q2,1,I,20180401.0,20210603.0,20210615,20210615,EXP,GB-MHRA-EYC 00252107,GB-ELI_LILLY_AND_COMPANY-GB202106002081,ELI LILLY AND CO,,56.0,YR,,M,Y,75.0,KG,20210615.0,,MD,GB,GB,2021,Q2,Adult
194188391,19418839,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, UNKNOWN",,,N,U,,,,0.5,MG,,,2021,Q2,Fatigue,,2021,Q2,1,I,20180401.0,20210603.0,20210615,20210615,EXP,GB-MHRA-EYC 00252107,GB-ELI_LILLY_AND_COMPANY-GB202106002081,ELI LILLY AND CO,,56.0,YR,,M,Y,75.0,KG,20210615.0,,MD,GB,GB,2021,Q2,Adult
194188391,19418839,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, UNKNOWN",,,N,U,,,,0.5,MG,,,2021,Q2,Folate deficiency,,2021,Q2,1,I,20180401.0,20210603.0,20210615,20210615,EXP,GB-MHRA-EYC 00252107,GB-ELI_LILLY_AND_COMPANY-GB202106002081,ELI LILLY AND CO,,56.0,YR,,M,Y,75.0,KG,20210615.0,,MD,GB,GB,2021,Q2,Adult
194188391,19418839,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, UNKNOWN",,,N,U,,,,0.5,MG,,,2021,Q2,Myalgia,,2021,Q2,1,I,20180401.0,20210603.0,20210615,20210615,EXP,GB-MHRA-EYC 00252107,GB-ELI_LILLY_AND_COMPANY-GB202106002081,ELI LILLY AND CO,,56.0,YR,,M,Y,75.0,KG,20210615.0,,MD,GB,GB,2021,Q2,Adult
194188391,19418839,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, UNKNOWN",,,N,U,,,,0.5,MG,,,2021,Q2,Vitamin D deficiency,,2021,Q2,1,I,20180401.0,20210603.0,20210615,20210615,EXP,GB-MHRA-EYC 00252107,GB-ELI_LILLY_AND_COMPANY-GB202106002081,ELI LILLY AND CO,,56.0,YR,,M,Y,75.0,KG,20210615.0,,MD,GB,GB,2021,Q2,Adult
194188391,19418839,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, UNKNOWN",,,N,U,,,,0.5,MG,,,2021,Q2,Weight decreased,,2021,Q2,1,I,20180401.0,20210603.0,20210615,20210615,EXP,GB-MHRA-EYC 00252107,GB-ELI_LILLY_AND_COMPANY-GB202106002081,ELI LILLY AND CO,,56.0,YR,,M,Y,75.0,KG,20210615.0,,MD,GB,GB,2021,Q2,Adult
194255701,19425570,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4,MG,ONCE PER WEEK",,,,,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Cholecystitis acute,,2021,Q2,1,I,20210313.0,20210521.0,20210617,20210617,EXP,,AT-NOVOPROD-815524,NOVO NORDISK,,47.0,YR,,F,Y,100.0,KG,20210617.0,,MD,AT,AT,2021,Q2,Adult
194255701,19425570,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4,MG,ONCE PER WEEK",,,,,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Cholelithiasis,,2021,Q2,1,I,20210313.0,20210521.0,20210617,20210617,EXP,,AT-NOVOPROD-815524,NOVO NORDISK,,47.0,YR,,F,Y,100.0,KG,20210617.0,,MD,AT,AT,2021,Q2,Adult
194255701,19425570,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4,MG,ONCE PER WEEK",,,,,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Gallbladder necrosis,,2021,Q2,1,I,20210313.0,20210521.0,20210617,20210617,EXP,,AT-NOVOPROD-815524,NOVO NORDISK,,47.0,YR,,F,Y,100.0,KG,20210617.0,,MD,AT,AT,2021,Q2,Adult
194325551,19432555,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Bronchitis,,2021,Q2,1,I,20210608.0,20210609.0,20210618,20210618,PER,,US-BEH-2021132819,CSL BEHRING,,64.0,YR,A,F,Y,,,20210618.0,,HP,US,US,2021,Q2,Adult
194325551,19432555,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,No adverse event,,2021,Q2,1,I,20210608.0,20210609.0,20210618,20210618,PER,,US-BEH-2021132819,CSL BEHRING,,64.0,YR,A,F,Y,,,20210618.0,,HP,US,US,2021,Q2,Adult
194325551,19432555,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,20210608.0,20210609.0,20210618,20210618,PER,,US-BEH-2021132819,CSL BEHRING,,64.0,YR,A,F,Y,,,20210618.0,,HP,US,US,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Asthma,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Chronic kidney disease,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Hyperlipidaemia,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Hypertension,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Lower respiratory tract infection,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Nasal congestion,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Oropharyngeal pain,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Pharyngitis,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Productive cough,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Sleep apnoea syndrome,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194391741,19439174,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q2,Urinary incontinence,,2021,Q2,1,I,,20210614.0,20210618,20210618,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210618.0,,MD,CA,CA,2021,Q2,Adult
194407391,19440739,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4,MG,ONCE PER WEEK",63.777,MG,Y,,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Gastroenteritis,,2021,Q2,1,I,20210118.0,20210204.0,20210621,20210621,EXP,,US-NOVOPROD-785740,NOVO NORDISK,,48.0,YR,,F,Y,109.0,KG,20210621.0,,MD,US,US,2021,Q2,Adult
194407391,19440739,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4,MG,ONCE PER WEEK",63.777,MG,Y,,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Nausea,,2021,Q2,1,I,20210118.0,20210204.0,20210621,20210621,EXP,,US-NOVOPROD-785740,NOVO NORDISK,,48.0,YR,,F,Y,109.0,KG,20210621.0,,MD,US,US,2021,Q2,Adult
194416611,19441661,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4 MG, QW",,,,,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Bile duct stone,,2021,Q2,1,I,20210403.0,20210610.0,20210621,20210621,EXP,,US-NOVOPROD-820671,NOVO NORDISK,,65.0,YR,,M,Y,92.0,KG,20210621.0,,MD,US,US,2021,Q2,Elderly
194470851,19447085,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Abdominal distension,,2021,Q2,1,I,20210504.0,,20210621,20210621,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.0,KG,20210518.0,N,PH,US,US,2021,Q2,Adult
194470851,19447085,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Abdominal pain,,2021,Q2,1,I,20210504.0,,20210621,20210621,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.0,KG,20210518.0,N,PH,US,US,2021,Q2,Adult
194470851,19447085,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210504.0,,20210621,20210621,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.0,KG,20210518.0,N,PH,US,US,2021,Q2,Adult
194470851,19447085,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210504.0,,20210621,20210621,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.0,KG,20210518.0,N,PH,US,US,2021,Q2,Adult
194470851,19447085,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Hypophagia,,2021,Q2,1,I,20210504.0,,20210621,20210621,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.0,KG,20210518.0,N,PH,US,US,2021,Q2,Adult
194470851,19447085,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,0.5,MG,,QW,2021,Q2,Urine output increased,,2021,Q2,1,I,20210504.0,,20210621,20210621,DIR,,,FDA-CTU,,58.0,YR,,M,N,106.0,KG,20210518.0,N,PH,US,US,2021,Q2,Adult
194479551,19447955,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,"?          OTHER STRENGTH:0.5MG/0.75ML, 1.5M;?",,,,,,,,0.5,MG,INJECTION,QW,2021,Q2,Cough,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194479551,19447955,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,"?          OTHER STRENGTH:0.5MG/0.75ML, 1.5M;?",,,,,,,,0.5,MG,INJECTION,QW,2021,Q2,Nausea,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194479551,19447955,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,"?          OTHER STRENGTH:0.5MG/0.75ML, 1.5M;?",,,,,,,,0.5,MG,INJECTION,QW,2021,Q2,Vomiting,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194479551,19447955,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN, 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,"?          OTHER STRENGTH:0.5MG/0.75ML, 1.5M;?",,,,,,,,0.5,MG,INJECTION,QW,2021,Q2,Wheezing,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194479891,19447989,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q2,Cough,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194479891,19447989,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q2,Nausea,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194479891,19447989,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q2,Vomiting,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194479891,19447989,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q2,Wheezing,,2021,Q2,1,I,20210618.0,,20210621,20210621,DIR,,,FDA-CTU,,70.0,YR,,M,N,,,20210618.0,N,PH,US,US,2021,Q2,Elderly
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Abdominal pain upper,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Acne cystic,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Allergy to chemicals,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Alopecia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Anaphylactic shock,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Anxiety,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Arthropod bite,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Arthropod sting,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Asthma,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Back pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Blood pressure increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,C-reactive protein increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chest discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chest pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chills,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Choking,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Claustrophobia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Cough,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Diplopia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Dizziness,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Electrocardiogram T wave abnormal,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Eye pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Fatigue,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Fibromyalgia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Food allergy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Gastrointestinal motility disorder,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Headache,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Hypersensitivity,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Illness,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Infection,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Influenza,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Injection site discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Injection site pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Insomnia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lethargy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract infection,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lymphadenopathy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Malaise,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Muscle spasms,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nasal congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nausea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oedema peripheral,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Optic neuritis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oropharyngeal pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oxygen saturation decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Paranasal sinus discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Platelet count increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Product dose omission issue,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Productive cough,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pruritus,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Psoriasis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Rash,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Red cell distribution width increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Respiratory tract congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Sinusitis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Swelling,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Throat irritation,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Vision blurred,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Vomiting,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Wheezing,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Abdominal pain upper,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Acne cystic,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Allergy to chemicals,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Alopecia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Anaphylactic shock,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Anxiety,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Arthropod bite,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Arthropod sting,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Asthma,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Back pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Blood pressure increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,C-reactive protein increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chest discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chest pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chills,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Choking,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Claustrophobia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Cough,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Diplopia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Dizziness,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Electrocardiogram T wave abnormal,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Eye pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Fatigue,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Fibromyalgia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Food allergy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Gastrointestinal motility disorder,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Headache,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Hypersensitivity,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Illness,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Infection,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Influenza,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Injection site discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Injection site pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Insomnia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lethargy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract infection,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lymphadenopathy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Malaise,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Muscle spasms,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nasal congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nausea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oedema peripheral,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Optic neuritis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oropharyngeal pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oxygen saturation decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Paranasal sinus discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Platelet count increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Product dose omission issue,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Productive cough,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pruritus,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Psoriasis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Rash,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Red cell distribution width increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Respiratory tract congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Sinusitis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Swelling,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Throat irritation,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Vision blurred,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Vomiting,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Wheezing,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Abdominal pain upper,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Acne cystic,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Allergy to chemicals,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Alopecia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Anaphylactic shock,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Anxiety,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Arthropod bite,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Arthropod sting,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Asthma,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Back pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Balance disorder,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Blood pressure increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,C-reactive protein increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chest discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chest pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Chills,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Choking,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Claustrophobia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Cough,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Diplopia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Dizziness,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Electrocardiogram T wave abnormal,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Eye pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Fatigue,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Fibromyalgia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Food allergy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Gastrointestinal motility disorder,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Haemoptysis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Headache,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Hypersensitivity,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Illness,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Infection,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Influenza,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Injection site discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Injection site pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Insomnia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lethargy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lower respiratory tract infection,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Lymphadenopathy,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Malaise,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Mean cell haemoglobin decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Muscle spasms,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nasal congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Nausea,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oedema peripheral,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Optic neuritis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oropharyngeal pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Oxygen saturation decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pain,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pain in extremity,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Paranasal sinus discomfort,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Platelet count increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Product dose omission issue,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Productive cough,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pruritus,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Psoriasis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Rash,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Red cell distribution width increased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Respiratory tract congestion,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Sinusitis,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Swelling,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Throat irritation,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Vision blurred,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Vomiting,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194583361,19458336,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DOSAGE FORM, QW (1 EVERY 1 WEEKS)",,,,,,,,1.0,DF,,/wk,2021,Q2,Wheezing,,2021,Q2,1,I,,20210616.0,20210624,20210624,EXP,,CA-MYLANLABS-2021M1036029,MYLAN,,34.0,YR,,F,Y,,,20210624.0,,CN,CA,CA,2021,Q2,Young Adult
194587631,19458763,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ,SOLN,PEN,1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q2,Pancreatitis acute,,2021,Q2,1,I,20200701.0,,20210625,20210625,DIR,,,FDA-CTU,,54.0,YR,,M,N,,,20210623.0,N,PH,US,US,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Asthma,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Hyperlipidaemia,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Lower respiratory tract infection,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Nasal congestion,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Oropharyngeal pain,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Pharyngitis,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Productive cough,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Sleep apnoea syndrome,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Type 2 diabetes mellitus,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194588311,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q2,Urinary incontinence,,2021,Q2,1,I,,20210614.0,20210624,20210624,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210624.0,,MD,CA,CA,2021,Q2,Adult
194672961,19467296,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20201005.0,20201012.0,20210628,20210628,EXP,,CA-NOVOPROD-759942,NOVO NORDISK,,78.0,YR,,M,Y,121.0,KG,20210628.0,,MD,CA,CA,2021,Q2,Elderly
194672961,19467296,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Bile duct stone,,2021,Q2,1,I,20201005.0,20201012.0,20210628,20210628,EXP,,CA-NOVOPROD-759942,NOVO NORDISK,,78.0,YR,,M,Y,121.0,KG,20210628.0,,MD,CA,CA,2021,Q2,Elderly
194672961,19467296,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Jaundice cholestatic,,2021,Q2,1,I,20201005.0,20201012.0,20210628,20210628,EXP,,CA-NOVOPROD-759942,NOVO NORDISK,,78.0,YR,,M,Y,121.0,KG,20210628.0,,MD,CA,CA,2021,Q2,Elderly
194672961,19467296,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q2,Pancreatic carcinoma metastatic,,2021,Q2,1,I,20201005.0,20201012.0,20210628,20210628,EXP,,CA-NOVOPROD-759942,NOVO NORDISK,,78.0,YR,,M,Y,121.0,KG,20210628.0,,MD,CA,CA,2021,Q2,Elderly
194765461,19476546,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210617.0,20210630,20210630,EXP,DE-BFARM-21005205,DE-ACCORD-229882,ACCORD,,65.0,YR,A,M,Y,,,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194765461,19476546,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210617.0,20210630,20210630,EXP,DE-BFARM-21005205,DE-ACCORD-229882,ACCORD,,65.0,YR,A,M,Y,,,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194765461,19476546,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,1,I,,20210617.0,20210630,20210630,EXP,DE-BFARM-21005205,DE-ACCORD-229882,ACCORD,,65.0,YR,A,M,Y,,,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194772411,19477241,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,QW,2021,Q2,Pancreatitis,,2021,Q2,1,I,20210610.0,,20210630,20210630,DIR,,,FDA-CTU,,72.0,YR,,M,N,,,20210629.0,N,,US,US,2021,Q2,Elderly
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Amnesia,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Anaemia,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Asthenia,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Balance disorder,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Bladder prolapse,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Blood glucose abnormal,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Blood lactic acid increased,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Cataract,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Cognitive disorder,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Colonoscopy,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Condition aggravated,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Decreased appetite,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Disturbance in attention,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Dizziness,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Eating disorder,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Fall,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Haematemesis,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Headache,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Hiatus hernia,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Hypoglycaemia,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Hypotension,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Impaired gastric emptying,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Incision site complication,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Infusion site pain,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Lid sulcus deepened,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Multiple sclerosis relapse,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Muscle atrophy,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Nausea,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Nervousness,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Peroneal nerve palsy,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Psychomotor hyperactivity,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Surgery,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Syncope,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Thrombosis,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Urinary bladder suspension,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Vaginoplasty,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Vomiting,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
1525613011,15256130,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,11,F,2017.0,20210809.0,20180808,20210812,EXP,,CA-SA-2018SA207305,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210812.0,,HP,CA,CA,2021,Q3,Adult
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Alopecia,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Anxiety,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Apraxia,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Atrophic vulvovaginitis,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Balance disorder,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Bite,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blindness,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood chloride decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood creatinine increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood iron decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood parathyroid hormone increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood phosphorus increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood potassium increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood pressure decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood pressure fluctuation,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood pressure increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood pressure systolic increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood sodium increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Blood urea increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Cholelithiasis,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Dry skin,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Erythema,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Faeces discoloured,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Fall,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Haematocrit decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Haemoglobin decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Head injury,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Headache,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Heart rate irregular,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Hepatic steatosis,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Hypophagia,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Insulin-like growth factor decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Joint swelling,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Lethargy,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Light chain analysis increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Limb discomfort,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Lymphocyte count decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Memory impairment,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Muscle spasms,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Muscular weakness,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Nerve injury,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Neuropathy peripheral,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Nocturia,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Osteoporosis,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Paraesthesia,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Peripheral swelling,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Protein urine present,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Pruritus,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Pulmonary mass,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Rash erythematous,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Red blood cell count decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Skin discolouration,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Sleep apnoea syndrome,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Sleep disorder,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Urethral caruncle,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Urinary incontinence,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Urine calcium/creatinine ratio increased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Vitamin B12 decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
170962883,17096288,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2021,Q3,White blood cell count decreased,,2021,Q3,3,F,,20210628.0,20191202,20210713,EXP,,CA-APOTEX-2019AP025459,APOTEX,,75.0,YR,,F,Y,40.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
172068055,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q3,Malaise,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, QD",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Malaise,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, Q.WK.",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Alanine aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, Q.WK.",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, Q.WK.",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, Q.WK.",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Malaise,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MILLIGRAM, Q.WK.",,,U,,,,,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Weight decreased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Alanine aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Malaise,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
172068055,17206805,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Weight decreased,,2021,Q3,5,F,,20210810.0,20191227,20210818,EXP,,CA-APOTEX-2019AP026426,APOTEX,,59.0,YR,,F,Y,,,20210818.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Angina pectoris,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Appetite disorder,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Asthma,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Chest discomfort,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Chest pain,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Cough,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Depressed mood,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Depressive symptom,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Dyspnoea,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Dyspnoea exertional,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Fall,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Flank pain,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Heart sounds,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Influenza,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Injury,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Insomnia,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Lower respiratory tract infection,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Nasal congestion,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Productive cough,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Prolonged expiration,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Pyrexia,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Rales,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Respiration abnormal,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Rhinorrhoea,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Stress,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Upper respiratory tract infection,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
175684663,17568466,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Wheezing,,2021,Q3,3,F,,20210913.0,20200320,20210921,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20210921.0,,HP,CA,CA,2021,Q3,Adult
181821725,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q3,Drug hypersensitivity,,2021,Q3,5,F,20180801.0,20210907.0,20200821,20210910,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210910.0,,HP,CA,CA,2021,Q3,Elderly
181821725,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q3,Incorrect dose administered,,2021,Q3,5,F,20180801.0,20210907.0,20200821,20210910,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210910.0,,HP,CA,CA,2021,Q3,Elderly
181821725,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q3,Metastases to bone,,2021,Q3,5,F,20180801.0,20210907.0,20200821,20210910,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210910.0,,HP,CA,CA,2021,Q3,Elderly
181821725,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q3,Oedema peripheral,,2021,Q3,5,F,20180801.0,20210907.0,20200821,20210910,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210910.0,,HP,CA,CA,2021,Q3,Elderly
181821725,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q3,Off label use,,2021,Q3,5,F,20180801.0,20210907.0,20200821,20210910,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210910.0,,HP,CA,CA,2021,Q3,Elderly
181821725,18182172,2,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2021,Q3,Weight decreased,,2021,Q3,5,F,20180801.0,20210907.0,20200821,20210910,EXP,,CA-JNJFOC-20191109429,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,158.9,KG,20210910.0,,HP,CA,CA,2021,Q3,Elderly
182379972,18237997,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q3,Alanine aminotransferase increased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q3,Malaise,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,QD,2021,Q3,Weight decreased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q3,Alanine aminotransferase increased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q3,Malaise,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182379972,18237997,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,QD,2021,Q3,Weight decreased,,2021,Q3,2,F,20181006.0,20210916.0,20200907,20210923,EXP,,CA-ASTRAZENECA-2020SF11850,ASTRAZENECA,,59.0,YR,,F,Y,,,20210923.0,,MD,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Angina pectoris,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Appetite disorder,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Asthma,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Chest discomfort,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Chest pain,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Cough,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Depressed mood,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Depressive symptom,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Dyspnoea,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Dyspnoea exertional,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Fall,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Flank pain,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Heart sounds,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Influenza,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Injury,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Insomnia,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Lower respiratory tract infection,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Nasal congestion,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Productive cough,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Prolonged expiration,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Pyrexia,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Rales,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Respiration abnormal,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Rhinorrhoea,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Stress,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Upper respiratory tract infection,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
182808893,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U, UNKNOWN,,,1.25,MG,,/wk,2021,Q3,Wheezing,,2021,Q3,3,F,,20210907.0,20200918,20210917,EXP,,CA-DRREDDYS-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20210917.0,,HP,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Angina pectoris,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Appetite disorder,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Asthma,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Chest discomfort,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Chest pain,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cough,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Depressed mood,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Depressive symptom,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Dyspnoea,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Dyspnoea exertional,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Fall,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Flank pain,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Heart sounds,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Influenza,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Injury,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Insomnia,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Lower respiratory tract infection,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Malaise,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Nasal congestion,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Productive cough,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Prolonged expiration,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Pyrexia,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Rales,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Respiration abnormal,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Rhinorrhoea,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Stress,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Upper respiratory tract infection,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Weight decreased,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183019475,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, Q.WK.",,,U,,,,,1.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Wheezing,,2021,Q3,5,F,,20210913.0,20200923,20210920,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20210920.0,,CN,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Asthma,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Chronic kidney disease,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Hyperlipidaemia,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Hypertension,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Lower respiratory tract infection,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Nasal congestion,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Nasopharyngitis,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Oropharyngeal pain,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Pharyngitis,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Productive cough,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Sleep apnoea syndrome,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
183089516,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, QD",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,,2021,Q3,Urinary incontinence,,2021,Q3,6,F,,20210727.0,20200924,20210806,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20210806.0,,MD,CA,CA,2021,Q3,Adult
186086835,18608683,1,PS,Semaglutide 7 mg,SEMAGLUTIDE,1,Oral,",MG,ONCE PER DAY",,,,,,,213051.0,,,TABLET,,2021,Q3,Cholecystitis acute,,2021,Q3,5,F,20201102.0,20210910.0,20201213,20210921,EXP,,UA-NOVOPROD-771731,NOVO NORDISK,,66.0,YR,,F,Y,82.0,KG,20210921.0,,MD,UA,UA,2021,Q3,Elderly
186086835,18608683,1,PS,Semaglutide 7 mg,SEMAGLUTIDE,1,Oral,",MG,ONCE PER DAY",,,,,,,213051.0,,,TABLET,,2021,Q3,Cholelithiasis,,2021,Q3,5,F,20201102.0,20210910.0,20201213,20210921,EXP,,UA-NOVOPROD-771731,NOVO NORDISK,,66.0,YR,,F,Y,82.0,KG,20210921.0,,MD,UA,UA,2021,Q3,Elderly
186620485,18662048,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3 MG, QD",570.0,MG,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q3,Cholecystitis,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3 MG, QD",570.0,MG,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q3,Cholelithiasis,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3 MG, QD",570.0,MG,N,,,,213051.0,3.0,MG,TABLET,QD,2021,Q3,Pleural effusion,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q3,Cholecystitis,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q3,Cholelithiasis,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,2,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q3,Pleural effusion,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q3,Cholecystitis,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q3,Cholelithiasis,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
186620485,18662048,3,SS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,UNK,570.0,MG,N,,,,213051.0,,,TABLET,,2021,Q3,Pleural effusion,,2021,Q3,5,F,20201217.0,20210914.0,20201224,20210922,EXP,,DK-NOVOPROD-775362,NOVO NORDISK,,79.0,YR,,M,Y,89.0,KG,20210922.0,,MD,DK,DK,2021,Q3,Elderly
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Breast tenderness,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Device breakage,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Device issue,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Insomnia,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Nipple pain,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Product adhesion issue,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Product physical issue,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Product quality issue,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Product residue present,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Product use in unapproved indication,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
187961353,18796135,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 UNK,,,,,,,,,,,,2021,Q3,Therapeutic product ineffective,,2021,Q3,3,F,202011.0,20210723.0,20210127,20210806,EXP,,NVSC2021US011291,NOVARTIS,,58.0,YR,,F,Y,102.04,KG,20210806.0,,CN,US,US,2021,Q3,Adult
188826855,18882685,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",60.0,MG,Y,,,,213051.0,3.0,MG,TABLET,QD,2021,Q3,Cholecystitis acute,,2021,Q3,5,F,20210127.0,20210713.0,20210211,20210726,EXP,,CZ-NOVOPROD-785390,NOVO NORDISK,,73.0,YR,,M,Y,91.0,KG,20210726.0,,MD,CZ,CZ,2021,Q3,Elderly
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Asthma,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Chronic kidney disease,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Hypertension,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Nasal congestion,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Nasopharyngitis,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Pharyngitis,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Productive cough,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189119154,18911915,13,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, ONCE A DAY",,,U,U,,,,0.25,MG,,QD,2021,Q3,Urinary incontinence,,2021,Q3,4,F,,20210716.0,20210219,20210730,EXP,,CA-AUROBINDO-AUR-APL-2021-006172,AUROBINDO,,51.0,YR,,F,Y,,,20210730.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Asthma,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Chronic kidney disease,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Hypertension,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Nasal congestion,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Nasopharyngitis,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Pharyngitis,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Productive cough,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
189476232,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U, UNKNOWN,,,0.25,MG,,QD,2021,Q3,Urinary incontinence,,2021,Q3,2,F,,20210719.0,20210226,20210720,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20210720.0,,CN,CA,CA,2021,Q3,Adult
190093924,19009392,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0 MG, QW",81.152,MG,N,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholecystitis acute,,2021,Q3,4,F,20210226.0,20210909.0,20210315,20210916,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210916.0,,MD,GB,GB,2021,Q3,Adult
190093924,19009392,2,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q3,Cholecystitis acute,,2021,Q3,4,F,20210226.0,20210909.0,20210315,20210916,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210916.0,,MD,GB,GB,2021,Q3,Adult
190093924,19009392,3,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q3,Cholecystitis acute,,2021,Q3,4,F,20210226.0,20210909.0,20210315,20210916,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210916.0,,MD,GB,GB,2021,Q3,Adult
190093924,19009392,4,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q3,Cholecystitis acute,,2021,Q3,4,F,20210226.0,20210909.0,20210315,20210916,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210916.0,,MD,GB,GB,2021,Q3,Adult
190093924,19009392,5,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,81.152,MG,N,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q3,Cholecystitis acute,,2021,Q3,4,F,20210226.0,20210909.0,20210315,20210916,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20210916.0,,MD,GB,GB,2021,Q3,Adult
190203573,19020357,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",770.0,MG,Y,,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Cholecystitis,,2021,Q3,3,F,20210126.0,20210713.0,20210317,20210723,EXP,,IN-NOVOPROD-788369,NOVO NORDISK,,55.0,YR,,M,Y,73.0,KG,20210723.0,,MD,IN,IN,2021,Q3,Adult
190874958,19087495,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",1596.0,MG,Y,,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Obstructive pancreatitis,,2021,Q3,8,F,20210325.0,20210830.0,20210402,20210906,EXP,,MX-NOVOPROD-799179,NOVO NORDISK,,63.0,YR,,F,Y,62.0,KG,20210906.0,,MD,MX,MX,2021,Q3,Adult
191513176,19151317,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",7700.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Acute kidney injury,,2021,Q3,6,F,20210330.0,20210714.0,20210419,20210726,EXP,,US-NOVOPROD-801615,NOVO NORDISK,,71.0,YR,,M,Y,161.0,KG,20210726.0,,MD,US,US,2021,Q3,Elderly
191513176,19151317,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",7700.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Cholecystitis acute,,2021,Q3,6,F,20210330.0,20210714.0,20210419,20210726,EXP,,US-NOVOPROD-801615,NOVO NORDISK,,71.0,YR,,M,Y,161.0,KG,20210726.0,,MD,US,US,2021,Q3,Elderly
191513176,19151317,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",7700.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Cholelithiasis,,2021,Q3,6,F,20210330.0,20210714.0,20210419,20210726,EXP,,US-NOVOPROD-801615,NOVO NORDISK,,71.0,YR,,M,Y,161.0,KG,20210726.0,,MD,US,US,2021,Q3,Elderly
191513176,19151317,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",7700.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Acute kidney injury,,2021,Q3,6,F,20210330.0,20210714.0,20210419,20210726,EXP,,US-NOVOPROD-801615,NOVO NORDISK,,71.0,YR,,M,Y,161.0,KG,20210726.0,,MD,US,US,2021,Q3,Elderly
191513176,19151317,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",7700.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Cholecystitis acute,,2021,Q3,6,F,20210330.0,20210714.0,20210419,20210726,EXP,,US-NOVOPROD-801615,NOVO NORDISK,,71.0,YR,,M,Y,161.0,KG,20210726.0,,MD,US,US,2021,Q3,Elderly
191513176,19151317,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"14 MG, QD",7700.0,MG,Y,N,,,213051.0,14.0,MG,TABLET,QD,2021,Q3,Cholelithiasis,,2021,Q3,6,F,20210330.0,20210714.0,20210419,20210726,EXP,,US-NOVOPROD-801615,NOVO NORDISK,,71.0,YR,,M,Y,161.0,KG,20210726.0,,MD,US,US,2021,Q3,Elderly
191562703,19156270,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.5,MG,ONCE PER WEEK",,,,,,,209637.0,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholecystitis acute,,2021,Q3,3,F,20201229.0,20210628.0,20210420,20210707,EXP,,RO-NOVOPROD-802761,NOVO NORDISK,,67.0,YR,,F,Y,76.0,KG,20210707.0,,MD,RO,RO,2021,Q3,Elderly
191562703,19156270,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.5,MG,ONCE PER WEEK",,,,,,,209637.0,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholelithiasis,,2021,Q3,3,F,20201229.0,20210628.0,20210420,20210707,EXP,,RO-NOVOPROD-802761,NOVO NORDISK,,67.0,YR,,F,Y,76.0,KG,20210707.0,,MD,RO,RO,2021,Q3,Elderly
191773574,19177357,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 MILLIGRAM, QD",66.0,MG,D,,,,,3.0,MG,TABLET,QD,2021,Q3,Constipation,,2021,Q3,4,F,20210419.0,20210625.0,20210425,20210705,EXP,,JP-009507513-2104JPN001292J,MERCK,,73.0,YR,,F,Y,,,20210705.0,,CN,JP,JP,2021,Q3,Elderly
191773574,19177357,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 MILLIGRAM, QD",66.0,MG,D,,,,,3.0,MG,TABLET,QD,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,4,F,20210419.0,20210625.0,20210425,20210705,EXP,,JP-009507513-2104JPN001292J,MERCK,,73.0,YR,,F,Y,,,20210705.0,,CN,JP,JP,2021,Q3,Elderly
192387533,19238753,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,3,F,20210426.0,20210722.0,20210510,20210723,EXP,GB-MHRA-EYC 00248995,GB-GLAXOSMITHKLINE-GBCH2021025576,GLAXOSMITHKLINE,,54.0,YR,,F,Y,120.0,KG,20210723.0,,CN,US,GB,2021,Q3,Adult
192387533,19238753,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,3,F,20210426.0,20210722.0,20210510,20210723,EXP,GB-MHRA-EYC 00248995,GB-GLAXOSMITHKLINE-GBCH2021025576,GLAXOSMITHKLINE,,54.0,YR,,F,Y,120.0,KG,20210723.0,,CN,US,GB,2021,Q3,Adult
192387533,19238753,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,3,F,20210426.0,20210722.0,20210510,20210723,EXP,GB-MHRA-EYC 00248995,GB-GLAXOSMITHKLINE-GBCH2021025576,GLAXOSMITHKLINE,,54.0,YR,,F,Y,120.0,KG,20210723.0,,CN,US,GB,2021,Q3,Adult
192387533,19238753,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Malaise,,2021,Q3,3,F,20210426.0,20210722.0,20210510,20210723,EXP,GB-MHRA-EYC 00248995,GB-GLAXOSMITHKLINE-GBCH2021025576,GLAXOSMITHKLINE,,54.0,YR,,F,Y,120.0,KG,20210723.0,,CN,US,GB,2021,Q3,Adult
192387533,19238753,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,3,F,20210426.0,20210722.0,20210510,20210723,EXP,GB-MHRA-EYC 00248995,GB-GLAXOSMITHKLINE-GBCH2021025576,GLAXOSMITHKLINE,,54.0,YR,,F,Y,120.0,KG,20210723.0,,CN,US,GB,2021,Q3,Adult
192387533,19238753,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,3,F,20210426.0,20210722.0,20210510,20210723,EXP,GB-MHRA-EYC 00248995,GB-GLAXOSMITHKLINE-GBCH2021025576,GLAXOSMITHKLINE,,54.0,YR,,F,Y,120.0,KG,20210723.0,,CN,US,GB,2021,Q3,Adult
192421852,19242185,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,20210426.0,20210712.0,20210511,20210715,EXP,GB-MHRA-EYC 00248995,GB-STRIDES ARCOLAB LIMITED-2021SP005259,STRIDES,,54.0,YR,,F,Y,120.0,KG,20210715.0,,HP,GB,GB,2021,Q3,Adult
192421852,19242185,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,2,F,20210426.0,20210712.0,20210511,20210715,EXP,GB-MHRA-EYC 00248995,GB-STRIDES ARCOLAB LIMITED-2021SP005259,STRIDES,,54.0,YR,,F,Y,120.0,KG,20210715.0,,HP,GB,GB,2021,Q3,Adult
192421852,19242185,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,20210426.0,20210712.0,20210511,20210715,EXP,GB-MHRA-EYC 00248995,GB-STRIDES ARCOLAB LIMITED-2021SP005259,STRIDES,,54.0,YR,,F,Y,120.0,KG,20210715.0,,HP,GB,GB,2021,Q3,Adult
192421852,19242185,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Malaise,,2021,Q3,2,F,20210426.0,20210712.0,20210511,20210715,EXP,GB-MHRA-EYC 00248995,GB-STRIDES ARCOLAB LIMITED-2021SP005259,STRIDES,,54.0,YR,,F,Y,120.0,KG,20210715.0,,HP,GB,GB,2021,Q3,Adult
192421852,19242185,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,20210426.0,20210712.0,20210511,20210715,EXP,GB-MHRA-EYC 00248995,GB-STRIDES ARCOLAB LIMITED-2021SP005259,STRIDES,,54.0,YR,,F,Y,120.0,KG,20210715.0,,HP,GB,GB,2021,Q3,Adult
192421852,19242185,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,20210426.0,20210712.0,20210511,20210715,EXP,GB-MHRA-EYC 00248995,GB-STRIDES ARCOLAB LIMITED-2021SP005259,STRIDES,,54.0,YR,,F,Y,120.0,KG,20210715.0,,HP,GB,GB,2021,Q3,Adult
192453842,19245384,21,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,20210426.0,20210711.0,20210512,20210721,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210721.0,,HP,GB,GB,2021,Q3,Adult
192453842,19245384,21,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,2,F,20210426.0,20210711.0,20210512,20210721,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210721.0,,HP,GB,GB,2021,Q3,Adult
192453842,19245384,21,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,20210426.0,20210711.0,20210512,20210721,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210721.0,,HP,GB,GB,2021,Q3,Adult
192453842,19245384,21,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Malaise,,2021,Q3,2,F,20210426.0,20210711.0,20210512,20210721,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210721.0,,HP,GB,GB,2021,Q3,Adult
192453842,19245384,21,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,20210426.0,20210711.0,20210512,20210721,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210721.0,,HP,GB,GB,2021,Q3,Adult
192453842,19245384,21,C,Semaglutide,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,20210426.0,20210711.0,20210512,20210721,EXP,,GB-AUROBINDO-AUR-APL-2021-018955,AUROBINDO,,54.0,YR,,F,Y,120.0,KG,20210721.0,,HP,GB,GB,2021,Q3,Adult
192517162,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,20210426.0,20210712.0,20210512,20210721,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210721.0,,PH,GB,GB,2021,Q3,Adult
192517162,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,2,F,20210426.0,20210712.0,20210512,20210721,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210721.0,,PH,GB,GB,2021,Q3,Adult
192517162,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,20210426.0,20210712.0,20210512,20210721,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210721.0,,PH,GB,GB,2021,Q3,Adult
192517162,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q3,Malaise,,2021,Q3,2,F,20210426.0,20210712.0,20210512,20210721,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210721.0,,PH,GB,GB,2021,Q3,Adult
192517162,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,20210426.0,20210712.0,20210512,20210721,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210721.0,,PH,GB,GB,2021,Q3,Adult
192517162,19251716,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,N,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,20210426.0,20210712.0,20210512,20210721,EXP,,GB-ANIPHARMA-2021-UK-000147,ANI,,54.0,YR,,F,Y,120.0,KG,20210721.0,,PH,GB,GB,2021,Q3,Adult
192589842,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,2,F,20210426.0,20210711.0,20210514,20210723,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
192589842,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,2,F,20210426.0,20210711.0,20210514,20210723,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
192589842,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,20210426.0,20210711.0,20210514,20210723,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
192589842,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Malaise,,2021,Q3,2,F,20210426.0,20210711.0,20210514,20210723,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
192589842,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Toxicity to various agents,,2021,Q3,2,F,20210426.0,20210711.0,20210514,20210723,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
192589842,19258984,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,20210426.0,20210711.0,20210514,20210723,EXP,GB-MHRA-EYC 00248995,NVSC2021GB102210,NOVARTIS,,54.0,YR,,F,Y,120.0,KG,20210723.0,,MD,GB,GB,2021,Q3,Adult
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Eyelid pain,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Lacrimation increased,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,No adverse event,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Ocular hyperaemia,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Photophobia,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Swelling face,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Swelling of eyelid,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Uveitis,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193795903,19379590,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Vision blurred,,2021,Q3,3,F,20210506.0,20210727.0,20210607,20210806,EXP,,CA-BEH-2021132392,CSL BEHRING,,77.0,YR,E,F,Y,71.6,KG,20210806.0,,HP,CA,CA,2021,Q3,Elderly
193796316,19379631,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",12.143,MG,Y,N,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholelithiasis migration,,2021,Q3,6,F,20210515.0,20210802.0,20210607,20210813,EXP,,FR-NOVOPROD-816263,NOVO NORDISK,,61.0,YR,,F,Y,83.0,KG,20210813.0,,MD,FR,FR,2021,Q3,Adult
193796316,19379631,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,0.24 UNK,12.143,MG,Y,N,,,215256.0,0.24,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholelithiasis migration,,2021,Q3,6,F,20210515.0,20210802.0,20210607,20210813,EXP,,FR-NOVOPROD-816263,NOVO NORDISK,,61.0,YR,,F,Y,83.0,KG,20210813.0,,MD,FR,FR,2021,Q3,Adult
194075102,19407510,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194075102,19407510,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 MG, QW",,,U,,,,,0.5,MG,,/wk,2021,Q3,Intentional product misuse,,2021,Q3,2,F,20210517.0,20210705.0,20210611,20210714,EXP,,NVSC2021ES125324,NOVARTIS,,68.0,YR,,M,Y,168.0,KG,20210714.0,,HP,ES,ES,2021,Q3,Elderly
194111889,19411188,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,UNK,37.357,MG,Y,,,,209637.0,,,SOLUTION FOR INJECTION,,2021,Q3,Cholecystitis,,2021,Q3,9,F,20210530.0,20210907.0,20210614,20210916,EXP,,JP-NOVOPROD-817849,NOVO NORDISK,,79.0,YR,,M,Y,75.0,KG,20210916.0,,MD,JP,JP,2021,Q3,Elderly
194111889,19411188,2,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.5,MG,ONCE PER WEEK",37.357,MG,Y,,,,209637.0,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholecystitis,,2021,Q3,9,F,20210530.0,20210907.0,20210614,20210916,EXP,,JP-NOVOPROD-817849,NOVO NORDISK,,79.0,YR,,M,Y,75.0,KG,20210916.0,,MD,JP,JP,2021,Q3,Elderly
194111889,19411188,3,SS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,0.25 MG ONCE PER WEEK,37.357,MG,Y,,,,209637.0,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholecystitis,,2021,Q3,9,F,20210530.0,20210907.0,20210614,20210916,EXP,,JP-NOVOPROD-817849,NOVO NORDISK,,79.0,YR,,M,Y,75.0,KG,20210916.0,,MD,JP,JP,2021,Q3,Elderly
194112254,19411225,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",483.0,MG,Y,,,,213051.0,3.0,MG,TABLET,QD,2021,Q3,Cholecystitis,,2021,Q3,4,F,20210601.0,20210817.0,20210614,20210823,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20210823.0,,MD,CO,CO,2021,Q3,Elderly
194112254,19411225,1,PS,Semaglutide 3 mg,SEMAGLUTIDE,1,Oral,"3.0,MG,ONCE PER DAY",483.0,MG,Y,,,,213051.0,3.0,MG,TABLET,QD,2021,Q3,Cholelithiasis,,2021,Q3,4,F,20210601.0,20210817.0,20210614,20210823,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20210823.0,,MD,CO,CO,2021,Q3,Elderly
194143364,19414336,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",,,,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholelithiasis,,2021,Q3,4,F,20210603.0,20210805.0,20210615,20210816,EXP,,TR-NOVOPROD-819074,NOVO NORDISK,,65.0,YR,,M,Y,110.0,KG,20210816.0,,MD,TR,TR,2021,Q3,Elderly
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Angina pectoris,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Appetite disorder,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Asthma,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Chest discomfort,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Chest pain,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Cough,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Depressed mood,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Depressive symptom,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea exertional,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Fall,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Flank pain,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Heart sounds,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Influenza,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Injury,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Insomnia,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Lower respiratory tract infection,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Nasal congestion,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Productive cough,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Pyrexia,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Rales,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Respiration abnormal,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Rhinorrhoea,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Stress,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Upper respiratory tract infection,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194155412,19415541,48,SS,Semaglutide,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Wheezing,,2021,Q3,2,F,,20210914.0,20210615,20210927,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20210927.0,,HP,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Asthma,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Chronic kidney disease,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Hypertension,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Nasal congestion,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Pharyngitis,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Productive cough,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194368423,19436842,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,SUBCUTANEOUS INJECTION,QD,2021,Q3,Urinary incontinence,,2021,Q3,3,F,,20210713.0,20210618,20210716,EXP,,CA-009507513-2007CAN011632,MERCK,,51.0,YR,,F,Y,,,20210716.0,,MD,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Asthma,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Chronic kidney disease,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Hypertension,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasal congestion,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Pharyngitis,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Productive cough,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194391743,19439174,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Urinary incontinence,,2021,Q3,3,F,,20210811.0,20210618,20210813,EXP,,CA-ASTRAZENECA-2021A530862,ASTRAZENECA,,51.0,YR,,F,Y,,,20210813.0,,,CA,CA,2021,Q3,Adult
194407393,19440739,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4 MG, QW",63.777,MG,D,,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Gastrointestinal inflammation,,2021,Q3,3,F,20210118.0,20210831.0,20210621,20210909,EXP,,US-NOVOPROD-785740,NOVO NORDISK,,48.0,YR,,F,Y,109.0,KG,20210909.0,,MD,US,US,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Asthma,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Hyperlipidaemia,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Hypertension,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Lower respiratory tract infection,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Nasal congestion,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Oropharyngeal pain,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Pharyngitis,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Productive cough,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Sleep apnoea syndrome,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194588313,19458831,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MG DAILY,,,U,N,,,,,,,,2021,Q3,Urinary incontinence,,2021,Q3,3,F,,20210811.0,20210624,20210818,EXP,,CA-ANIPHARMA-2021-CA-000896,ANI,,51.0,YR,,F,Y,,,20210818.0,,MD,CA,CA,2021,Q3,Adult
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Eye oedema,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Hypoaesthesia,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Incontinence,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Incorrect dose administered,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Off label use,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Pain in extremity,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Periorbital swelling,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Peripheral swelling,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Rash,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Rash macular,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194595309,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 MG,,,,,,,,0.25,MG,,,2021,Q3,Renal pain,,2021,Q3,9,F,202107.0,20210909.0,20210624,20210914,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20210914.0,,HP,US,US,2021,Q3,Elderly
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Asthma,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Chronic kidney disease,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Hypertension,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Nasal congestion,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Nasopharyngitis,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Pharyngitis,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Productive cough,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194844242,19484424,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, 1 EVERY 1 DAYS; DOSAGE FORM SOLUTION SUBCUTANEOUS",,,U,,,,,0.25,MG,INJECTION,QD,2021,Q3,Urinary incontinence,,2021,Q3,2,F,,20210713.0,20210701,20210719,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20210719.0,,CN,US,CA,2021,Q3,Adult
194883101,19488310,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNKNOWN,,,,,,,,1.0,MG,INJECTION,/wk,2021,Q3,Drug ineffective,,2021,Q3,1,I,20210127.0,20210209.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0063,BIODELIVERY SCIENCES INTERNATIONAL,,69.0,YR,E,F,Y,49.94,KG,20210702.0,,CN,US,US,2021,Q3,Elderly
194883101,19488310,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNKNOWN,,,,,,,,1.0,MG,INJECTION,/wk,2021,Q3,Headache,,2021,Q3,1,I,20210127.0,20210209.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0063,BIODELIVERY SCIENCES INTERNATIONAL,,69.0,YR,E,F,Y,49.94,KG,20210702.0,,CN,US,US,2021,Q3,Elderly
194883101,19488310,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNKNOWN,,,,,,,,1.0,MG,INJECTION,/wk,2021,Q3,Therapeutic response decreased,,2021,Q3,1,I,20210127.0,20210209.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0063,BIODELIVERY SCIENCES INTERNATIONAL,,69.0,YR,E,F,Y,49.94,KG,20210702.0,,CN,US,US,2021,Q3,Elderly
195161263,19516126,21,C,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,"0.2 ML (0.25MG), ONCE WEEKLY ON THE SAME DAY OF EACH WEEK",,,,,,,,0.2,ML,FORMULATION UNKNOWN,/wk,2021,Q3,Urinary retention,,2021,Q3,3,F,20210421.0,20210525.0,20210709,20210831,PER,,US-ASTELLAS-2021US016053,ASTELLAS,,69.0,YR,,F,Y,107.0,KG,20210831.0,,MD,US,US,2021,Q3,Elderly
195192371,19519237,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q3,Hypophagia,,2021,Q3,1,I,20210607.0,,20210712,20210712,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20210708.0,N,PH,US,US,2021,Q3,Elderly
195192371,19519237,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q3,Nausea,,2021,Q3,1,I,20210607.0,,20210712,20210712,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20210708.0,N,PH,US,US,2021,Q3,Elderly
195192371,19519237,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q3,Pancreatitis,,2021,Q3,1,I,20210607.0,,20210712,20210712,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20210708.0,N,PH,US,US,2021,Q3,Elderly
195192371,19519237,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 1MG/0.75ML INJ, SOLN, PEN 1.5ML",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,QW,2021,Q3,Vomiting,,2021,Q3,1,I,20210607.0,,20210712,20210712,DIR,,,FDA-CTU,,80.0,YR,,M,N,,,20210708.0,N,PH,US,US,2021,Q3,Elderly
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Asthma,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Chronic kidney disease,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Hypertension,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Pharyngitis,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Productive cough,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195232521,19523252,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Urinary incontinence,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,CA-BAUSCH-BL-2021-022862,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210712.0,,MD,CA,CA,2021,Q3,Adult
195244831,19524483,7,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Back pain,,2021,Q3,1,I,20210708.0,,20210712,20210712,DIR,,,FDA-CTU,,73.0,YR,,F,N,65.3,KG,20210712.0,N,PH,US,US,2021,Q3,Elderly
195244831,19524483,7,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Chest pain,,2021,Q3,1,I,20210708.0,,20210712,20210712,DIR,,,FDA-CTU,,73.0,YR,,F,N,65.3,KG,20210712.0,N,PH,US,US,2021,Q3,Elderly
195244831,19524483,7,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Fibrin D dimer increased,,2021,Q3,1,I,20210708.0,,20210712,20210712,DIR,,,FDA-CTU,,73.0,YR,,F,N,65.3,KG,20210712.0,N,PH,US,US,2021,Q3,Elderly
195244831,19524483,7,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Infusion related reaction,,2021,Q3,1,I,20210708.0,,20210712,20210712,DIR,,,FDA-CTU,,73.0,YR,,F,N,65.3,KG,20210712.0,N,PH,US,US,2021,Q3,Elderly
195244831,19524483,7,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Pulmonary mass,,2021,Q3,1,I,20210708.0,,20210712,20210712,DIR,,,FDA-CTU,,73.0,YR,,F,N,65.3,KG,20210712.0,N,PH,US,US,2021,Q3,Elderly
195244831,19524483,7,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Therapy cessation,,2021,Q3,1,I,20210708.0,,20210712,20210712,DIR,,,FDA-CTU,,73.0,YR,,F,N,65.3,KG,20210712.0,N,PH,US,US,2021,Q3,Elderly
195251981,19525198,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q3,Diarrhoea,,2021,Q3,1,I,20210621.0,,20210713,20210713,DIR,,,FDA-CTU,,33.0,YR,,M,N,116.0,KG,20210623.0,N,,US,US,2021,Q3,Young Adult
195251981,19525198,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q3,Nausea,,2021,Q3,1,I,20210621.0,,20210713,20210713,DIR,,,FDA-CTU,,33.0,YR,,M,N,116.0,KG,20210623.0,N,,US,US,2021,Q3,Young Adult
195251981,19525198,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q3,Vomiting,,2021,Q3,1,I,20210621.0,,20210713,20210713,DIR,,,FDA-CTU,,33.0,YR,,M,N,116.0,KG,20210623.0,N,,US,US,2021,Q3,Young Adult
195259361,19525936,1,PS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"UNK, QD",,,Y,N,,,213051.0,,,TABLET,QD,2021,Q3,Gallbladder disorder,,2021,Q3,1,I,20210502.0,20210521.0,20210713,20210713,EXP,,BG-NOVOPROD-815474,NOVO NORDISK,,69.0,YR,,F,Y,75.0,KG,20210712.0,,MD,BG,BG,2021,Q3,Elderly
195259361,19525936,2,SS,Semaglutide 14 mg,SEMAGLUTIDE,1,Oral,"UNK UNK, QD",,,Y,N,,,213051.0,,,TABLET,QD,2021,Q3,Gallbladder disorder,,2021,Q3,1,I,20210502.0,20210521.0,20210713,20210713,EXP,,BG-NOVOPROD-815474,NOVO NORDISK,,69.0,YR,,F,Y,75.0,KG,20210712.0,,MD,BG,BG,2021,Q3,Elderly
195381511,19538151,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,NVSC2021CA153379,NOVARTIS,,37.0,YR,,F,Y,116.0,KG,20210713.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
195381511,19538151,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,NVSC2021CA153379,NOVARTIS,,37.0,YR,,F,Y,116.0,KG,20210713.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
195381511,19538151,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,NVSC2021CA153379,NOVARTIS,,37.0,YR,,F,Y,116.0,KG,20210713.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
195381511,19538151,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,NVSC2021CA153379,NOVARTIS,,37.0,YR,,F,Y,116.0,KG,20210713.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
195381511,19538151,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,NVSC2021CA153379,NOVARTIS,,37.0,YR,,F,Y,116.0,KG,20210713.0,,HP,COUNTRY NOT SPECIFIED,CA,2021,Q3,Adult
195916231,19591623,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Asthma,,2021,Q3,1,I,,20210708.0,20210722,20210722,EXP,,CA-APOTEX-2021AP017678,APOTEX,,70.0,YR,,M,Y,,,20210722.0,,CN,CA,CA,2021,Q3,Elderly
195916231,19591623,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Diabetes mellitus,,2021,Q3,1,I,,20210708.0,20210722,20210722,EXP,,CA-APOTEX-2021AP017678,APOTEX,,70.0,YR,,M,Y,,,20210722.0,,CN,CA,CA,2021,Q3,Elderly
195916231,19591623,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210708.0,20210722,20210722,EXP,,CA-APOTEX-2021AP017678,APOTEX,,70.0,YR,,M,Y,,,20210722.0,,CN,CA,CA,2021,Q3,Elderly
195916231,19591623,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210708.0,20210722,20210722,EXP,,CA-APOTEX-2021AP017678,APOTEX,,70.0,YR,,M,Y,,,20210722.0,,CN,CA,CA,2021,Q3,Elderly
195916231,19591623,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210708.0,20210722,20210722,EXP,,CA-APOTEX-2021AP017678,APOTEX,,70.0,YR,,M,Y,,,20210722.0,,CN,CA,CA,2021,Q3,Elderly
195916231,19591623,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 MILLIGRAM, Q.WK.",,,U,,,,,0.25,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Wheezing,,2021,Q3,1,I,,20210708.0,20210722,20210722,EXP,,CA-APOTEX-2021AP017678,APOTEX,,70.0,YR,,M,Y,,,20210722.0,,CN,CA,CA,2021,Q3,Elderly
195925144,19592514,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",13.0,MG,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Bile duct stone,,2021,Q3,4,F,20210220.0,20210916.0,20210722,20210924,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20210924.0,,MD,GB,GB,2021,Q3,Elderly
195925144,19592514,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",13.0,MG,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholecystitis acute,,2021,Q3,4,F,20210220.0,20210916.0,20210722,20210924,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20210924.0,,MD,GB,GB,2021,Q3,Elderly
195925144,19592514,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",13.0,MG,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Gallbladder rupture,,2021,Q3,4,F,20210220.0,20210916.0,20210722,20210924,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20210924.0,,MD,GB,GB,2021,Q3,Elderly
195925144,19592514,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",13.0,MG,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Gastrointestinal wall thickening,,2021,Q3,4,F,20210220.0,20210916.0,20210722,20210924,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20210924.0,,MD,GB,GB,2021,Q3,Elderly
195925144,19592514,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1 MG, QW",13.0,MG,D,,,,215256.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Hepatobiliary procedural complication,,2021,Q3,4,F,20210220.0,20210916.0,20210722,20210924,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20210924.0,,MD,GB,GB,2021,Q3,Elderly
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Depression,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Dissociation,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Haemorrhagic ovarian cyst,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Headache,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Irregular sleep phase,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Menstrual disorder,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Menstruation irregular,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Mood altered,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Muscle spasms,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Nausea,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Off label use,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Paraesthesia,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Product availability issue,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Sleep-related eating disorder,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Stress,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Suicidal ideation,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195960851,19596085,4,SS,Semaglutide,SEMAGLUTIDE,1,Unknown,"1 MILLIGRAM, EVERY WEEK",,,U,U,,,,1.0,MG,,/wk,2021,Q3,Vomiting,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,,CA-AUROBINDO-AUR-APL-2021-030461,AUROBINDO,,24.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Young Adult
195982891,19598289,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML)",SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2021,Q3,Pancreatitis,,2021,Q3,1,I,20210528.0,,20210722,20210722,DIR,,,FDA-CTU,,69.0,YR,,F,N,105.23,KG,20210720.0,N,PH,US,US,2021,Q3,Elderly
195997141,19599714,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,D,D,,,,0.25,MG,,QW,2021,Q3,Abdominal pain,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,D,D,,,,0.25,MG,,QW,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,D,D,,,,0.25,MG,,QW,2021,Q3,Nausea,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,D,D,,,,0.25,MG,,QW,2021,Q3,Pancreatitis,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,D,D,,,,0.25,MG,,QW,2021,Q3,Treatment noncompliance,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,D,D,,,,0.25,MG,,QW,2021,Q3,Vomiting,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Faecal calprotectin increased,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Food intolerance,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Intentional product use issue,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Mucous stools,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Pruritus,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Rectal tenesmus,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Road traffic accident,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Skin lesion,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Somnolence,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196026211,19602621,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN?SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2021,Q3,Therapeutic response shortened,,2021,Q3,1,I,,20200309.0,20210723,20210723,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-08951,SAMSUNG BIOEPIS,,22.0,YR,A,F,Y,62.0,KG,20210723.0,,CN,CA,CA,2021,Q3,Youth
196076571,19607657,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Alanine aminotransferase increased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Alanine aminotransferase increased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Malaise,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196076571,19607657,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210719.0,20210726,20210726,EXP,,CA-BAUSCH-BL-2021-025862,BAUSCH AND LOMB,,59.0,YR,,F,Y,,,20210726.0,,HP,CA,CA,2021,Q3,Adult
196083015,19608301,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholecystitis,,2021,Q3,5,F,20210708.0,20210823.0,20210726,20210830,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20210830.0,,MD,IL,IL,2021,Q3,Adult
196083015,19608301,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholelithiasis,,2021,Q3,5,F,20210708.0,20210823.0,20210726,20210830,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20210830.0,,MD,IL,IL,2021,Q3,Adult
196145191,19614519,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,20210711.0,20210718.0,20210727,20210727,EXP,,GB-ASTRAZENECA-2021A627908,ASTRAZENECA,,48.0,YR,,M,Y,111.0,KG,20210727.0,,PH,GB,GB,2021,Q3,Adult
196273422,19627342,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Haematuria,,2021,Q3,2,F,20190313.0,20210816.0,20210729,20210819,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-074106,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,96.0,KG,20210819.0,,HP,US,US,2021,Q3,Elderly
196273422,19627342,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Intentional product use issue,,2021,Q3,2,F,20190313.0,20210816.0,20210729,20210819,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-074106,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,96.0,KG,20210819.0,,HP,US,US,2021,Q3,Elderly
196330151,19633015,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118290",BOEHRINGER INGELHEIM,,79.0,YR,E,F,Y,,,20210729.0,,MD,AU,AU,2021,Q3,Elderly
196341003,19634100,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Blood alkaline phosphatase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Gamma-glutamyltransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.7,MG,ONCE PER WEEK",,,,,,,215256.0,1.7,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Alanine aminotransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.7,MG,ONCE PER WEEK",,,,,,,215256.0,1.7,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.7,MG,ONCE PER WEEK",,,,,,,215256.0,1.7,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Blood alkaline phosphatase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.7,MG,ONCE PER WEEK",,,,,,,215256.0,1.7,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Gamma-glutamyltransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,3,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,3,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,3,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Blood alkaline phosphatase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196341003,19634100,3,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Gamma-glutamyltransferase increased,,2021,Q3,3,F,20210715.0,20210902.0,20210730,20210910,EXP,,AT-NOVOPROD-831187,NOVO NORDISK,,52.0,YR,,M,Y,103.0,KG,20210910.0,,MD,AT,AT,2021,Q3,Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Amenorrhoea,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood potassium decreased,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dyspepsia,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dysphonia,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hypersensitivity,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Illness,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Nasal congestion,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Rash,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Respiratory disorder,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196474541,19647454,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Urticaria,,2021,Q3,1,I,20210706.0,20210720.0,20210802,20210802,PER,,NVSC2021US165201,NOVARTIS,,31.0,YR,,F,Y,120.18,KG,20210802.0,,CN,US,US,2021,Q3,Young Adult
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Amnesia,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Asthenia,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood sodium decreased,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dizziness,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Dysphonia,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Hypokinesia,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Laziness,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Lung neoplasm,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Nasopharyngitis,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Product dose omission issue,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Rhinorrhoea,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196503145,19650314,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Wrong technique in product usage process,,2021,Q3,5,F,20210724.0,20210928.0,20210802,20210930,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20210930.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
196512421,19651242,1,PS,"SEMAGLUTIDE (SEMAGLUTIDE 0.5MG/0.375ML INJ, SOLN, PEN 1.5ML)",SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.25,MG,,QW,2021,Q3,Myalgia,,2021,Q3,1,I,20201020.0,,20210802,20210802,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20201130.0,N,PH,US,US,2021,Q3,Elderly
196597951,19659795,1,PS,SEMAGLUTIDE UNKNOWN,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,,20210726.0,20210805,20210805,EXP,CA- HEALTHCANVIG- E2B_03811841,CA-NOVOPROD-832921,NOVO NORDISK,,20.0,YR,,F,Y,,,20210805.0,,CN,CA,CA,2021,Q3,Youth
196597951,19659795,1,PS,SEMAGLUTIDE UNKNOWN,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210726.0,20210805,20210805,EXP,CA- HEALTHCANVIG- E2B_03811841,CA-NOVOPROD-832921,NOVO NORDISK,,20.0,YR,,F,Y,,,20210805.0,,CN,CA,CA,2021,Q3,Youth
196597951,19659795,1,PS,SEMAGLUTIDE UNKNOWN,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210726.0,20210805,20210805,EXP,CA- HEALTHCANVIG- E2B_03811841,CA-NOVOPROD-832921,NOVO NORDISK,,20.0,YR,,F,Y,,,20210805.0,,CN,CA,CA,2021,Q3,Youth
196599461,19659946,4,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Rash pruritic,,2021,Q3,1,I,20201214.0,,20210804,20210804,DIR,,,FDA-CTU,,58.0,YR,,F,N,119.7,KG,20210804.0,N,HP,US,US,2021,Q3,Adult
196599461,19659946,4,C,semaglutide,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Urticaria,,2021,Q3,1,I,20201214.0,,20210804,20210804,DIR,,,FDA-CTU,,58.0,YR,,F,N,119.7,KG,20210804.0,N,HP,US,US,2021,Q3,Adult
196635243,19663524,8,C,Semaglutide,SEMAGLUTIDE,1,Oral,7 MILLIGRAM,,,,,,,,7.0,MG,UNKNOWN,QD,2021,Q3,Gastrointestinal haemorrhage,,2021,Q3,3,F,20210721.0,20210809.0,20210805,20210811,EXP,,US-CELGENEUS-USA-20210800566,CELGENE,,74.0,YR,,M,Y,90.0,KG,20210811.0,,MD,US,US,2021,Q3,Elderly
196700201,19670020,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,7.0,MG,,QD,2021,Q3,Gait disturbance,,2021,Q3,1,I,20210618.0,20210622.0,20210806,20210806,EXP,,US-ROCHE-2856408,ROCHE,,54.0,YR,,F,Y,125.2,KG,20210806.0,,HP,US,US,2021,Q3,Adult
196700201,19670020,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,7.0,MG,,QD,2021,Q3,Meniscus injury,,2021,Q3,1,I,20210618.0,20210622.0,20210806,20210806,EXP,,US-ROCHE-2856408,ROCHE,,54.0,YR,,F,Y,125.2,KG,20210806.0,,HP,US,US,2021,Q3,Adult
196734781,19673478,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,500 MG TWICE DAILY,,,,,,,,1.0,G,,/wk,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,,20210805.0,20210809,20210809,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119712",BOEHRINGER INGELHEIM,"AMIANDA E, GAVIGAN T, TALISHINSKIY T, EWING D, SCHMIDT H. TWO CASES OF EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER BARIATRIC SURGERY ASSOCIATED WITH SODIUM?GLUCOSE COTRANSPORTER?2 INHIBITOR US. OBESITY SURGERY. 2021? 31:8: 3848?3850.",54.0,YR,A,M,Y,,,20210809.0,,HP,US,US,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Hyperlipidaemia,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Pharyngitis,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Productive cough,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Sleep apnoea syndrome,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196737971,19673797,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Urinary incontinence,,2021,Q3,1,I,,20210726.0,20210809,20210809,EXP,CA-HEALTHCANVIG-03813844,CA-NOVOPROD-832897,NOVO NORDISK,,51.0,YR,,F,Y,,,20210809.0,,MD,CA,CA,2021,Q3,Adult
196745731,19674573,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4 MG, QW",141.6,MG,Y,N,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Bile duct stone,,2021,Q3,1,I,20210203.0,20210217.0,20210809,20210809,EXP,,HU-NOVOPROD-789021,NOVO NORDISK,,71.0,YR,,F,Y,89.0,KG,20210809.0,,MD,HU,HU,2021,Q3,Elderly
196745731,19674573,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"2.4 MG, QW",141.6,MG,Y,N,,,215256.0,2.4,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholelithiasis,,2021,Q3,1,I,20210203.0,20210217.0,20210809,20210809,EXP,,HU-NOVOPROD-789021,NOVO NORDISK,,71.0,YR,,F,Y,89.0,KG,20210809.0,,MD,HU,HU,2021,Q3,Elderly
196745731,19674573,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,"0.24 MG, QW",141.6,MG,Y,N,,,215256.0,0.24,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Bile duct stone,,2021,Q3,1,I,20210203.0,20210217.0,20210809,20210809,EXP,,HU-NOVOPROD-789021,NOVO NORDISK,,71.0,YR,,F,Y,89.0,KG,20210809.0,,MD,HU,HU,2021,Q3,Elderly
196745731,19674573,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,"0.24 MG, QW",141.6,MG,Y,N,,,215256.0,0.24,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Cholelithiasis,,2021,Q3,1,I,20210203.0,20210217.0,20210809,20210809,EXP,,HU-NOVOPROD-789021,NOVO NORDISK,,71.0,YR,,F,Y,89.0,KG,20210809.0,,MD,HU,HU,2021,Q3,Elderly
196745802,19674580,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Bile duct stone,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196745802,19674580,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperplastic cholecystopathy,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196745802,19674580,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Bile duct stone,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196745802,19674580,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperplastic cholecystopathy,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196745802,19674580,3,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Bile duct stone,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196745802,19674580,3,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperplastic cholecystopathy,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196745802,19674580,4,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",48.652,MG,,,,,215256.0,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Bile duct stone,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196745802,19674580,4,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, QW",48.652,MG,,,,,215256.0,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Hyperplastic cholecystopathy,,2021,Q3,2,F,20210420.0,20210831.0,20210809,20210909,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20210909.0,,MD,US,US,2021,Q3,Elderly
196752441,19675244,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, NACH SCHEMA, FERTIGSPRITZEN",,,,,,,,2.0,MG,,,2021,Q3,C-reactive protein increased,,2021,Q3,1,I,,20210730.0,20210809,20210809,PER,DE-ADRED-06590-03,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00957,SHILPA MEDICARE,,63.0,YR,A,M,Y,94.0,KG,20210809.0,,PH,DE,DE,2021,Q3,Adult
196752441,19675244,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, NACH SCHEMA, FERTIGSPRITZEN",,,,,,,,2.0,MG,,,2021,Q3,Pyelonephritis,,2021,Q3,1,I,,20210730.0,20210809,20210809,PER,DE-ADRED-06590-03,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00957,SHILPA MEDICARE,,63.0,YR,A,M,Y,94.0,KG,20210809.0,,PH,DE,DE,2021,Q3,Adult
196752441,19675244,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, NACH SCHEMA, FERTIGSPRITZEN",,,,,,,,2.0,MG,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210730.0,20210809,20210809,PER,DE-ADRED-06590-03,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00957,SHILPA MEDICARE,,63.0,YR,A,M,Y,94.0,KG,20210809.0,,PH,DE,DE,2021,Q3,Adult
196762441,19676244,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNKNOWN,,,,,,,,,,TABLET,,2021,Q3,Arthralgia,,2021,Q3,1,I,,20210802.0,20210809,20210809,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-18710,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,69.0,KG,20210809.0,,HP,CA,CA,2021,Q3,Adult
196762441,19676244,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNKNOWN,,,,,,,,,,TABLET,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210802.0,20210809,20210809,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-18710,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,69.0,KG,20210809.0,,HP,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Asthma,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Chronic kidney disease,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Hypertension,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Pharyngitis,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Productive cough,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196778311,19677831,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q3,Urinary incontinence,,2021,Q3,1,I,,20210726.0,20210810,20210810,EXP,,CA-BAUSCH-BL-2021-026450,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20210810.0,,CN,CA,CA,2021,Q3,Adult
196864821,19686482,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, AS SCHEDULE, PREFILLED SYRINGE",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,C-reactive protein increased,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,DE-FRESENIUS KABI-FK202108285,FRESENIUS KABI,,63.0,YR,,M,Y,94.0,KG,20210811.0,,HP,NL,DE,2021,Q3,Adult
196864821,19686482,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, AS SCHEDULE, PREFILLED SYRINGE",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Pyelonephritis,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,DE-FRESENIUS KABI-FK202108285,FRESENIUS KABI,,63.0,YR,,M,Y,94.0,KG,20210811.0,,HP,NL,DE,2021,Q3,Adult
196864821,19686482,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, AS SCHEDULE, PREFILLED SYRINGE",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210802.0,20210811,20210811,EXP,,DE-FRESENIUS KABI-FK202108285,FRESENIUS KABI,,63.0,YR,,M,Y,94.0,KG,20210811.0,,HP,NL,DE,2021,Q3,Adult
196895661,19689566,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,C-reactive protein increased,,2021,Q3,1,I,,20210730.0,20210811,20210811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013196,ELI LILLY AND CO,,63.0,YR,,M,Y,94.0,KG,20210811.0,,PH,DE,DE,2021,Q3,Adult
196895661,19689566,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,Chills,,2021,Q3,1,I,,20210730.0,20210811,20210811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013196,ELI LILLY AND CO,,63.0,YR,,M,Y,94.0,KG,20210811.0,,PH,DE,DE,2021,Q3,Adult
196895661,19689566,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,Pyelonephritis,,2021,Q3,1,I,,20210730.0,20210811,20210811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013196,ELI LILLY AND CO,,63.0,YR,,M,Y,94.0,KG,20210811.0,,PH,DE,DE,2021,Q3,Adult
196895661,19689566,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210730.0,20210811,20210811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013196,ELI LILLY AND CO,,63.0,YR,,M,Y,94.0,KG,20210811.0,,PH,DE,DE,2021,Q3,Adult
196895661,19689566,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,Urosepsis,,2021,Q3,1,I,,20210730.0,20210811,20210811,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013196,ELI LILLY AND CO,,63.0,YR,,M,Y,94.0,KG,20210811.0,,PH,DE,DE,2021,Q3,Adult
196941691,19694169,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.25 MG,,,U,U,,,209637.0,,,,,2021,Q3,Diastolic dysfunction,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.25 MG,,,U,U,,,209637.0,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.25 MG,,,U,U,,,209637.0,,,,,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.25 MG,,,U,U,,,209637.0,,,,,2021,Q3,Left atrial enlargement,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,2,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.5MG,,,U,U,,,209637.0,,,,,2021,Q3,Diastolic dysfunction,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,2,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.5MG,,,U,U,,,209637.0,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,2,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.5MG,,,U,U,,,209637.0,,,,,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196941691,19694169,2,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,0.5MG,,,U,U,,,209637.0,,,,,2021,Q3,Left atrial enlargement,,2021,Q3,1,I,,20210803.0,20210813,20210813,EXP,,BR-NOVOPROD-836696,NOVO NORDISK,,41.0,YR,,M,Y,82.0,KG,20210813.0,,MD,BR,BR,2021,Q3,Adult
196943421,19694342,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, NACH SCHEMA, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,C-reactive protein increased,,2021,Q3,1,I,,20210802.0,20210812,20210812,EXP,,NVSC2021DE175163,NOVARTIS,,63.0,YR,,M,Y,94.0,KG,20210812.0,,HP,DE,DE,2021,Q3,Adult
196943421,19694342,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, NACH SCHEMA, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Pyelonephritis,,2021,Q3,1,I,,20210802.0,20210812,20210812,EXP,,NVSC2021DE175163,NOVARTIS,,63.0,YR,,M,Y,94.0,KG,20210812.0,,HP,DE,DE,2021,Q3,Adult
196943421,19694342,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, NACH SCHEMA, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210802.0,20210812,20210812,EXP,,NVSC2021DE175163,NOVARTIS,,63.0,YR,,M,Y,94.0,KG,20210812.0,,HP,DE,DE,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Chronic kidney disease,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Hyperlipidaemia,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Pharyngitis,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Productive cough,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Sleep apnoea syndrome,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197080931,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 EVERY 1 DAYS,,,U,,,,,0.25,MG,,,2021,Q3,Urinary incontinence,,2021,Q3,1,I,,20210807.0,20210817,20210817,EXP,CA-MHPD-E2B-03434660,CA-ACCORD-235248,ACCORD,,51.0,YR,,F,Y,,,20210817.0,,HP,CA,CA,2021,Q3,Adult
197323471,19732347,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Haemorrhagic stroke,,2021,Q3,1,I,20210312.0,20210811.0,20210822,20210822,EXP,,GB-TEVA-2021-GB-1943305,TEVA,UNKNOWN. UNKNOWN.,69.0,YR,E,M,Y,,,20210821.0,,HP,GB,GB,2021,Q3,Elderly
197323471,19732347,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Haemorrhagic stroke,,2021,Q3,1,I,20210312.0,20210811.0,20210822,20210822,EXP,,GB-TEVA-2021-GB-1943305,TEVA,UNKNOWN. UNKNOWN.,69.0,YR,E,M,Y,,,20210821.0,,HP,GB,GB,2021,Q3,Elderly
197323471,19732347,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Haemorrhagic stroke,,2021,Q3,1,I,20210312.0,20210811.0,20210822,20210822,EXP,,GB-TEVA-2021-GB-1943305,TEVA,UNKNOWN. UNKNOWN.,69.0,YR,E,M,Y,,,20210821.0,,HP,GB,GB,2021,Q3,Elderly
197405251,19740525,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO THE SCHEME, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,C-reactive protein increased,,2021,Q3,1,I,,20210811.0,20210824,20210824,EXP,DE-BFARM-21007372,DE-ACCORD-236103,ACCORD,,63.0,YR,A,M,Y,94.0,KG,20210824.0,,PH,DE,DE,2021,Q3,Adult
197405251,19740525,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO THE SCHEME, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Pyelonephritis,,2021,Q3,1,I,,20210811.0,20210824,20210824,EXP,DE-BFARM-21007372,DE-ACCORD-236103,ACCORD,,63.0,YR,A,M,Y,94.0,KG,20210824.0,,PH,DE,DE,2021,Q3,Adult
197405251,19740525,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO THE SCHEME, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210811.0,20210824,20210824,EXP,DE-BFARM-21007372,DE-ACCORD-236103,ACCORD,,63.0,YR,A,M,Y,94.0,KG,20210824.0,,PH,DE,DE,2021,Q3,Adult
197442622,19744262,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO THE SCHEME, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Chills,,2021,Q3,2,F,,20210903.0,20210825,20210915,EXP,DE-BFARM-21007375,DE-ACCORD-236153,ACCORD,,63.0,YR,A,M,Y,95.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Adult
197442622,19744262,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO THE SCHEME, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,2,F,,20210903.0,20210825,20210915,EXP,DE-BFARM-21007375,DE-ACCORD-236153,ACCORD,,63.0,YR,A,M,Y,95.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Adult
197442622,19744262,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO THE SCHEME, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,2,F,,20210903.0,20210825,20210915,EXP,DE-BFARM-21007375,DE-ACCORD-236153,ACCORD,,63.0,YR,A,M,Y,95.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Adult
197442622,19744262,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO THE SCHEME, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Urosepsis,,2021,Q3,2,F,,20210903.0,20210825,20210915,EXP,DE-BFARM-21007375,DE-ACCORD-236153,ACCORD,,63.0,YR,A,M,Y,95.0,KG,20210915.0,,PH,DE,DE,2021,Q3,Adult
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Ankle fracture,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Coronary artery disease,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Hypercholesterolaemia,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Hypertension,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Lower limb fracture,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Myocardial infarction,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Obesity,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197454701,19745470,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 MILLIGRAM, QW",,,,,,,,0.5,MG,,/wk,2021,Q3,Peripheral arterial occlusive disease,,2021,Q3,1,I,201602.0,20210819.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1054589,MYLAN,,73.0,YR,,M,Y,87.0,KG,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197654661,19765466,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q3,Blood pressure increased,,2021,Q3,1,I,,20210820.0,20210830,20210830,EXP,,CA-TEVA-2021-CA-1946126,TEVA,,71.0,YR,E,M,Y,,,20210830.0,,CN,CA,CA,2021,Q3,Elderly
197654661,19765466,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210820.0,20210830,20210830,EXP,,CA-TEVA-2021-CA-1946126,TEVA,,71.0,YR,E,M,Y,,,20210830.0,,CN,CA,CA,2021,Q3,Elderly
197721921,19772192,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,20210715.0,20210829.0,20210901,20210901,EXP,GB-MHRA-EYC 00259232,NVSC2021GB196280,NOVARTIS,,49.0,YR,,M,Y,,,20210901.0,,HP,GB,GB,2021,Q3,Adult
197845131,19784513,1,PS,Semaglutide B 1.34 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"1.0,MG,ONCE PER WEEK",,,,,,,209637.0,1.0,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Detachment of retinal pigment epithelium,,2021,Q3,1,I,20210804.0,20210806.0,20210903,20210903,EXP,,RU-NOVOPROD-836758,NOVO NORDISK,,71.0,YR,,F,Y,97.0,KG,20210903.0,,MD,RU,RU,2021,Q3,Elderly
197876111,19787611,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Acute respiratory failure,,2021,Q3,1,I,2020.0,20210831.0,20210903,20210903,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-124363",BOEHRINGER INGELHEIM,"ENG T, ELAMIR Y, HARRINGTON M, BRITO M. EUGLYCEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM?GLUCOSE COTRANSPORTER 2 INHIBITOR USE AND SARS?COV?2: A CASE REPORT. JOURNAL OF GENERAL INTERNAL MEDICINE. 2021? 36: 328?",77.0,YR,E,M,Y,,,20210903.0,,HP,US,US,2021,Q3,Elderly
197876111,19787611,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,COVID-19,,2021,Q3,1,I,2020.0,20210831.0,20210903,20210903,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-124363",BOEHRINGER INGELHEIM,"ENG T, ELAMIR Y, HARRINGTON M, BRITO M. EUGLYCEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM?GLUCOSE COTRANSPORTER 2 INHIBITOR USE AND SARS?COV?2: A CASE REPORT. JOURNAL OF GENERAL INTERNAL MEDICINE. 2021? 36: 328?",77.0,YR,E,M,Y,,,20210903.0,,HP,US,US,2021,Q3,Elderly
197876111,19787611,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,COVID-19 pneumonia,,2021,Q3,1,I,2020.0,20210831.0,20210903,20210903,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-124363",BOEHRINGER INGELHEIM,"ENG T, ELAMIR Y, HARRINGTON M, BRITO M. EUGLYCEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM?GLUCOSE COTRANSPORTER 2 INHIBITOR USE AND SARS?COV?2: A CASE REPORT. JOURNAL OF GENERAL INTERNAL MEDICINE. 2021? 36: 328?",77.0,YR,E,M,Y,,,20210903.0,,HP,US,US,2021,Q3,Elderly
197876111,19787611,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,2020.0,20210831.0,20210903,20210903,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-124363",BOEHRINGER INGELHEIM,"ENG T, ELAMIR Y, HARRINGTON M, BRITO M. EUGLYCEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM?GLUCOSE COTRANSPORTER 2 INHIBITOR USE AND SARS?COV?2: A CASE REPORT. JOURNAL OF GENERAL INTERNAL MEDICINE. 2021? 36: 328?",77.0,YR,E,M,Y,,,20210903.0,,HP,US,US,2021,Q3,Elderly
197876111,19787611,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Respiratory failure,,2021,Q3,1,I,2020.0,20210831.0,20210903,20210903,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-124363",BOEHRINGER INGELHEIM,"ENG T, ELAMIR Y, HARRINGTON M, BRITO M. EUGLYCEMIC DIABETIC KETOACIDOSIS ASSOCIATED WITH SODIUM?GLUCOSE COTRANSPORTER 2 INHIBITOR USE AND SARS?COV?2: A CASE REPORT. JOURNAL OF GENERAL INTERNAL MEDICINE. 2021? 36: 328?",77.0,YR,E,M,Y,,,20210903.0,,HP,US,US,2021,Q3,Elderly
198025961,19802596,1,PS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,,20210830.0,20210908,20210908,EXP,CA-HEALTHCANVIG-03938497,CA-NOVOPROD-842890,NOVO NORDISK,,55.0,YR,,M,Y,145.0,KG,20210908.0,,CN,CA,CA,2021,Q3,Adult
198036041,19803604,13,C,semaglutide 2mg/1.5ml,,2,,,,,,,,,,,,,,2021,Q3,Infusion related reaction,,2021,Q3,1,I,20210905.0,,20210908,20210908,DIR,,,FDA-CTU,,55.0,YR,,M,N,150.9,KG,20210908.0,N,PH,US,US,2021,Q3,Adult
198036041,19803604,13,C,semaglutide 2mg/1.5ml,,2,,,,,,,,,,,,,,2021,Q3,Lip swelling,,2021,Q3,1,I,20210905.0,,20210908,20210908,DIR,,,FDA-CTU,,55.0,YR,,M,N,150.9,KG,20210908.0,N,PH,US,US,2021,Q3,Adult
198036041,19803604,13,C,semaglutide 2mg/1.5ml,,2,,,,,,,,,,,,,,2021,Q3,Pruritus,,2021,Q3,1,I,20210905.0,,20210908,20210908,DIR,,,FDA-CTU,,55.0,YR,,M,N,150.9,KG,20210908.0,N,PH,US,US,2021,Q3,Adult
198084621,19808462,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, PRE?FILLED SYRINGES",,,,,,,,,,INJECTION,,2021,Q3,Chills,,2021,Q3,1,I,,20210831.0,20210909,20210909,PER,DE-ADRED-06590-04,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-01057,SHILPA MEDICARE,,63.0,YR,A,M,Y,95.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Adult
198084621,19808462,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, PRE?FILLED SYRINGES",,,,,,,,,,INJECTION,,2021,Q3,Pain,,2021,Q3,1,I,,20210831.0,20210909,20210909,PER,DE-ADRED-06590-04,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-01057,SHILPA MEDICARE,,63.0,YR,A,M,Y,95.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Adult
198084621,19808462,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, PRE?FILLED SYRINGES",,,,,,,,,,INJECTION,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210831.0,20210909,20210909,PER,DE-ADRED-06590-04,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-01057,SHILPA MEDICARE,,63.0,YR,A,M,Y,95.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Adult
198093421,19809342,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG (NACH SCHEMA, FERTIGSPRITZEN)",,,U,,,,,2.0,MG,,,2021,Q3,Chills,,2021,Q3,1,I,,20210902.0,20210909,20210909,EXP,,NVSC2021DE200275,NOVARTIS,,63.0,YR,,M,Y,95.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093421,19809342,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG (NACH SCHEMA, FERTIGSPRITZEN)",,,U,,,,,2.0,MG,,,2021,Q3,Pain,,2021,Q3,1,I,,20210902.0,20210909,20210909,EXP,,NVSC2021DE200275,NOVARTIS,,63.0,YR,,M,Y,95.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093421,19809342,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG (NACH SCHEMA, FERTIGSPRITZEN)",,,U,,,,,2.0,MG,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210902.0,20210909,20210909,EXP,,NVSC2021DE200275,NOVARTIS,,63.0,YR,,M,Y,95.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198154441,19815444,1,PS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.24 MG, QW",3.935,MG,Y,N,,,215256.0,0.24,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Drug-induced liver injury,,2021,Q3,1,I,20210116.0,20210118.0,20210910,20210910,EXP,,PT-NOVOPROD-781419,NOVO NORDISK,,45.0,YR,,F,Y,72.0,KG,20210910.0,,MD,PT,PT,2021,Q3,Adult
198154441,19815444,2,SS,Semaglutide B 3.0 mg/ml PDS290,SEMAGLUTIDE,1,Subcutaneous,"0.5,MG,ONCE PER WEEK",3.935,MG,Y,N,,,215256.0,0.5,MG,SOLUTION FOR INJECTION,/wk,2021,Q3,Drug-induced liver injury,,2021,Q3,1,I,20210116.0,20210118.0,20210910,20210910,EXP,,PT-NOVOPROD-781419,NOVO NORDISK,,45.0,YR,,F,Y,72.0,KG,20210910.0,,MD,PT,PT,2021,Q3,Adult
198172851,19817285,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,Chills,,2021,Q3,1,I,,20210831.0,20210910,20210910,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108013236,ELI LILLY AND CO,,63.0,YR,,M,Y,95.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Adult
198172851,19817285,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,Pain,,2021,Q3,1,I,,20210831.0,20210910,20210910,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108013236,ELI LILLY AND CO,,63.0,YR,,M,Y,95.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Adult
198172851,19817285,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, UNKNOWN",,,,,,,,2.0,MG,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210831.0,20210910,20210910,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108013236,ELI LILLY AND CO,,63.0,YR,,M,Y,95.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Adult
198187571,19818757,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Alanine aminotransferase increased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Malaise,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Alanine aminotransferase increased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Blood creatine phosphokinase increased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198187571,19818757,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210902.0,20210912,20210912,EXP,,CA-TEVA-2021-CA-1951847,TEVA,,59.0,YR,A,F,Y,,,20210912.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Angina pectoris,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Appetite disorder,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Asthma,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Chest pain,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Cough,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Depressed mood,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Depressive symptom,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Fall,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Flank pain,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Heart sounds,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Influenza,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Injury,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Insomnia,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Productive cough,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Prolonged expiration,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Rales,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Respiration abnormal,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Rhinorrhoea,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Stress,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Upper respiratory tract infection,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198198451,19819845,28,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/wk,2021,Q3,Wheezing,,2021,Q3,1,I,,20210906.0,20210913,20210913,EXP,,CA-BAUSCH-BL-2021-031194,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20210913.0,,HP,CA,CA,2021,Q3,Adult
198295141,19829514,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO PLAN, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Chills,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-FRESENIUS KABI-FK202109616,FRESENIUS KABI,,63.0,YR,,M,Y,95.0,KG,20210914.0,,HP,NL,DE,2021,Q3,Adult
198295141,19829514,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO PLAN, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Pain,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-FRESENIUS KABI-FK202109616,FRESENIUS KABI,,63.0,YR,,M,Y,95.0,KG,20210914.0,,HP,NL,DE,2021,Q3,Adult
198295141,19829514,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 MG, ACCORDING TO PLAN, PREFILLED SYRINGES",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-FRESENIUS KABI-FK202109616,FRESENIUS KABI,,63.0,YR,,M,Y,95.0,KG,20210914.0,,HP,NL,DE,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Asthma,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Chronic kidney disease,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Hyperlipidaemia,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Hypertension,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Pharyngitis,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Productive cough,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Sleep apnoea syndrome,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198328391,19832839,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 MILLIGRAM DAILY;,,,U,,,,,0.25,MG,,QD,2021,Q3,Urinary incontinence,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,CA-TEVA-2021-CA-1952744,TEVA,,51.0,YR,A,F,Y,,,20210914.0,,MD,CA,CA,2021,Q3,Adult
198340602,19834060,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Deafness,,2021,Q3,2,F,20200601.0,20210908.0,20210915,20210916,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20210916.0,,CN,DE,DE,2021,Q3,Elderly
198340602,19834060,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,2,F,20200601.0,20210908.0,20210915,20210916,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20210916.0,,CN,DE,DE,2021,Q3,Elderly
198340602,19834060,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,20200601.0,20210908.0,20210915,20210916,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20210916.0,,CN,DE,DE,2021,Q3,Elderly
198340602,19834060,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Overdose,,2021,Q3,2,F,20200601.0,20210908.0,20210915,20210916,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20210916.0,,CN,DE,DE,2021,Q3,Elderly
198340602,19834060,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Vertigo,,2021,Q3,2,F,20200601.0,20210908.0,20210915,20210916,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20210916.0,,CN,DE,DE,2021,Q3,Elderly
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Angina pectoris,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Appetite disorder,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Asthma,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Chest pain,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Cough,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Depressed mood,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Depressive symptom,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Fall,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Flank pain,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Heart sounds,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Influenza,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Injury,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Insomnia,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Productive cough,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Prolonged expiration,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Rales,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Respiration abnormal,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Rhinorrhoea,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Stress,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Upper respiratory tract infection,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198657731,19865773,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, WEEKLY",,,U,U,,,,1.25,MG,,/wk,2021,Q3,Wheezing,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,CA-PURDUE-USA-2021-0284846,PURDUE,,61.0,YR,,F,Y,,,20210921.0,,CN,CA,CA,2021,Q3,Adult
198660081,19866008,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,1.0,MG,,QW,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210909.0,,20210922,20210922,DIR,,,FDA-CTU,,71.0,YR,,F,N,64.44,KG,20210922.0,Y,MD,US,US,2021,Q3,Elderly
198660081,19866008,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,1.0,MG,,QW,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210909.0,,20210922,20210922,DIR,,,FDA-CTU,,71.0,YR,,F,N,64.44,KG,20210922.0,Y,MD,US,US,2021,Q3,Elderly
198660081,19866008,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,1.0,MG,,QW,2021,Q3,Decreased appetite,,2021,Q3,1,I,20210909.0,,20210922,20210922,DIR,,,FDA-CTU,,71.0,YR,,F,N,64.44,KG,20210922.0,Y,MD,US,US,2021,Q3,Elderly
198660081,19866008,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,1.0,MG,,QW,2021,Q3,Diarrhoea,,2021,Q3,1,I,20210909.0,,20210922,20210922,DIR,,,FDA-CTU,,71.0,YR,,F,N,64.44,KG,20210922.0,Y,MD,US,US,2021,Q3,Elderly
198660081,19866008,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,1.0,MG,,QW,2021,Q3,Hyperkalaemia,,2021,Q3,1,I,20210909.0,,20210922,20210922,DIR,,,FDA-CTU,,71.0,YR,,F,N,64.44,KG,20210922.0,Y,MD,US,US,2021,Q3,Elderly
198660081,19866008,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,1.0,MG,,QW,2021,Q3,Nausea,,2021,Q3,1,I,20210909.0,,20210922,20210922,DIR,,,FDA-CTU,,71.0,YR,,F,N,64.44,KG,20210922.0,Y,MD,US,US,2021,Q3,Elderly
198660081,19866008,1,PS,Semaglutide,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:WEEKLY;?,,,Y,D,,,,1.0,MG,,QW,2021,Q3,Toxicity to various agents,,2021,Q3,1,I,20210909.0,,20210922,20210922,DIR,,,FDA-CTU,,71.0,YR,,F,N,64.44,KG,20210922.0,Y,MD,US,US,2021,Q3,Elderly
198699961,19869996,11,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,"0.50 MG, QW",,,U,U,,,,0.5,MG,,/wk,2021,Q3,Depression,,2021,Q3,1,I,202104.0,20210913.0,20210923,20210923,EXP,,BR-NOVOPROD-847787,NOVO NORDISK,,64.0,YR,,F,Y,82.8,KG,20210923.0,,MD,BR,BR,2021,Q3,Adult
198699961,19869996,11,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,"0.50 MG, QW",,,U,U,,,,0.5,MG,,/wk,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,202104.0,20210913.0,20210923,20210923,EXP,,BR-NOVOPROD-847787,NOVO NORDISK,,64.0,YR,,F,Y,82.8,KG,20210923.0,,MD,BR,BR,2021,Q3,Adult
198699961,19869996,11,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,"0.50 MG, QW",,,U,U,,,,0.5,MG,,/wk,2021,Q3,Intentional product misuse,,2021,Q3,1,I,202104.0,20210913.0,20210923,20210923,EXP,,BR-NOVOPROD-847787,NOVO NORDISK,,64.0,YR,,F,Y,82.8,KG,20210923.0,,MD,BR,BR,2021,Q3,Adult
198699961,19869996,11,SS,Semaglutide Unknown,SEMAGLUTIDE,1,Unknown,"0.50 MG, QW",,,U,U,,,,0.5,MG,,/wk,2021,Q3,Vulvovaginal pain,,2021,Q3,1,I,202104.0,20210913.0,20210923,20210923,EXP,,BR-NOVOPROD-847787,NOVO NORDISK,,64.0,YR,,F,Y,82.8,KG,20210923.0,,MD,BR,BR,2021,Q3,Adult
198783691,19878369,1,PS,SEMAGLUTIDE (SEMAGLUTIDE 3MG TAB),SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Small intestinal obstruction,,2021,Q3,1,I,20210826.0,,20210923,20210923,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20210921.0,N,PH,US,US,2021,Q3,Elderly
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Angina pectoris,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Appetite disorder,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Chest pain,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Cough,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Depressed mood,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Depressive symptom,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Fall,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Flank pain,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Heart sounds,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Influenza,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Injury,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Insomnia,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Loss of personal independence in daily activities,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Malaise,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Productive cough,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Prolonged expiration,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Rales,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Respiration abnormal,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Rhinorrhoea,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Stress,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Upper respiratory tract infection,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198804951,19880495,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 MG QW,,,U,,,,,1.25,MG,,,2021,Q3,Wheezing,,2021,Q3,1,I,,20210906.0,20210924,20210924,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-CA-VDP-2021-002176,VALIDUS,,61.0,YR,,F,Y,,,20210924.0,,CN,US,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Angina pectoris,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Appetite disorder,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Asthma,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Chest pain,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Cough,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Depressed mood,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Depressive symptom,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Dyspnoea exertional,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Fall,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Flank pain,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Heart sounds,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Influenza,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Injury,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Insomnia,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Lower respiratory tract infection,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Malaise,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Nasal congestion,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Nasopharyngitis,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Productive cough,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Prolonged expiration,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Rales,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Respiration abnormal,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Rhinorrhoea,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Sleep disorder due to a general medical condition,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Stress,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Upper respiratory tract infection,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198816071,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 MG, QW (1 EVERY 1 WEEKS)",,,U,,,,,1.25,MG,,/wk,2021,Q3,Wheezing,,2021,Q3,1,I,,20210917.0,20210925,20210925,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20210925.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Anxiety,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Feeling abnormal,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Feeling jittery,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Food craving,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Headache,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Heart rate increased,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Hormone level abnormal,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Nervousness,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Vaginal infection,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2021,Q3,Vulvovaginal dryness,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Anxiety,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Feeling abnormal,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Feeling jittery,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Food craving,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Headache,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Heart rate increased,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Hormone level abnormal,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Nervousness,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Vaginal infection,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198834551,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2021,Q3,Vulvovaginal dryness,,2021,Q3,1,I,,20210920.0,20210926,20210926,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20210927.0,,HP,CA,CA,2021,Q3,Adult
198881691,19888169,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Deafness,,2021,Q3,1,I,20200601.0,20210920.0,20210927,20210927,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20210927.0,,CN,DE,DE,2021,Q3,Elderly
198881691,19888169,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,1,I,20200601.0,20210920.0,20210927,20210927,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20210927.0,,CN,DE,DE,2021,Q3,Elderly
198881691,19888169,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Hypertensive crisis,,2021,Q3,1,I,20200601.0,20210920.0,20210927,20210927,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20210927.0,,CN,DE,DE,2021,Q3,Elderly
198881691,19888169,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Overdose,,2021,Q3,1,I,20200601.0,20210920.0,20210927,20210927,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20210927.0,,CN,DE,DE,2021,Q3,Elderly
198881691,19888169,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Vertigo,,2021,Q3,1,I,20200601.0,20210920.0,20210927,20210927,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20210927.0,,CN,DE,DE,2021,Q3,Elderly
198969351,19896935,3,SS,Semaglutide,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Deafness,,2021,Q3,1,I,20200601.0,20210918.0,20210930,20210930,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20210930.0,,CN,DE,DE,2021,Q3,Elderly
198969351,19896935,3,SS,Semaglutide,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Gait disturbance,,2021,Q3,1,I,20200601.0,20210918.0,20210930,20210930,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20210930.0,,CN,DE,DE,2021,Q3,Elderly
198969351,19896935,3,SS,Semaglutide,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Hypertensive crisis,,2021,Q3,1,I,20200601.0,20210918.0,20210930,20210930,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20210930.0,,CN,DE,DE,2021,Q3,Elderly
198969351,19896935,3,SS,Semaglutide,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Overdose,,2021,Q3,1,I,20200601.0,20210918.0,20210930,20210930,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20210930.0,,CN,DE,DE,2021,Q3,Elderly
198969351,19896935,3,SS,Semaglutide,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q3,Vertigo,,2021,Q3,1,I,20200601.0,20210918.0,20210930,20210930,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20210930.0,,CN,DE,DE,2021,Q3,Elderly
199000231,19900023,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY, INJECTION/INFUSION SOLUTION",,,,,,,,0.5,MG,SOLUTION FOR INJECTION/INFUSION,/wk,2021,Q3,Fatigue,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066605,MYLAN,,65.0,YR,,M,Y,,,20210929.0,,PH,DE,DE,2021,Q3,Elderly
199000231,19900023,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY, INJECTION/INFUSION SOLUTION",,,,,,,,0.5,MG,SOLUTION FOR INJECTION/INFUSION,/wk,2021,Q3,Hypotension,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066605,MYLAN,,65.0,YR,,M,Y,,,20210929.0,,PH,DE,DE,2021,Q3,Elderly
199000231,19900023,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 MG, WEEKLY, INJECTION/INFUSION SOLUTION",,,,,,,,0.5,MG,SOLUTION FOR INJECTION/INFUSION,/wk,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210924.0,20210929,20210929,EXP,,DE-MYLANLABS-2021M1066605,MYLAN,,65.0,YR,,M,Y,,,20210929.0,,PH,DE,DE,2021,Q3,Elderly
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Drug use disorder,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Emotional distress,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Impaired quality of life,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Intentional product use issue,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Joint injury,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
199057891,19905789,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q3,Somatic symptom disorder,,2021,Q3,1,I,,20210920.0,20210930,20210930,EXP,,CA-TEVA-2021-CA-1958568,TEVA,,44.0,YR,A,M,Y,,,20210930.0,,HP,CA,CA,2021,Q3,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nerve compression,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Lung disorder,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Muscle spasms,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Asthma,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Musculoskeletal stiffness,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood pressure increased,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Optic nerve disorder,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Visual impairment,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Drug hypersensitivity,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Forced expiratory volume decreased,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood pressure systolic increased,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Rales,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nerve injury,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Sputum discoloured,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood cholesterol increased,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Middle insomnia,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Eye disorder,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood pressure increased,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Wheezing,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Bronchospasm,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Gastroenteritis,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Visual field defect,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nasal discharge discolouration,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Heart rate increased,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Paranasal sinus discomfort,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Eye pain,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Periarthritis,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cervical spinal stenosis,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blindness,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nasal congestion,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nervous system disorder,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Sinusitis,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1177931126,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Neuritis,,2021,Q4,26,F,20120306.0,20210108.0,20151125,20211111,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20211111.0,,MD,CA,CA,2021,Q4,Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Heart rate decreased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Drug ineffective,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Cortisol decreased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Facial pain,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Insulin-like growth factor increased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Sinusitis,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Stress,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Back pain,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Nasal congestion,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Infectious mononucleosis,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Blood pressure increased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Blood cholesterol abnormal,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Groin abscess,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Subcutaneous abscess,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Movement disorder,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Laryngitis bacterial,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Abdominal pain,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Heart rate increased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Blood pressure diastolic decreased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Blood growth hormone increased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Body temperature decreased,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Anxiety,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Drug resistance,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Headache,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1436788031,14367880,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Ligament sprain,,2021,Q4,31,F,20151225.0,20211221.0,20180109,20211227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20211227.0,,CN,CA,CA,2021,Q4,Young Adult
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Agitation,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Drug ineffective,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Conjunctivitis,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Myalgia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Delirium,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Autoinflammatory disease,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Eye inflammation,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Fatigue,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Pyrexia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Bronchitis,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Dyspnoea,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Dementia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Muscular weakness,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Hypertension,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Vascular cognitive impairment,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Treatment failure,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Amnesia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Skin disorder,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Ocular discomfort,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Joint swelling,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Lethargy,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Blood pressure systolic increased,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Ocular hyperaemia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Arthralgia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Mood swings,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Gene mutation,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Pneumonia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Drug intolerance,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Decreased appetite,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Glaucoma,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Weight decreased,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Fatigue,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Paranoia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Upper respiratory tract infection,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Rash,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Serum amyloid A protein increased,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Deafness neurosensory,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Chills,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Urticaria,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Illness,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Asthenia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Cryopyrin associated periodic syndrome,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Arthralgia,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
1672248913,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2021,Q4,Eye pain,,2021,Q4,13,F,20190301.0,20211210.0,20190820,20211218,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20211218.0,,MD,CA,CA,2021,Q4,Elderly
178228033,17822803,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,,,Injection,/WK,2021,Q4,Vitamin B12 decreased,,2021,Q4,3,F,20200328.0,20211122.0,20200526,20211129,EXP,FR-AFSSAPS-AM20200588,FR-EMD Serono-E2B_90077605,EMD SERONO INC,,73.0,YR,E,M,Y,81.0,KG,20211129.0,,MD,FR,,2021,Q4,Elderly
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Weight increased,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Hepatic cancer,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Second primary malignancy,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Heart valve incompetence,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Malaise,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Migraine,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Fall,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Rib fracture,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Musculoskeletal chest pain,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Hypersensitivity,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Headache,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179206699,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2021,Q4,Blood pressure increased,,2021,Q4,9,F,20200201.0,20211021.0,20200621,20211028,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20211028.0,,CN,CA,CA,2021,Q4,Adult
179240133,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,3,F,,20211030.0,20200622,20211112,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Adult
179240133,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2021,Q4,Malaise,,2021,Q4,3,F,,20211030.0,20200622,20211112,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Adult
179240133,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,3,F,,20211030.0,20200622,20211112,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Adult
179240133,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,3,F,,20211030.0,20200622,20211112,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Adult
179240133,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2021,Q4,Weight decreased,,2021,Q4,3,F,,20211030.0,20200622,20211112,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20211112.0,,MD,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Angina pectoris,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Appetite disorder,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Asthma,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Chest pain,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Cough,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Dyspnoea exertional,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Depressed mood,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Depressive symptom,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Dyspnoea,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Fall,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Flank pain,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Heart sounds,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Influenza,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Injury,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Insomnia,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Lower respiratory tract infection,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Nasal congestion,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Nasopharyngitis,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Malaise,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Productive cough,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Prolonged expiration,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Pyrexia,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Rales,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Respiration abnormal,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Rhinorrhoea,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Weight decreased,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Stress,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Upper respiratory tract infection,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Wheezing,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
181601215,18160121,45,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,Solution,/WK,2021,Q4,Chest discomfort,,2021,Q4,5,F,,20210920.0,20200818,20211004,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20211004.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Sleep apnoea syndrome,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Chronic kidney disease,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Lower respiratory tract infection,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Nasal congestion,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Nasopharyngitis,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Productive cough,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Oropharyngeal pain,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Urinary incontinence,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Pharyngitis,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Asthma,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Hypertension,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Hyperlipidaemia,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
183089517,18308951,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, qd",,,U,,,,,0.25,MG,Solution for injection,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,7,F,,20211012.0,20200924,20211020,EXP,,CA-APOTEX-2020AP018080,APOTEX,,51.0,YR,,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
184795859,18479585,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, qw",,,,,,,209637.0,0.25,MG,Solution for injection,/WK,2021,Q4,Cholelithiasis,,2021,Q4,9,F,20201004.0,20211111.0,20201109,20211122,EXP,,JP-NOVOPROD-763484,NOVO NORDISK,,78.0,YR,,M,Y,75.0,KG,20211122.0,,MD,JP,JP,2021,Q4,Elderly
184795859,18479585,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, qw",,,,,,,209637.0,0.25,MG,Solution for injection,/WK,2021,Q4,Cholangitis acute,,2021,Q4,9,F,20201004.0,20211111.0,20201109,20211122,EXP,,JP-NOVOPROD-763484,NOVO NORDISK,,78.0,YR,,M,Y,75.0,KG,20211122.0,,MD,JP,JP,2021,Q4,Elderly
186846167,18684616,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,7,F,20200914.0,20211118.0,20201230,20211129,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20211129.0,,MD,US,US,2021,Q4,Adult
186846167,18684616,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2021,Q4,Vitreous haemorrhage,,2021,Q4,7,F,20200914.0,20211118.0,20201230,20211129,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20211129.0,,MD,US,US,2021,Q4,Adult
186846167,18684616,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,7,F,20200914.0,20211118.0,20201230,20211129,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20211129.0,,MD,US,US,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Oxygen saturation decreased,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Right ventricular failure,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Pulmonary veno-occlusive disease,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Ulcer haemorrhage,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Gout,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Oxygen consumption increased,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Pulmonary arterial hypertension,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188491314,18849131,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q4,Right-to-left cardiac shunt,,2021,Q4,4,F,20200101.0,20211109.0,20210204,20211119,EXP,,CA-JNJFOC-A-CH2020-203225,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,82.0,KG,20211119.0,,MD,CA,CA,2021,Q4,Adult
188826856,18882685,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",60.0,MG,Y,,,,213051.0,3.0,MG,Tablet,QD,2021,Q4,Cholecystitis acute,,2021,Q4,6,F,20210127.0,20211109.0,20210211,20211116,EXP,,CZ-NOVOPROD-785390,NOVO NORDISK,,73.0,YR,,M,Y,91.0,KG,20211116.0,,MD,CZ,CZ,2021,Q4,Elderly
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Asthma,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Pharyngitis,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Urinary incontinence,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Chronic kidney disease,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Sleep apnoea syndrome,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Hyperlipidaemia,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Nasopharyngitis,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Productive cough,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Oropharyngeal pain,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Hypertension,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Lower respiratory tract infection,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Nasal congestion,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189476233,18947623,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,U,Unknown,,,0.25,MG,,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,3,F,,20211203.0,20210226,20211203,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-085192",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211203.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Oropharyngeal pain,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Hyperlipidaemia,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Productive cough,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Sleep apnoea syndrome,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Chronic kidney disease,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Urinary incontinence,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Asthma,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Nasal congestion,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Hypertension,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Nasopharyngitis,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Pharyngitis,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
189705732,18970573,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Lower respiratory tract infection,,2021,Q4,2,F,,20211129.0,20210304,20211207,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211207.0,,CN,CA,CA,2021,Q4,Adult
190701074,19070107,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,N,,,,213051.0,,,Tablet,,2021,Q4,Cholelithiasis,,2021,Q4,4,F,20210309.0,20210922.0,20210329,20211004,EXP,,TW-NOVOPROD-798209,NOVO NORDISK,,68.0,YR,,M,Y,62.0,KG,20211004.0,,MD,TW,TW,2021,Q4,Elderly
190701074,19070107,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,N,,,,213051.0,,,Tablet,,2021,Q4,Cholecystitis acute,,2021,Q4,4,F,20210309.0,20210922.0,20210329,20211004,EXP,,TW-NOVOPROD-798209,NOVO NORDISK,,68.0,YR,,M,Y,62.0,KG,20211004.0,,MD,TW,TW,2021,Q4,Elderly
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Anxiety,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Diarrhoea,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Constipation,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Fatigue,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Feeling abnormal,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Feeling jittery,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Food craving,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Headache,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Heart rate increased,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Hormone level abnormal,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Nervousness,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Urinary tract infection,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Vaginal infection,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Vulvovaginal dryness,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.5 milligram,,,U,,,,,1.5,MG,Solution,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Anxiety,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Diarrhoea,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Constipation,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Fatigue,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Feeling abnormal,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Feeling jittery,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Food craving,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Headache,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Heart rate increased,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Hormone level abnormal,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Nervousness,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Urinary tract infection,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Vaginal infection,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Vulvovaginal dryness,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191056492,19105649,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,U,,,,,1.0,MG,Solution,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,,20210922.0,20210408,20211006,EXP,,CA-AUROBINDO-AUR-APL-2021-014423,AUROBINDO,,43.0,YR,,F,Y,178.0,KG,20211006.0,,HP,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Asthma,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Dyspnoea,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Hypoacusis,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Depression,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191402622,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Wheezing,,2021,Q4,2,F,,20211208.0,20210415,20211217,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20211217.0,,MD,CA,CA,2021,Q4,Adult
191562704,19156270,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",,,,,,,209637.0,0.5,MG,Solution for injection,/WK,2021,Q4,Cholecystitis acute,,2021,Q4,4,F,20201229.0,20211203.0,20210420,20211214,EXP,,RO-NOVOPROD-802761,NOVO NORDISK,,67.0,YR,,F,Y,76.0,KG,20211214.0,,MD,RO,RO,2021,Q4,Elderly
191562704,19156270,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",,,,,,,209637.0,0.5,MG,Solution for injection,/WK,2021,Q4,Cholelithiasis,,2021,Q4,4,F,20201229.0,20211203.0,20210420,20211214,EXP,,RO-NOVOPROD-802761,NOVO NORDISK,,67.0,YR,,F,Y,76.0,KG,20211214.0,,MD,RO,RO,2021,Q4,Elderly
192337814,19233781,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 mg, qd",2604.0,MG,Y,N,,,213051.0,7.0,MG,Tablet,QD,2021,Q4,Gallbladder empyema,,2021,Q4,4,F,20201220.0,20211118.0,20210507,20211123,EXP,,RS-NOVOPROD-777560,NOVO NORDISK,,80.0,YR,,M,Y,70.0,KG,20211123.0,,MD,RS,RS,2021,Q4,Elderly
192337814,19233781,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",2604.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2021,Q4,Gallbladder empyema,,2021,Q4,4,F,20201220.0,20211118.0,20210507,20211123,EXP,,RS-NOVOPROD-777560,NOVO NORDISK,,80.0,YR,,M,Y,70.0,KG,20211123.0,,MD,RS,RS,2021,Q4,Elderly
192520998,19252099,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",1904.0,MG,D,,,,213051.0,14.0,MG,Tablet,QD,2021,Q4,Bile duct stone,,2021,Q4,8,F,20210413.0,20210921.0,20210513,20211001,EXP,,GB-NOVOPROD-810168,NOVO NORDISK,,71.0,YR,,F,Y,,,20211001.0,,MD,GB,GB,2021,Q4,Elderly
194112255,19411225,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,483.0,MG,D,,,,213051.0,,,Tablet,,2021,Q4,Cholelithiasis,,2021,Q4,5,F,20210601.0,20211201.0,20210614,20211206,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20211206.0,,MD,CO,CO,2021,Q4,Elderly
194112255,19411225,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,483.0,MG,D,,,,213051.0,,,Tablet,,2021,Q4,Cholecystitis,,2021,Q4,5,F,20210601.0,20211201.0,20210614,20211206,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20211206.0,,MD,CO,CO,2021,Q4,Elderly
194112255,19411225,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",483.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2021,Q4,Cholelithiasis,,2021,Q4,5,F,20210601.0,20211201.0,20210614,20211206,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20211206.0,,MD,CO,CO,2021,Q4,Elderly
194112255,19411225,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",483.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2021,Q4,Cholecystitis,,2021,Q4,5,F,20210601.0,20211201.0,20210614,20211206,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20211206.0,,MD,CO,CO,2021,Q4,Elderly
194112255,19411225,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,483.0,MG,D,,,,213051.0,,,Tablet,,2021,Q4,Cholelithiasis,,2021,Q4,5,F,20210601.0,20211201.0,20210614,20211206,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20211206.0,,MD,CO,CO,2021,Q4,Elderly
194112255,19411225,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,483.0,MG,D,,,,213051.0,,,Tablet,,2021,Q4,Cholecystitis,,2021,Q4,5,F,20210601.0,20211201.0,20210614,20211206,EXP,,CO-NOVOPROD-820082,NOVO NORDISK,,72.0,YR,,F,Y,67.0,KG,20211206.0,,MD,CO,CO,2021,Q4,Elderly
195925145,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2021,Q4,Hepatobiliary procedural complication,,2021,Q4,5,F,20210220.0,20211012.0,20210722,20211021,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20211021.0,,MD,GB,GB,2021,Q4,Elderly
195925145,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2021,Q4,Bile duct stone,,2021,Q4,5,F,20210220.0,20211012.0,20210722,20211021,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20211021.0,,MD,GB,GB,2021,Q4,Elderly
195925145,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2021,Q4,Gastrointestinal wall thickening,,2021,Q4,5,F,20210220.0,20211012.0,20210722,20211021,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20211021.0,,MD,GB,GB,2021,Q4,Elderly
195925145,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2021,Q4,Cholecystitis acute,,2021,Q4,5,F,20210220.0,20211012.0,20210722,20211021,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20211021.0,,MD,GB,GB,2021,Q4,Elderly
195925145,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2021,Q4,Gallbladder rupture,,2021,Q4,5,F,20210220.0,20211012.0,20210722,20211021,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20211021.0,,MD,GB,GB,2021,Q4,Elderly
196083017,19608301,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2021,Q4,Cholelithiasis,,2021,Q4,7,F,20210708.0,20211114.0,20210726,20211119,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20211119.0,,MD,IL,IL,2021,Q4,Adult
196083017,19608301,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2021,Q4,Cholecystitis,,2021,Q4,7,F,20210708.0,20211114.0,20210726,20211119,EXP,,IL-NOVOPROD-828509,NOVO NORDISK,,47.0,YR,,M,Y,86.0,KG,20211119.0,,MD,IL,IL,2021,Q4,Adult
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Rhinorrhoea,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood sodium decreased,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Laziness,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nausea,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Amnesia,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dysphonia,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pulmonary mass,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Wrong technique in product usage process,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nasopharyngitis,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cough,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Headache,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196503148,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Hypokinesia,,2021,Q4,8,F,20210724.0,20211123.0,20210802,20211125,PER,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
196745803,19674580,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,Solution for injection,,2021,Q4,Hyperplastic cholecystopathy,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
196745803,19674580,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,Solution for injection,,2021,Q4,Bile duct stone,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
196745803,19674580,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,Solution for injection,,2021,Q4,Hyperplastic cholecystopathy,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
196745803,19674580,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,Solution for injection,,2021,Q4,Bile duct stone,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
196745803,19674580,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,Solution for injection,,2021,Q4,Hyperplastic cholecystopathy,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
196745803,19674580,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,48.652,MG,,,,,215256.0,,,Solution for injection,,2021,Q4,Bile duct stone,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
196745803,19674580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",48.652,MG,,,,,215256.0,0.5,MG,Solution for injection,/WK,2021,Q4,Hyperplastic cholecystopathy,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
196745803,19674580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",48.652,MG,,,,,215256.0,0.5,MG,Solution for injection,/WK,2021,Q4,Bile duct stone,,2021,Q4,3,F,20210420.0,20211115.0,20210809,20211129,EXP,,US-NOVOPROD-809060,NOVO NORDISK,,76.0,YR,,M,Y,97.0,KG,20211129.0,,MD,US,US,2021,Q4,Elderly
197649432,19764943,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2021,Q4,Decreased appetite,,2021,Q4,2,F,,20211123.0,20210831,20211202,EXP,,CA-APOTEX-2021AP039441,APOTEX,,61.0,YR,,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
197649432,19764943,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,2,F,,20211123.0,20210831,20211202,EXP,,CA-APOTEX-2021AP039441,APOTEX,,61.0,YR,,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
197649432,19764943,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2021,Q4,Blood creatine increased,,2021,Q4,2,F,,20211123.0,20210831,20211202,EXP,,CA-APOTEX-2021AP039441,APOTEX,,61.0,YR,,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
197649432,19764943,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2021,Q4,Rhabdomyolysis,,2021,Q4,2,F,,20211123.0,20210831,20211202,EXP,,CA-APOTEX-2021AP039441,APOTEX,,61.0,YR,,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
197649432,19764943,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2021,Q4,Muscle spasms,,2021,Q4,2,F,,20211123.0,20210831,20211202,EXP,,CA-APOTEX-2021AP039441,APOTEX,,61.0,YR,,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
197649432,19764943,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,2,F,,20211123.0,20210831,20211202,EXP,,CA-APOTEX-2021AP039441,APOTEX,,61.0,YR,,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
197649432,19764943,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2021,Q4,Flank pain,,2021,Q4,2,F,,20211123.0,20210831,20211202,EXP,,CA-APOTEX-2021AP039441,APOTEX,,61.0,YR,,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
198154442,19815444,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",3.935,MG,Y,N,,,215256.0,0.24,MG,Solution for injection,/WK,2021,Q4,Drug-induced liver injury,,2021,Q4,2,F,20210116.0,20211026.0,20210910,20211101,EXP,,PT-NOVOPROD-781419,NOVO NORDISK,,45.0,YR,,F,Y,72.0,KG,20211101.0,,MD,PT,PT,2021,Q4,Adult
198154442,19815444,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",3.935,MG,Y,N,,,215256.0,0.5,MG,Solution for injection,/WK,2021,Q4,Drug-induced liver injury,,2021,Q4,2,F,20210116.0,20211026.0,20210910,20211101,EXP,,PT-NOVOPROD-781419,NOVO NORDISK,,45.0,YR,,F,Y,72.0,KG,20211101.0,,MD,PT,PT,2021,Q4,Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Suicidal ideation,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Muscle spasms,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Paraesthesia,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Nausea,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Vomiting,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Apathy,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Appendix disorder,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Crying,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Gallbladder disorder,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Pain,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Sleep apnoea syndrome,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Urinary tract infection,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Off label use,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Product availability issue,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Headache,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Depression,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Dissociation,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Haemorrhagic ovarian cyst,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Irregular sleep phase,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Menstrual disorder,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Menstruation irregular,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Mood altered,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Sleep-related eating disorder,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198629552,19862955,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,1.0,MG,,/WK,2021,Q4,Stress,,2021,Q4,2,F,,20210913.0,20210921,20211004,EXP,,CA-ASTRAZENECA-2021A183570,ASTRAZENECA,,24.0,YR,,F,Y,,,20211004.0,,MD,CA,CA,2021,Q4,Young Adult
198969352,19896935,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Hypertensive crisis,,2021,Q4,2,F,20200601.0,20210918.0,20210930,20211027,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20211027.0,,HP,DE,DE,2021,Q4,Elderly
198969352,19896935,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Vertigo,,2021,Q4,2,F,20200601.0,20210918.0,20210930,20211027,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20211027.0,,HP,DE,DE,2021,Q4,Elderly
198969352,19896935,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Deafness,,2021,Q4,2,F,20200601.0,20210918.0,20210930,20211027,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20211027.0,,HP,DE,DE,2021,Q4,Elderly
198969352,19896935,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,2,F,20200601.0,20210918.0,20210930,20211027,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20211027.0,,HP,DE,DE,2021,Q4,Elderly
198969352,19896935,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Overdose,,2021,Q4,2,F,20200601.0,20210918.0,20210930,20211027,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20211027.0,,HP,DE,DE,2021,Q4,Elderly
199225771,19922577,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Hepatic enzyme increased,,2021,Q4,1,I,,20210926.0,20211005,20211005,EXP,,CA-TEVA-2021-CA-1961194,TEVA,,61.0,YR,A,F,Y,,,20211005.0,,HP,CA,CA,2021,Q4,Adult
199225771,19922577,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Arthritis,,2021,Q4,1,I,,20210926.0,20211005,20211005,EXP,,CA-TEVA-2021-CA-1961194,TEVA,,61.0,YR,A,F,Y,,,20211005.0,,HP,CA,CA,2021,Q4,Adult
199225771,19922577,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,1,I,,20210926.0,20211005,20211005,EXP,,CA-TEVA-2021-CA-1961194,TEVA,,61.0,YR,A,F,Y,,,20211005.0,,HP,CA,CA,2021,Q4,Adult
199239411,19923941,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q4,Abdominal pain upper,,2021,Q4,1,I,20210722.0,,20211005,20211005,DIR,FDA-CDER-CTU-2021-73827,,FDA-CTU,,52.0,YR,,F,N,122.0,KG,20211003.0,N,PH,US,US,2021,Q4,Adult
199239411,19923941,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q4,Hepatosplenomegaly,,2021,Q4,1,I,20210722.0,,20211005,20211005,DIR,FDA-CDER-CTU-2021-73827,,FDA-CTU,,52.0,YR,,F,N,122.0,KG,20211003.0,N,PH,US,US,2021,Q4,Adult
199239411,19923941,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20210722.0,,20211005,20211005,DIR,FDA-CDER-CTU-2021-73827,,FDA-CTU,,52.0,YR,,F,N,122.0,KG,20211003.0,N,PH,US,US,2021,Q4,Adult
199239411,19923941,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q4,Nausea,,2021,Q4,1,I,20210722.0,,20211005,20211005,DIR,FDA-CDER-CTU-2021-73827,,FDA-CTU,,52.0,YR,,F,N,122.0,KG,20211003.0,N,PH,US,US,2021,Q4,Adult
199239411,19923941,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q4,Vomiting,,2021,Q4,1,I,20210722.0,,20211005,20211005,DIR,FDA-CDER-CTU-2021-73827,,FDA-CTU,,52.0,YR,,F,N,122.0,KG,20211003.0,N,PH,US,US,2021,Q4,Adult
199239411,19923941,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,QW,2021,Q4,Abdominal pain,,2021,Q4,1,I,20210722.0,,20211005,20211005,DIR,FDA-CDER-CTU-2021-73827,,FDA-CTU,,52.0,YR,,F,N,122.0,KG,20211003.0,N,PH,US,US,2021,Q4,Adult
199247781,19924778,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211005.0,20211006,20211006,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-130885",BOEHRINGER INGELHEIM,"Dresbach J, Landeen C, Janikowski C, Malesker M. Euglycemic ketoacidosis secondary to empagliflozin and ketogenic diet. Journal of the American College of Clinical Pharmacy. 2021; 4: 1248-",48.0,YR,A,M,Y,,,20211006.0,,PH,US,US,2021,Q4,Adult
199247781,19924778,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211005.0,20211006,20211006,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-130885",BOEHRINGER INGELHEIM,"Dresbach J, Landeen C, Janikowski C, Malesker M. Euglycemic ketoacidosis secondary to empagliflozin and ketogenic diet. Journal of the American College of Clinical Pharmacy. 2021; 4: 1248-",48.0,YR,A,M,Y,,,20211006.0,,PH,US,US,2021,Q4,Adult
199379211,19937921,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,20200723.0,20210928.0,20211011,20211011,EXP,,SI-NOVOPROD-852154,NOVO NORDISK,,78.0,YR,,M,Y,,,20211011.0,,MD,SI,SI,2021,Q4,Elderly
199379211,19937921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Glomerular filtration rate decreased,,2021,Q4,1,I,20200723.0,20210928.0,20211011,20211011,EXP,,SI-NOVOPROD-852154,NOVO NORDISK,,78.0,YR,,M,Y,,,20211011.0,,MD,SI,SI,2021,Q4,Elderly
199387042,19938704,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20210801.0,20211015.0,20211011,20211020,EXP,,NVSJ2021JP013863,NOVARTIS,,70.0,YR,,M,Y,,,20211020.0,,MD,JP,JP,2021,Q4,Elderly
199387042,19938704,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blister,,2021,Q4,2,F,20210801.0,20211015.0,20211011,20211020,EXP,,NVSJ2021JP013863,NOVARTIS,,70.0,YR,,M,Y,,,20211020.0,,MD,JP,JP,2021,Q4,Elderly
199387042,19938704,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pemphigoid,,2021,Q4,2,F,20210801.0,20211015.0,20211011,20211020,EXP,,NVSJ2021JP013863,NOVARTIS,,70.0,YR,,M,Y,,,20211020.0,,MD,JP,JP,2021,Q4,Elderly
199395181,19939518,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Urticaria,,2021,Q4,1,I,20210927.0,20211008.0,20211011,20211011,EXP,,US-BEH-2021136883,CSL BEHRING,,53.0,YR,A,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199395181,19939518,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Swollen tongue,,2021,Q4,1,I,20210927.0,20211008.0,20211011,20211011,EXP,,US-BEH-2021136883,CSL BEHRING,,53.0,YR,A,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199395181,19939518,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Urticaria,,2021,Q4,1,I,20210927.0,20211008.0,20211011,20211011,EXP,,US-BEH-2021136883,CSL BEHRING,,53.0,YR,A,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199395181,19939518,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,20210927.0,20211008.0,20211011,20211011,EXP,,US-BEH-2021136883,CSL BEHRING,,53.0,YR,A,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199474182,19947418,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,,20211223.0,20211013,20211224,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-132249",BOEHRINGER INGELHEIM,,47.0,YR,A,F,Y,,,20211224.0,,MD,JP,JP,2021,Q4,Adult
199528631,19952863,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,N,D,,,,0.5,MG,,QD,2021,Q4,Pancreatitis,,2021,Q4,1,I,20210816.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75496,,FDA-CTU,,77.0,YR,,M,N,129.0,KG,20210930.0,N,PH,US,US,2021,Q4,Elderly
199529921,19952992,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.25,MG,,QW,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210630.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75533,,FDA-CTU,,53.0,YR,,F,N,90.0,KG,20210919.0,N,PH,US,US,2021,Q4,Adult
199529921,19952992,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.25,MG,,QW,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210630.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75533,,FDA-CTU,,53.0,YR,,F,N,90.0,KG,20210919.0,N,PH,US,US,2021,Q4,Adult
199529921,19952992,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.25,MG,,QW,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,20210630.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75533,,FDA-CTU,,53.0,YR,,F,N,90.0,KG,20210919.0,N,PH,US,US,2021,Q4,Adult
199529921,19952992,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.25,MG,,QW,2021,Q4,Blood urea increased,,2021,Q4,1,I,20210630.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75533,,FDA-CTU,,53.0,YR,,F,N,90.0,KG,20210919.0,N,PH,US,US,2021,Q4,Adult
199531462,19953146,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,Y,,LP56694,,,0.25,MG,,,2021,Q4,Rib fracture,,2021,Q4,2,F,20210801.0,20211022.0,20211013,20211027,EXP,,NVSC2021MX234000,NOVARTIS,,67.0,YR,,M,Y,78.3,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
199531462,19953146,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,Y,,LP56694,,,0.25,MG,,,2021,Q4,Secretion discharge,,2021,Q4,2,F,20210801.0,20211022.0,20211013,20211027,EXP,,NVSC2021MX234000,NOVARTIS,,67.0,YR,,M,Y,78.3,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
199531462,19953146,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,Y,,LP56694,,,0.25,MG,,,2021,Q4,Abdominal pain upper,,2021,Q4,2,F,20210801.0,20211022.0,20211013,20211027,EXP,,NVSC2021MX234000,NOVARTIS,,67.0,YR,,M,Y,78.3,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
199531462,19953146,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,Y,,LP56694,,,0.25,MG,,,2021,Q4,Diabetes mellitus,,2021,Q4,2,F,20210801.0,20211022.0,20211013,20211027,EXP,,NVSC2021MX234000,NOVARTIS,,67.0,YR,,M,Y,78.3,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
199531462,19953146,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,Y,,LP56694,,,0.25,MG,,,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210801.0,20211022.0,20211013,20211027,EXP,,NVSC2021MX234000,NOVARTIS,,67.0,YR,,M,Y,78.3,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
199531462,19953146,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,Y,,LP56694,,,0.25,MG,,,2021,Q4,Productive cough,,2021,Q4,2,F,20210801.0,20211022.0,20211013,20211027,EXP,,NVSC2021MX234000,NOVARTIS,,67.0,YR,,M,Y,78.3,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
199531462,19953146,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,Y,,LP56694,,,0.25,MG,,,2021,Q4,Fall,,2021,Q4,2,F,20210801.0,20211022.0,20211013,20211027,EXP,,NVSC2021MX234000,NOVARTIS,,67.0,YR,,M,Y,78.3,KG,20211027.0,,CN,MX,MX,2021,Q4,Elderly
199533271,19953327,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.5,MG,,QW,2021,Q4,Nausea,,2021,Q4,1,I,20210617.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75555,,FDA-CTU,,54.0,YR,,F,N,102.0,KG,20210831.0,N,PH,US,US,2021,Q4,Adult
199533271,19953327,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.5,MG,,QW,2021,Q4,Abdominal pain,,2021,Q4,1,I,20210617.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75555,,FDA-CTU,,54.0,YR,,F,N,102.0,KG,20210831.0,N,PH,US,US,2021,Q4,Adult
199533271,19953327,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.5,MG,,QW,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210617.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75555,,FDA-CTU,,54.0,YR,,F,N,102.0,KG,20210831.0,N,PH,US,US,2021,Q4,Adult
199533271,19953327,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.5,MG,,QW,2021,Q4,Vomiting,,2021,Q4,1,I,20210617.0,,20211012,20211012,DIR,FDA-CDER-CTU-2021-75555,,FDA-CTU,,54.0,YR,,F,N,102.0,KG,20210831.0,N,PH,US,US,2021,Q4,Adult
199587523,19958752,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2021,Q4,Jaundice cholestatic,,2021,Q4,3,F,20210726.0,20211030.0,20211015,20211110,EXP,,SK-NOVOPROD-854554,NOVO NORDISK,,51.0,YR,,M,Y,124.0,KG,20211110.0,,MD,SK,SK,2021,Q4,Adult
199626592,19962659,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,Solution for injection,,2021,Q4,Pancreatitis,,2021,Q4,2,F,20211003.0,20211019.0,20211018,20211101,EXP,,BE-NOVOPROD-854616,NOVO NORDISK,,70.0,YR,,M,Y,113.0,KG,20211101.0,,MD,BE,BE,2021,Q4,Elderly
199626592,19962659,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2021,Q4,Pancreatitis,,2021,Q4,2,F,20211003.0,20211019.0,20211018,20211101,EXP,,BE-NOVOPROD-854616,NOVO NORDISK,,70.0,YR,,M,Y,113.0,KG,20211101.0,,MD,BE,BE,2021,Q4,Elderly
199626592,19962659,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,Solution for injection,,2021,Q4,Pancreatitis,,2021,Q4,2,F,20211003.0,20211019.0,20211018,20211101,EXP,,BE-NOVOPROD-854616,NOVO NORDISK,,70.0,YR,,M,Y,113.0,KG,20211101.0,,MD,BE,BE,2021,Q4,Elderly
199632001,19963200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:weekly;,,,,D,,,,,,,,2021,Q4,Disturbance in attention,,2021,Q4,1,I,20211016.0,,20211016,20211016,DIR,586822,,FDA-CTU,,67.0,YR,,F,N,141.75,KG,20211016.0,N,MD,US,US,2021,Q4,Elderly
199632001,19963200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:weekly;,,,,D,,,,,,,,2021,Q4,Frustration tolerance decreased,,2021,Q4,1,I,20211016.0,,20211016,20211016,DIR,586822,,FDA-CTU,,67.0,YR,,F,N,141.75,KG,20211016.0,N,MD,US,US,2021,Q4,Elderly
199632001,19963200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:weekly;,,,,D,,,,,,,,2021,Q4,Gastrointestinal disorder,,2021,Q4,1,I,20211016.0,,20211016,20211016,DIR,586822,,FDA-CTU,,67.0,YR,,F,N,141.75,KG,20211016.0,N,MD,US,US,2021,Q4,Elderly
199632001,19963200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:weekly;,,,,D,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20211016.0,,20211016,20211016,DIR,586822,,FDA-CTU,,67.0,YR,,F,N,141.75,KG,20211016.0,N,MD,US,US,2021,Q4,Elderly
199632001,19963200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:weekly;,,,,D,,,,,,,,2021,Q4,Depression,,2021,Q4,1,I,20211016.0,,20211016,20211016,DIR,586822,,FDA-CTU,,67.0,YR,,F,N,141.75,KG,20211016.0,N,MD,US,US,2021,Q4,Elderly
199632001,19963200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:weekly;,,,,D,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,20211016.0,,20211016,20211016,DIR,586822,,FDA-CTU,,67.0,YR,,F,N,141.75,KG,20211016.0,N,MD,US,US,2021,Q4,Elderly
199632001,19963200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,?          OTHER FREQUENCY:weekly;,,,,D,,,,,,,,2021,Q4,Binge eating,,2021,Q4,1,I,20211016.0,,20211016,20211016,DIR,586822,,FDA-CTU,,67.0,YR,,F,N,141.75,KG,20211016.0,N,MD,US,US,2021,Q4,Elderly
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Hyperlipidaemia,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Oropharyngeal pain,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Nasal congestion,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Chronic kidney disease,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Sleep apnoea syndrome,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Nasopharyngitis,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Hypertension,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Urinary incontinence,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Productive cough,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Asthma,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Pharyngitis,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199669312,19966931,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2021,Q4,Lower respiratory tract infection,,2021,Q4,2,F,,20211213.0,20211019,20211221,EXP,,CA-BAUSCH-BL-2021-034575,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211221.0,,MD,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Chest pain,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Wheezing,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Insomnia,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Malaise,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Angina pectoris,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Appetite disorder,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Asthma,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Chest discomfort,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Cough,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Depressed mood,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Depressive symptom,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Fall,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Injury,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Flank pain,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Heart sounds,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Influenza,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Lower respiratory tract infection,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Nasal congestion,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Productive cough,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Prolonged expiration,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Rales,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Respiration abnormal,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Rhinorrhoea,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Stress,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Upper respiratory tract infection,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199676581,19967658,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211011.0,20211019,20211019,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20211019.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Depressive symptom,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Heart sounds,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Malaise,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Prolonged expiration,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Rales,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Wheezing,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Angina pectoris,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Appetite disorder,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Asthma,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Chest pain,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Cough,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Depressed mood,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Fall,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Flank pain,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Influenza,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Injury,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Insomnia,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Lower respiratory tract infection,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Nasal congestion,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Productive cough,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Pyrexia,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Respiration abnormal,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Rhinorrhoea,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Stress,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Upper respiratory tract infection,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Weight decreased,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199793471,19979347,67,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2021,Q4,Chest discomfort,,2021,Q4,1,I,,20210831.0,20211020,20211020,EXP,,CA-TEVA-2021-CA-1949596,TEVA,,61.0,YR,A,F,Y,,,20211020.0,,HP,CA,CA,2021,Q4,Adult
199806391,19980639,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,Unknown,,,,,,,2021,Q4,Pneumonia,,2021,Q4,1,I,,20211015.0,20211022,20211022,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132780",BOEHRINGER INGELHEIM,"D^Ornellas R, DOUEN A, PANETTI R, SAMUEL J, APERGIS G. UNUSUAL SUSPECT: EUGLYCEMIC DIABETIC KETOACIDOSIS IN A TYPE 2 DIABETIC: WHAT EVERY DOCTOR NEEDS TO KNOW. Chest. 2021; 160: 970-",50.0,YR,A,M,Y,,,20211022.0,,HP,US,US,2021,Q4,Adult
199806391,19980639,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,Unknown,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211015.0,20211022,20211022,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132780",BOEHRINGER INGELHEIM,"D^Ornellas R, DOUEN A, PANETTI R, SAMUEL J, APERGIS G. UNUSUAL SUSPECT: EUGLYCEMIC DIABETIC KETOACIDOSIS IN A TYPE 2 DIABETIC: WHAT EVERY DOCTOR NEEDS TO KNOW. Chest. 2021; 160: 970-",50.0,YR,A,M,Y,,,20211022.0,,HP,US,US,2021,Q4,Adult
199808701,19980870,2,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 milligram, qd",,,U,,Unknown,,,3.0,MG,,QD,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211006.0,20211022,20211022,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-20024,LUPIN,"Jones A, Mospan C. Successful concomitant use of oral semaglutide with levothyroxine to achieve glycemic control: A case report. Journal of the American College of Clinical Pharmacy. 2021;4(9):1251",52.0,YR,,F,Y,,,20211022.0,,PH,US,US,2021,Q4,Adult
199808701,19980870,2,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 milligram, qd",,,U,,Unknown,,,3.0,MG,,QD,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211006.0,20211022,20211022,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-20024,LUPIN,"Jones A, Mospan C. Successful concomitant use of oral semaglutide with levothyroxine to achieve glycemic control: A case report. Journal of the American College of Clinical Pharmacy. 2021;4(9):1251",52.0,YR,,F,Y,,,20211022.0,,PH,US,US,2021,Q4,Adult
199808701,19980870,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 milligram, qd",,,U,,Unknown,,,14.0,MG,,QD,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211006.0,20211022,20211022,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-20024,LUPIN,"Jones A, Mospan C. Successful concomitant use of oral semaglutide with levothyroxine to achieve glycemic control: A case report. Journal of the American College of Clinical Pharmacy. 2021;4(9):1251",52.0,YR,,F,Y,,,20211022.0,,PH,US,US,2021,Q4,Adult
199808701,19980870,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 milligram, qd",,,U,,Unknown,,,14.0,MG,,QD,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211006.0,20211022,20211022,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-20024,LUPIN,"Jones A, Mospan C. Successful concomitant use of oral semaglutide with levothyroxine to achieve glycemic control: A case report. Journal of the American College of Clinical Pharmacy. 2021;4(9):1251",52.0,YR,,F,Y,,,20211022.0,,PH,US,US,2021,Q4,Adult
199863661,19986366,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Chills,,2021,Q4,1,I,20211006.0,20211010.0,20211022,20211022,EXP,GB-MHRA-WEBCOVID-202110091936335720-LAQWA,GB-NOVOPROD-855534,NOVO NORDISK,,68.0,YR,,F,Y,79.0,KG,20211022.0,,CN,GB,GB,2021,Q4,Elderly
199863661,19986366,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,20211006.0,20211010.0,20211022,20211022,EXP,GB-MHRA-WEBCOVID-202110091936335720-LAQWA,GB-NOVOPROD-855534,NOVO NORDISK,,68.0,YR,,F,Y,79.0,KG,20211022.0,,CN,GB,GB,2021,Q4,Elderly
199863661,19986366,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,1,I,20211006.0,20211010.0,20211022,20211022,EXP,GB-MHRA-WEBCOVID-202110091936335720-LAQWA,GB-NOVOPROD-855534,NOVO NORDISK,,68.0,YR,,F,Y,79.0,KG,20211022.0,,CN,GB,GB,2021,Q4,Elderly
199863661,19986366,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,20211006.0,20211010.0,20211022,20211022,EXP,GB-MHRA-WEBCOVID-202110091936335720-LAQWA,GB-NOVOPROD-855534,NOVO NORDISK,,68.0,YR,,F,Y,79.0,KG,20211022.0,,CN,GB,GB,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Headache,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Eyelid pain,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Vision blurred,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Uveitis,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Swelling face,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Photophobia,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Ocular hyperaemia,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Lacrimation increased,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199876971,19987697,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,UNK,,2021,Q4,Swelling of eyelid,,2021,Q4,1,I,,20211012.0,20211022,20211022,EXP,,CA-TAKEDA-2021TUS063706,TAKEDA,,77.0,YR,,F,Y,71.0,KG,20211022.0,,HP,CA,CA,2021,Q4,Elderly
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Granulomatosis with polyangiitis,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Weight increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Off label use,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Arthralgia,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Blood albumin decreased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Blood creatinine increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Blood osmolarity decreased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Blood pressure diastolic abnormal,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Blood pressure systolic increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Cushingoid,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,C-reactive protein increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Cataract,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Contusion,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Dehydration,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Eosinophil count increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Episcleritis,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,White blood cell count increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Herpes zoster,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Intentional product use issue,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Mean cell haemoglobin concentration decreased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Mean cell volume decreased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Monocyte count increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Musculoskeletal pain,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Musculoskeletal stiffness,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Neutrophil count increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Oedema,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Protein total increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Proteinuria,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Red blood cell count increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Red cell distribution width increased,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Renal vasculitis,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Vasculitis,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199931711,19993171,45,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, 1 every 1 Weeks",,,,,,,,1.0,MG,,/WK,2021,Q4,Vitreous detachment,,2021,Q4,1,I,,20211011.0,20211025,20211025,EXP,,CA-PFIZER INC-202101357886,PFIZER,,60.0,YR,,F,Y,,,20211025.0,,HP,CA,CA,2021,Q4,Adult
199975991,19997599,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,UNKNOWN,,,,,,,2021,Q4,Asthmatic crisis,,2021,Q4,1,I,20210923.0,20211012.0,20211026,20211026,EXP,ES-AEMPS-1023187,ES-ROCHE-2943843,ROCHE,,45.0,YR,,M,Y,,,20211026.0,,MD,ES,ES,2021,Q4,Adult
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Metabolic disorder,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Ventricular tachycardia,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Gastrointestinal disorder,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Vomiting,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Nausea,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Pancreatitis,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008451,20000845,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,LP57253,20231101.0,,1.0,MG,,QW,2021,Q4,Lipase increased,,2021,Q4,1,I,20210923.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79931,,FDA-CTU,,74.0,YR,,M,N,74.0,KG,20211025.0,N,PH,US,US,2021,Q4,Elderly
200008891,20000889,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,Y,,,,0.5,MG,,QW,2021,Q4,Movement disorder,,2021,Q4,1,I,20210830.0,,20211026,20211026,DIR,FDA-CDER-CTU-2021-79956,,FDA-CTU,,65.0,YR,,F,N,105.69,KG,20211026.0,N,MD,US,US,2021,Q4,Elderly
200008891,20000889,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,Y,,,,0.5,MG,,QW,2021,Q4,Tremor,,2021,Q4,1,I,20210830.0,,20211026,20211026,DIR,FDA-CDER-CTU-2021-79956,,FDA-CTU,,65.0,YR,,F,N,105.69,KG,20211026.0,N,MD,US,US,2021,Q4,Elderly
200011981,20001198,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,0.5,MG,,QW,2021,Q4,Diarrhoea,,2021,Q4,1,I,20200420.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-80039,,FDA-CTU,,74.0,YR,,M,N,,,20200617.0,N,PH,US,US,2021,Q4,Elderly
200012311,20001231,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,QW,2021,Q4,Gastrooesophageal reflux disease,,2021,Q4,1,I,20200505.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-80031,,FDA-CTU,,73.0,YR,,M,N,,,20200714.0,N,PH,US,US,2021,Q4,Elderly
200013601,20001360,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,,1.0,MG,,QW,2021,Q4,Thyroid cancer,,2021,Q4,1,I,20210901.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-79972,,FDA-CTU,,79.0,YR,,M,N,93.0,KG,20211012.0,N,PH,US,US,2021,Q4,Elderly
200040881,20004088,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,QW,2021,Q4,Diarrhoea,,2021,Q4,1,I,20200505.0,,20211027,20211027,DIR,FDA-CDER-CTU-2021-80029,,FDA-CTU,,64.0,YR,,M,N,,,20200714.0,N,PH,US,US,2021,Q4,Adult
200154551,20015455,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,1.0,MG,,QW,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20210805.0,,20211029,20211029,DIR,FDA-CDER-CTU-2021-80712,,FDA-CTU,,44.0,YR,,M,N,,,20211021.0,N,PH,US,,2021,Q4,Adult
200154551,20015455,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,1.0,MG,,QW,2021,Q4,Presyncope,,2021,Q4,1,I,20210805.0,,20211029,20211029,DIR,FDA-CDER-CTU-2021-80712,,FDA-CTU,,44.0,YR,,M,N,,,20211021.0,N,PH,US,,2021,Q4,Adult
200154551,20015455,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,1.0,MG,,QW,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210805.0,,20211029,20211029,DIR,FDA-CDER-CTU-2021-80712,,FDA-CTU,,44.0,YR,,M,N,,,20211021.0,N,PH,US,,2021,Q4,Adult
200154551,20015455,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,1.0,MG,,QW,2021,Q4,Azotaemia,,2021,Q4,1,I,20210805.0,,20211029,20211029,DIR,FDA-CDER-CTU-2021-80712,,FDA-CTU,,44.0,YR,,M,N,,,20211021.0,N,PH,US,,2021,Q4,Adult
200154551,20015455,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,1.0,MG,,QW,2021,Q4,Ventricular dysfunction,,2021,Q4,1,I,20210805.0,,20211029,20211029,DIR,FDA-CDER-CTU-2021-80712,,FDA-CTU,,44.0,YR,,M,N,,,20211021.0,N,PH,US,,2021,Q4,Adult
200158111,20015811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Rash,,2021,Q4,1,I,20210908.0,,20211101,20211101,DIR,FDA-CDER-CTU-2021-81418,,FDA-CTU,,64.0,YR,,M,N,81.0,KG,20211019.0,N,PH,US,,2021,Q4,Adult
200158111,20015811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,20210908.0,,20211101,20211101,DIR,FDA-CDER-CTU-2021-81418,,FDA-CTU,,64.0,YR,,M,N,81.0,KG,20211019.0,N,PH,US,,2021,Q4,Adult
200158111,20015811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210908.0,,20211101,20211101,DIR,FDA-CDER-CTU-2021-81418,,FDA-CTU,,64.0,YR,,M,N,81.0,KG,20211019.0,N,PH,US,,2021,Q4,Adult
200158111,20015811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210908.0,,20211101,20211101,DIR,FDA-CDER-CTU-2021-81418,,FDA-CTU,,64.0,YR,,M,N,81.0,KG,20211019.0,N,PH,US,,2021,Q4,Adult
200158111,20015811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Gastrooesophageal reflux disease,,2021,Q4,1,I,20210908.0,,20211101,20211101,DIR,FDA-CDER-CTU-2021-81418,,FDA-CTU,,64.0,YR,,M,N,81.0,KG,20211019.0,N,PH,US,,2021,Q4,Adult
200158111,20015811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20210908.0,,20211101,20211101,DIR,FDA-CDER-CTU-2021-81418,,FDA-CTU,,64.0,YR,,M,N,81.0,KG,20211019.0,N,PH,US,,2021,Q4,Adult
200159771,20015977,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,1,I,20211029.0,,20211102,20211102,DIR,589139,,FDA-CTU,,61.0,YR,,F,N,149.5,KG,20211102.0,N,PH,US,,2021,Q4,Adult
200159771,20015977,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211029.0,,20211102,20211102,DIR,589139,,FDA-CTU,,61.0,YR,,F,N,149.5,KG,20211102.0,N,PH,US,,2021,Q4,Adult
200159771,20015977,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Infusion related reaction,,2021,Q4,1,I,20211029.0,,20211102,20211102,DIR,589139,,FDA-CTU,,61.0,YR,,F,N,149.5,KG,20211102.0,N,PH,US,,2021,Q4,Adult
200159771,20015977,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211029.0,,20211102,20211102,DIR,589139,,FDA-CTU,,61.0,YR,,F,N,149.5,KG,20211102.0,N,PH,US,,2021,Q4,Adult
200210301,20021030,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 milligram,  nach Schema, Fertigspritzen",,,,,,,,2.0,MG,Injection,,2021,Q4,C-reactive protein increased,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,DE-MYLANLABS-2021M1076688,MYLAN,,63.0,YR,,M,Y,94.0,KG,20211101.0,,PH,DE,DE,2021,Q4,Adult
200210301,20021030,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 milligram,  nach Schema, Fertigspritzen",,,,,,,,2.0,MG,Injection,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,DE-MYLANLABS-2021M1076688,MYLAN,,63.0,YR,,M,Y,94.0,KG,20211101.0,,PH,DE,DE,2021,Q4,Adult
200210301,20021030,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 milligram,  nach Schema, Fertigspritzen",,,,,,,,2.0,MG,Injection,,2021,Q4,Pyelonephritis,,2021,Q4,1,I,,20211025.0,20211101,20211101,EXP,,DE-MYLANLABS-2021M1076688,MYLAN,,63.0,YR,,M,Y,94.0,KG,20211101.0,,PH,DE,DE,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Sleep apnoea syndrome,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Urinary incontinence,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Asthma,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Hyperlipidaemia,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Pharyngitis,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Productive cough,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Hypertension,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Lower respiratory tract infection,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Nasal congestion,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200216911,20021691,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2021,Q4,Oropharyngeal pain,,2021,Q4,1,I,,20211024.0,20211101,20211101,EXP,,CA-TEVA-2021-CA-1972054,TEVA,,51.0,YR,A,F,Y,,,20211101.0,,MD,CA,CA,2021,Q4,Adult
200240092,20024009,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,2,F,20211029.0,20211116.0,20211102,20211118,PER,,US-BEH-2021137692,CSL BEHRING,,60.0,YR,A,F,Y,,,20211118.0,,CN,US,US,2021,Q4,Adult
200240092,20024009,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2021,Q4,Blood pressure increased,,2021,Q4,2,F,20211029.0,20211116.0,20211102,20211118,PER,,US-BEH-2021137692,CSL BEHRING,,60.0,YR,A,F,Y,,,20211118.0,,CN,US,US,2021,Q4,Adult
200378751,20037875,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Urinary tract infection staphylococcal,,2021,Q4,1,I,,20211027.0,20211105,20211105,EXP,CA- HEALTHCANVIG- E2B_04190950,CA-NOVOPROD-861529,NOVO NORDISK,,72.0,YR,,M,Y,,,20211105.0,,CN,CA,CA,2021,Q4,Elderly
200521742,20052174,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,20211017.0,20211104.0,20211110,20211124,EXP,,NVSJ2021JP017323,NOVARTIS,,77.0,YR,,F,Y,,,20211124.0,,MD,JP,JP,2021,Q4,Elderly
200521742,20052174,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Escherichia pyelonephritis,,2021,Q4,2,F,20211017.0,20211104.0,20211110,20211124,EXP,,NVSJ2021JP017323,NOVARTIS,,77.0,YR,,F,Y,,,20211124.0,,MD,JP,JP,2021,Q4,Elderly
200544982,20054498,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW(1 milligram every 1 day)",,,U,,,,,1.0,MG,,/WK,2021,Q4,Mesenteric panniculitis,,2021,Q4,2,F,20211001.0,20211125.0,20211110,20211202,EXP,,NVSC2021FR254670,NOVARTIS,,57.0,YR,,F,Y,,,20211202.0,,CN,FR,FR,2021,Q4,Adult
200592332,20059233,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,,20211110.0,20211111,20211115,EXP,,US-BAUSCH-BL-2021-036939,BAUSCH AND LOMB,"Halderman A, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. Journal of the American society of nephrology. 2021;32:139.",77.0,YR,,M,Y,,,20211115.0,,HP,US,US,2021,Q4,Elderly
200592332,20059233,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211110.0,20211111,20211115,EXP,,US-BAUSCH-BL-2021-036939,BAUSCH AND LOMB,"Halderman A, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. Journal of the American society of nephrology. 2021;32:139.",77.0,YR,,M,Y,,,20211115.0,,HP,US,US,2021,Q4,Elderly
200631411,20063141,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 Once a week,,,,,,,,,,,,2021,Q4,Balanitis candida,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200631411,20063141,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 Once a week,,,,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200631411,20063141,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 Once a week,,,,,,,,,,,,2021,Q4,Penile pain,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200631411,20063141,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 Once a week,,,,,,,,,,,,2021,Q4,Skin lesion,,2021,Q4,1,I,20201201.0,20211104.0,20211112,20211112,EXP,,GB-AstraZeneca-2021A797073,ASTRAZENECA,,61.0,YR,,M,Y,69.0,KG,20211112.0,,MD,GB,,2021,Q4,Adult
200632251,20063225,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2021,Q4,Benign prostatic hyperplasia,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632251,20063225,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632251,20063225,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632251,20063225,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2021,Q4,Benign prostatic hyperplasia,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632251,20063225,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2021,Q4,Weight decreased,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200632251,20063225,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20211105.0,20211112,20211112,EXP,,DE-AstraZeneca-2021A787405,ASTRAZENECA,,65.0,YR,,M,Y,99.0,KG,20211112.0,,MD,DE,,2021,Q4,Elderly
200681461,20068146,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,UNKNOWN,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211110.0,20211115,20211115,EXP,,US-drreddys-SPO/USA/21/0143720,DR REDDYS,"Halderman A, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. J Am Soc Nephrol. 2021;32:139-139. doi:UNKNOWN",77.0,YR,E,M,Y,,,20211115.0,,HP,US,US,2021,Q4,Elderly
200681461,20068146,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,UNKNOWN,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211110.0,20211115,20211115,EXP,,US-drreddys-SPO/USA/21/0143720,DR REDDYS,"Halderman A, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. J Am Soc Nephrol. 2021;32:139-139. doi:UNKNOWN",77.0,YR,E,M,Y,,,20211115.0,,HP,US,US,2021,Q4,Elderly
200693611,20069361,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.5,MG,,QW,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210512.0,,20211112,20211112,DIR,FDA-CDER-CTU-2021-85033,,FDA-CTU,,77.0,YR,,M,N,67.13,KG,20210806.0,N,PH,US,,2021,Q4,Elderly
200693611,20069361,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.5,MG,,QW,2021,Q4,Syncope,,2021,Q4,1,I,20210512.0,,20211112,20211112,DIR,FDA-CDER-CTU-2021-85033,,FDA-CTU,,77.0,YR,,M,N,67.13,KG,20210806.0,N,PH,US,,2021,Q4,Elderly
200693611,20069361,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.5,MG,,QW,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,20210512.0,,20211112,20211112,DIR,FDA-CDER-CTU-2021-85033,,FDA-CTU,,77.0,YR,,M,N,67.13,KG,20210806.0,N,PH,US,,2021,Q4,Elderly
200693611,20069361,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.5,MG,,QW,2021,Q4,Lactic acidosis,,2021,Q4,1,I,20210512.0,,20211112,20211112,DIR,FDA-CDER-CTU-2021-85033,,FDA-CTU,,77.0,YR,,M,N,67.13,KG,20210806.0,N,PH,US,,2021,Q4,Elderly
200762491,20076249,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211109.0,20211116,20211116,EXP,,US-EMD Serono-9279442,EMD SERONO INC,"Halderman A, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Journal of the American Society of Nephrology. 2021 JAN 01;32:139.",77.0,YR,E,M,Y,,,20211116.0,,HP,US,,2021,Q4,Elderly
200762491,20076249,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211109.0,20211116,20211116,EXP,,US-EMD Serono-9279442,EMD SERONO INC,"Halderman A, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Journal of the American Society of Nephrology. 2021 JAN 01;32:139.",77.0,YR,E,M,Y,,,20211116.0,,HP,US,,2021,Q4,Elderly
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Chronic kidney disease,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Hyperlipidaemia,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Hypertension,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Nasal congestion,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Urinary incontinence,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Asthma,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Lower respiratory tract infection,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Nasopharyngitis,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Sleep apnoea syndrome,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Productive cough,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Pharyngitis,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200775564,20077556,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Oropharyngeal pain,,2021,Q4,4,F,,20211224.0,20211116,20211229,EXP,,CA-009507513-2111CAN003179,MERCK,,51.0,YR,,F,Y,,,20211229.0,,MD,CA,CA,2021,Q4,Adult
200818482,20081848,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2 milligram,,,,,,,,2.0,MG,Injection,,2021,Q4,Pain,,2021,Q4,2,F,,20211111.0,20211117,20211119,EXP,,DE-MYLANLABS-2021M1083653,MYLAN,,63.0,YR,,M,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Adult
200818482,20081848,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2 milligram,,,,,,,,2.0,MG,Injection,,2021,Q4,Pyrexia,,2021,Q4,2,F,,20211111.0,20211117,20211119,EXP,,DE-MYLANLABS-2021M1083653,MYLAN,,63.0,YR,,M,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Adult
200818482,20081848,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2 milligram,,,,,,,,2.0,MG,Injection,,2021,Q4,Chills,,2021,Q4,2,F,,20211111.0,20211117,20211119,EXP,,DE-MYLANLABS-2021M1083653,MYLAN,,63.0,YR,,M,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Adult
200848941,20084894,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, UNKNOWN",,,Y,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211111.0,20211118,20211118,EXP,,NVSC2021US259255,NOVARTIS,"Halderman AK, Kandarpa M. AKI Induced by Oral Semaglutide Leading to Metformin-Induced Lactic Acidosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32:139",77.0,YR,,M,Y,,,20211118.0,,HP,US,US,2021,Q4,Elderly
200856801,20085680,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,US-APOTEX-2021AP045371,APOTEX,"Halderman AK, Kandarpa M.. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Journal of the American Society of Nephrology. 2021;32:139",77.0,YR,,M,Y,,,20211118.0,,HP,US,US,2021,Q4,Elderly
200856801,20085680,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211110.0,20211118,20211118,EXP,,US-APOTEX-2021AP045371,APOTEX,"Halderman AK, Kandarpa M.. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Journal of the American Society of Nephrology. 2021;32:139",77.0,YR,,M,Y,,,20211118.0,,HP,US,US,2021,Q4,Elderly
200861442,20086144,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",323.317,MG,,,,,215256.0,2.4,MG,Solution for injection,/WK,2021,Q4,Bile duct stone,,2021,Q4,2,F,20211106.0,20211123.0,20211118,20211202,EXP,,TR-NOVOPROD-864758,NOVO NORDISK,,61.0,YR,,M,Y,107.0,KG,20211202.0,,MD,TR,TR,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Productive cough,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Nasopharyngitis,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Urinary incontinence,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Hypertension,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Nasal congestion,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Lower respiratory tract infection,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Oropharyngeal pain,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Pharyngitis,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Sleep apnoea syndrome,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Chronic kidney disease,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Hyperlipidaemia,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Asthma,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200869053,20086905,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,3,F,,20211224.0,20211118,20211230,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20211230.0,,MD,CA,CA,2021,Q4,Adult
200873271,20087327,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 mg, qw",,,,,,,209637.0,2.0,MG,,/WK,2021,Q4,Atrioventricular block second degree,,2021,Q4,1,I,20210901.0,20211104.0,20211118,20211118,EXP,CH-SM-2021-26006,CH-NOVOPROD-864459,NOVO NORDISK,,39.0,YR,,F,Y,,,20211118.0,,MD,CH,CH,2021,Q4,Adult
200873271,20087327,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 mg, qw",,,,,,,209637.0,2.0,MG,,/WK,2021,Q4,Tachycardia,,2021,Q4,1,I,20210901.0,20211104.0,20211118,20211118,EXP,CH-SM-2021-26006,CH-NOVOPROD-864459,NOVO NORDISK,,39.0,YR,,F,Y,,,20211118.0,,MD,CH,CH,2021,Q4,Adult
200945951,20094595,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211108.0,20211122,20211122,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068858,GLENMARK,"Halderman AK, Kandarpa M.. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Kidney Week 2021. San Diego CA United States. 2021;32:139",77.0,YR,,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
200945951,20094595,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211108.0,20211122,20211122,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068858,GLENMARK,"Halderman AK, Kandarpa M.. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Kidney Week 2021. San Diego CA United States. 2021;32:139",77.0,YR,,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
200995491,20099549,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211110.0,20211123,20211123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318401,RANBAXY,"Halderman AK, Kandarpa M. AKI Induced by Oral Semaglutide Leading to Metformin-Induced Lactic Acidosis. J Am Soc Nephrol. 2021;Nov 04:32139(ABSTRACT: PO0288)",77.0,YR,,M,Y,,,20211123.0,,HP,US,US,2021,Q4,Elderly
200995491,20099549,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211110.0,20211123,20211123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-318401,RANBAXY,"Halderman AK, Kandarpa M. AKI Induced by Oral Semaglutide Leading to Metformin-Induced Lactic Acidosis. J Am Soc Nephrol. 2021;Nov 04:32139(ABSTRACT: PO0288)",77.0,YR,,M,Y,,,20211123.0,,HP,US,US,2021,Q4,Elderly
201004142,20100414,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,Y,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,,20211122.0,20211123,20211202,EXP,,US-AUROBINDO-AUR-APL-2021-047080,AUROBINDO,"Halderman AK, Kandarpa M.. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Journal of the American Society of Nephrology.. 2021;32:139",77.0,YR,,M,Y,,,20211202.0,,HP,US,US,2021,Q4,Elderly
201004142,20100414,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,Y,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,2,F,,20211122.0,20211123,20211202,EXP,,US-AUROBINDO-AUR-APL-2021-047080,AUROBINDO,"Halderman AK, Kandarpa M.. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis.. Journal of the American Society of Nephrology.. 2021;32:139",77.0,YR,,M,Y,,,20211202.0,,HP,US,US,2021,Q4,Elderly
201037271,20103727,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Deafness,,2021,Q4,1,I,20200601.0,20211117.0,20211123,20211123,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20211123.0,,HP,DE,DE,2021,Q4,Elderly
201037271,20103727,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Hypertensive crisis,,2021,Q4,1,I,20200601.0,20211117.0,20211123,20211123,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20211123.0,,HP,DE,DE,2021,Q4,Elderly
201037271,20103727,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Vertigo,,2021,Q4,1,I,20200601.0,20211117.0,20211123,20211123,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20211123.0,,HP,DE,DE,2021,Q4,Elderly
201037271,20103727,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Overdose,,2021,Q4,1,I,20200601.0,20211117.0,20211123,20211123,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20211123.0,,HP,DE,DE,2021,Q4,Elderly
201037271,20103727,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,1,I,20200601.0,20211117.0,20211123,20211123,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20211123.0,,HP,DE,DE,2021,Q4,Elderly
201065281,20106528,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211110.0,20211124,20211124,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-22943,LUPIN,"Halderman AK, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. Journal of the American Society of Nephrology. 2021;32:139",77.0,YR,,M,Y,,,20211124.0,,HP,US,US,2021,Q4,Elderly
201079381,20107938,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Unknown",,,D,,Unknown,,,,,,,2021,Q4,Contraindicated product administered,,2021,Q4,1,I,20210526.0,20210527.0,20211124,20211124,PER,,US-PERRIGO-21US007153,PERRIGO,,74.0,YR,,M,Y,65.76,KG,20211124.0,,CN,US,US,2021,Q4,Elderly
201079381,20107938,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Unknown",,,D,,Unknown,,,,,,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20210526.0,20210527.0,20211124,20211124,PER,,US-PERRIGO-21US007153,PERRIGO,,74.0,YR,,M,Y,65.76,KG,20211124.0,,CN,US,US,2021,Q4,Elderly
201079381,20107938,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Unknown",,,D,,Unknown,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210526.0,20210527.0,20211124,20211124,PER,,US-PERRIGO-21US007153,PERRIGO,,74.0,YR,,M,Y,65.76,KG,20211124.0,,CN,US,US,2021,Q4,Elderly
201195121,20119512,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW(1 milligram every 1 day)",,,,,,,,1.0,MG,,/WK,2021,Q4,Mesenteric panniculitis,,2021,Q4,1,I,20211001.0,20211118.0,20211126,20211126,EXP,,FR-AstraZeneca-2021A806450,ASTRAZENECA,,57.0,YR,,F,Y,,,20211126.0,,MD,FR,,2021,Q4,Adult
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Arthralgia,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Frequent bowel movements,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Fluid retention,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Injection site bruising,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Gait disturbance,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Swelling face,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Swelling,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Injection site haemorrhage,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Psoriatic arthropathy,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201227731,20122773,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211122.0,20211128,20211128,PER,,CA-AMGEN-CANSP2021186636,AMGEN,,70.0,YR,E,F,Y,,,20211128.0,,CN,CA,CA,2021,Q4,Elderly
201232821,20123282,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",28.8,MG,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2021,Q4,Abortion spontaneous,,2021,Q4,1,I,20211008.0,20211115.0,20211129,20211129,EXP,,US-NOVOPROD-863279,NOVO NORDISK,,26.0,YR,,F,Y,82.2,KG,20211129.0,,MD,US,US,2021,Q4,Young Adult
201232821,20123282,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",28.8,MG,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2021,Q4,Maternal exposure during pregnancy,,2021,Q4,1,I,20211008.0,20211115.0,20211129,20211129,EXP,,US-NOVOPROD-863279,NOVO NORDISK,,26.0,YR,,F,Y,82.2,KG,20211129.0,,MD,US,US,2021,Q4,Young Adult
201234691,20123469,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,32.64,MG,Y,N,,,215256.0,,,Solution for injection,,2021,Q4,Cholecystitis infective,,2021,Q4,1,I,20211003.0,20211116.0,20211129,20211129,EXP,,AT-NOVOPROD-867664,NOVO NORDISK,,69.0,YR,,M,Y,118.0,KG,20211129.0,,MD,AT,AT,2021,Q4,Elderly
201234691,20123469,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24,mg,Once per week",32.64,MG,Y,N,,,215256.0,0.24,MG,Solution for injection,/WK,2021,Q4,Cholecystitis infective,,2021,Q4,1,I,20211003.0,20211116.0,20211129,20211129,EXP,,AT-NOVOPROD-867664,NOVO NORDISK,,69.0,YR,,M,Y,118.0,KG,20211129.0,,MD,AT,AT,2021,Q4,Elderly
201234691,20123469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.24 UNK,32.64,MG,Y,N,,,215256.0,0.24,MG,Solution for injection,/WK,2021,Q4,Cholecystitis infective,,2021,Q4,1,I,20211003.0,20211116.0,20211129,20211129,EXP,,AT-NOVOPROD-867664,NOVO NORDISK,,69.0,YR,,M,Y,118.0,KG,20211129.0,,MD,AT,AT,2021,Q4,Elderly
201234691,20123469,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,32.64,MG,Y,N,,,215256.0,,,Solution for injection,,2021,Q4,Cholecystitis infective,,2021,Q4,1,I,20211003.0,20211116.0,20211129,20211129,EXP,,AT-NOVOPROD-867664,NOVO NORDISK,,69.0,YR,,M,Y,118.0,KG,20211129.0,,MD,AT,AT,2021,Q4,Elderly
201235862,20123586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2021,Q4,Diabetic retinal oedema,,2021,Q4,2,F,20211117.0,20211214.0,20211129,20211222,EXP,,RU-NOVOPROD-868163,NOVO NORDISK,,71.0,YR,,F,Y,69.0,KG,20211222.0,,MD,RU,RU,2021,Q4,Elderly
201235862,20123586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2021,Q4,Diabetic retinal oedema,,2021,Q4,2,F,20211117.0,20211214.0,20211129,20211222,EXP,,RU-NOVOPROD-868163,NOVO NORDISK,,71.0,YR,,F,Y,69.0,KG,20211222.0,,MD,RU,RU,2021,Q4,Elderly
201236131,20123613,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25mg 1X week,,,U,U,,,209637.0,,,,,2021,Q4,Coronary artery occlusion,,2021,Q4,1,I,,20211117.0,20211129,20211129,EXP,,BR-NOVOPROD-869062,NOVO NORDISK,,56.0,YR,,F,Y,,,20211129.0,,MD,BR,BR,2021,Q4,Adult
201255482,20125548,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,U,,,209637.0,,,,,2021,Q4,Drug-induced liver injury,,2021,Q4,2,F,,20211116.0,20211129,20211130,EXP,,US-NOVOPROD-869647,NOVO NORDISK,Enslin Sarah; Bartell Nicholas; Kaul Vivek. The First Reported Case of Drug-Induced Liver Injury Caused by Semaglutide. The American Journal of Gastroenterology. 2021;116:p S1141,79.0,YR,,M,Y,,,20211130.0,,MD,US,US,2021,Q4,Elderly
201296391,20129639,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Urticaria,,2021,Q4,1,I,20211129.0,,20211129,20211129,DIR,592851,,FDA-CTU,,33.0,YR,,F,N,106.0,KG,20211129.0,N,PH,US,,2021,Q4,Young Adult
201296391,20129639,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Paraesthesia oral,,2021,Q4,1,I,20211129.0,,20211129,20211129,DIR,592851,,FDA-CTU,,33.0,YR,,F,N,106.0,KG,20211129.0,N,PH,US,,2021,Q4,Young Adult
201296391,20129639,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,20211129.0,,20211129,20211129,DIR,592851,,FDA-CTU,,33.0,YR,,F,N,106.0,KG,20211129.0,N,PH,US,,2021,Q4,Young Adult
201296391,20129639,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Paraesthesia oral,,2021,Q4,1,I,20211129.0,,20211129,20211129,DIR,592851,,FDA-CTU,,33.0,YR,,F,N,106.0,KG,20211129.0,N,PH,US,,2021,Q4,Young Adult
201335862,20133586,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Injection,/WK,2021,Q4,Transient ischaemic attack,,2021,Q4,2,F,20211119.0,20211209.0,20211201,20211216,EXP,,GB-ROCHE-2962873,ROCHE,,66.0,YR,,M,Y,102.0,KG,20211216.0,,MD,GB,,2021,Q4,Elderly
201336371,20133637,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,,,,,,,,2021,Q4,Lactic acidosis,,2021,Q4,1,I,,20211122.0,20211201,20211201,EXP,,US-TEVA-2021-US-1982278,TEVA,"Halderman AK, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. J-Am-Soc-Nephrol 2021;32:139 (plus poster) abstr. PO0288.",77.0,YR,E,M,Y,,,20211129.0,,HP,US,US,2021,Q4,Elderly
201336371,20133637,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211122.0,20211201,20211201,EXP,,US-TEVA-2021-US-1982278,TEVA,"Halderman AK, Kandarpa M. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. J-Am-Soc-Nephrol 2021;32:139 (plus poster) abstr. PO0288.",77.0,YR,E,M,Y,,,20211129.0,,HP,US,US,2021,Q4,Elderly
201342025,20134202,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,5,F,20211029.0,20211203.0,20211201,20211215,EXP,,NVSC2021NL265354,NOVARTIS,,56.0,YR,,M,Y,162.0,KG,20211215.0,,MD,NL,NL,2021,Q4,Adult
201365171,20136517,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,20211126.0,20211130.0,20211201,20211201,EXP,GB-MHRA-EYC 00267714,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-141260",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,125.0,KG,20211201.0,,HP,GB,GB,2021,Q4,Adult
201409851,20140985,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211122.0,20211202,20211202,EXP,,CA-TEVA-2021-CA-1981816,TEVA,,61.0,YR,A,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
201409851,20140985,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211122.0,20211202,20211202,EXP,,CA-TEVA-2021-CA-1981816,TEVA,,61.0,YR,A,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
201409851,20140985,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Flank pain,,2021,Q4,1,I,,20211122.0,20211202,20211202,EXP,,CA-TEVA-2021-CA-1981816,TEVA,,61.0,YR,A,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
201409851,20140985,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood creatine increased,,2021,Q4,1,I,,20211122.0,20211202,20211202,EXP,,CA-TEVA-2021-CA-1981816,TEVA,,61.0,YR,A,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
201409851,20140985,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Muscle spasms,,2021,Q4,1,I,,20211122.0,20211202,20211202,EXP,,CA-TEVA-2021-CA-1981816,TEVA,,61.0,YR,A,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
201409851,20140985,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Blood creatine phosphokinase increased,,2021,Q4,1,I,,20211122.0,20211202,20211202,EXP,,CA-TEVA-2021-CA-1981816,TEVA,,61.0,YR,A,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
201409851,20140985,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2021,Q4,Rhabdomyolysis,,2021,Q4,1,I,,20211122.0,20211202,20211202,EXP,,CA-TEVA-2021-CA-1981816,TEVA,,61.0,YR,A,F,Y,79.0,KG,20211202.0,,HP,CA,CA,2021,Q4,Adult
201420151,20142015,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2021,Q4,Thyroiditis,,2021,Q4,1,I,,20211130.0,20211202,20211202,EXP,,CA-Fresenius Kabi-FK202113299,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211202.0,,PH,CA,,2021,Q4,Elderly
201420151,20142015,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2021,Q4,Cardiac flutter,,2021,Q4,1,I,,20211130.0,20211202,20211202,EXP,,CA-Fresenius Kabi-FK202113299,FRESENIUS KABI,,69.0,YR,,M,Y,,,20211202.0,,PH,CA,,2021,Q4,Elderly
201444691,20144469,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2021,Q4,Abdominal distension,,2021,Q4,1,I,20211018.0,,20211202,20211202,DIR,FDA-CDER-CTU-2021-91053,,FDA-CTU,,60.0,YR,,M,N,,,20211109.0,N,PH,US,,2021,Q4,Adult
201444691,20144469,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211018.0,,20211202,20211202,DIR,FDA-CDER-CTU-2021-91053,,FDA-CTU,,60.0,YR,,M,N,,,20211109.0,N,PH,US,,2021,Q4,Adult
201444691,20144469,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2021,Q4,Flatulence,,2021,Q4,1,I,20211018.0,,20211202,20211202,DIR,FDA-CDER-CTU-2021-91053,,FDA-CTU,,60.0,YR,,M,N,,,20211109.0,N,PH,US,,2021,Q4,Adult
201444691,20144469,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211018.0,,20211202,20211202,DIR,FDA-CDER-CTU-2021-91053,,FDA-CTU,,60.0,YR,,M,N,,,20211109.0,N,PH,US,,2021,Q4,Adult
201458671,20145867,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"OTHER STRENGTH : 1MG/0.75ML, 1.5ML;?Frequency : Weekly;?",,,D,D,,,,1.0,MG,,QW,2021,Q4,Retinopathy,,2021,Q4,1,I,20211119.0,,20211203,20211203,DIR,FDA-CDER-CTU-2021-91184,,FDA-CTU,,73.0,YR,,M,N,85.28,KG,20211202.0,N,PH,US,,2021,Q4,Elderly
201477682,20147768,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Staphylococcal infection,,2021,Q4,2,F,20211117.0,20211207.0,20211203,20211214,PER,,US-CELGENEUS-USA-20211108161,CELGENE,,78.0,YR,,,Y,,,20211214.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Liver injury,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Pallor,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Hyperhidrosis,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Alanine aminotransferase increased,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Mental status changes,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Drug level increased,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, QW",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Encephalopathy,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Liver injury,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Pallor,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Hyperhidrosis,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Mental status changes,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Drug level increased,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201496692,20149669,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Encephalopathy,,2021,Q4,2,F,,20211201.0,20211206,20211208,EXP,,US-SAKK-2021SA392096AA,SANOFI AVENTIS,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116:S1192",66.0,YR,E,M,Y,,,20211208.0,,MD,US,US,2021,Q4,Elderly
201498601,20149860,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 tab qd,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211101.0,20211125.0,20211206,20211206,EXP,GB-MHRA-ADR 26239393,GB-NOVOPROD-870784,NOVO NORDISK,,66.0,YR,,F,Y,92.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201498601,20149860,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 tab qd,,,,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,20211101.0,20211125.0,20211206,20211206,EXP,GB-MHRA-ADR 26239393,GB-NOVOPROD-870784,NOVO NORDISK,,66.0,YR,,F,Y,92.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201508721,20150872,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, QW",,,U,,,,,0.25,MG,,/WK,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211125.0,20211206,20211206,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK069177,GLENMARK,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. Annual Scientific Meeting of the American College of Gastroenterology, ACG 2021.. 2021;116 (SUPPL):(ppS1192)",66.0,YR,,M,Y,,,20211206.0,,HP,US,US,2021,Q4,Elderly
201508721,20150872,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, QW",,,U,,,,,0.25,MG,,/WK,2021,Q4,Liver injury,,2021,Q4,1,I,,20211125.0,20211206,20211206,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK069177,GLENMARK,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. Annual Scientific Meeting of the American College of Gastroenterology, ACG 2021.. 2021;116 (SUPPL):(ppS1192)",66.0,YR,,M,Y,,,20211206.0,,HP,US,US,2021,Q4,Elderly
201508721,20150872,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, QW",,,U,,,,,0.25,MG,,/WK,2021,Q4,Hepatic function abnormal,,2021,Q4,1,I,,20211125.0,20211206,20211206,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK069177,GLENMARK,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. Annual Scientific Meeting of the American College of Gastroenterology, ACG 2021.. 2021;116 (SUPPL):(ppS1192)",66.0,YR,,M,Y,,,20211206.0,,HP,US,US,2021,Q4,Elderly
201508721,20150872,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, QW",,,U,,,,,0.25,MG,,/WK,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211125.0,20211206,20211206,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK069177,GLENMARK,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. Annual Scientific Meeting of the American College of Gastroenterology, ACG 2021.. 2021;116 (SUPPL):(ppS1192)",66.0,YR,,M,Y,,,20211206.0,,HP,US,US,2021,Q4,Elderly
201508721,20150872,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, QW",,,U,,,,,0.25,MG,,/WK,2021,Q4,Encephalopathy,,2021,Q4,1,I,,20211125.0,20211206,20211206,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK069177,GLENMARK,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. Annual Scientific Meeting of the American College of Gastroenterology, ACG 2021.. 2021;116 (SUPPL):(ppS1192)",66.0,YR,,M,Y,,,20211206.0,,HP,US,US,2021,Q4,Elderly
201529761,20152976,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20210415.0,20211126.0,20211206,20211206,EXP,,GB-TEVA-2021-GB-1984029,TEVA,,65.0,YR,E,M,Y,80.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201529761,20152976,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210415.0,20211126.0,20211206,20211206,EXP,,GB-TEVA-2021-GB-1984029,TEVA,,65.0,YR,E,M,Y,80.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201529761,20152976,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20210415.0,20211126.0,20211206,20211206,EXP,,GB-TEVA-2021-GB-1984029,TEVA,,65.0,YR,E,M,Y,80.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201529761,20152976,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20210415.0,20211126.0,20211206,20211206,EXP,,GB-TEVA-2021-GB-1984029,TEVA,,65.0,YR,E,M,Y,80.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201529761,20152976,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Gastrointestinal disorder,,2021,Q4,1,I,20210415.0,20211126.0,20211206,20211206,EXP,,GB-TEVA-2021-GB-1984029,TEVA,,65.0,YR,E,M,Y,80.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201646641,20164664,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Strength: 1 mg,,,,,,,,1.0,MG,Solution for injection in pre-filled pen,,2021,Q4,Mesenteric panniculitis,,2021,Q4,1,I,20211001.0,20211129.0,20211209,20211209,EXP,FR-AFSSAPS-AM20212865,FR-Accord-246973,ACCORD,,57.0,YR,A,F,Y,74.0,KG,20211209.0,,MD,FR,FR,2021,Q4,Adult
201647381,20164738,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"OTHER STRENGTH : 0.5MG/0.375MG, 1.5;?Frequency : Weekly;?",,,Y,,LP56122,20231031.0,,0.5,MG,,QW,2021,Q4,Bile duct stone,,2021,Q4,1,I,20211122.0,,20211208,20211208,DIR,FDA-CDER-CTU-2021-92319,,FDA-CTU,,67.0,YR,,M,N,,,20211207.0,N,PH,US,,2021,Q4,Elderly
201647381,20164738,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"OTHER STRENGTH : 0.5MG/0.375MG, 1.5;?Frequency : Weekly;?",,,Y,,LP56122,20231031.0,,0.5,MG,,QW,2021,Q4,Cholangitis,,2021,Q4,1,I,20211122.0,,20211208,20211208,DIR,FDA-CDER-CTU-2021-92319,,FDA-CTU,,67.0,YR,,M,N,,,20211207.0,N,PH,US,,2021,Q4,Elderly
201677991,20167799,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (0.25 mg q weekly)",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Encephalopathy,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,US-AUROBINDO-AUR-APL-2021-050269,AUROBINDO,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. American Journal of Gastroenterology. 2021;116 SUPPL:S1192",66.0,YR,,M,Y,,,20211210.0,,MD,US,US,2021,Q4,Elderly
201677991,20167799,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (0.25 mg q weekly)",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,US-AUROBINDO-AUR-APL-2021-050269,AUROBINDO,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. American Journal of Gastroenterology. 2021;116 SUPPL:S1192",66.0,YR,,M,Y,,,20211210.0,,MD,US,US,2021,Q4,Elderly
201677991,20167799,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (0.25 mg q weekly)",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,US-AUROBINDO-AUR-APL-2021-050269,AUROBINDO,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. American Journal of Gastroenterology. 2021;116 SUPPL:S1192",66.0,YR,,M,Y,,,20211210.0,,MD,US,US,2021,Q4,Elderly
201677991,20167799,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (0.25 mg q weekly)",,,Y,,,,,0.25,MG,,/WK,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211201.0,20211210,20211210,EXP,,US-AUROBINDO-AUR-APL-2021-050269,AUROBINDO,"Marks J, Dara P, Edwards C.. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment.. American Journal of Gastroenterology. 2021;116 SUPPL:S1192",66.0,YR,,M,Y,,,20211210.0,,MD,US,US,2021,Q4,Elderly
201680771,20168077,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, qw",,,Y,U,,,209637.0,0.5,MG,,/WK,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211129.0,20211210,20211210,EXP,,CA-NOVOPROD-873831,NOVO NORDISK,"Moss, Kasey. Acute esophageal necrosis as a complication of diabetic ketoacidosis: A case report. World Journal of Clinical Cases. 2021;9:9571-9576",63.0,YR,,M,Y,94.0,KG,20211210.0,,HP,CA,CA,2021,Q4,Adult
201680771,20168077,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,U,,,209637.0,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211129.0,20211210,20211210,EXP,,CA-NOVOPROD-873831,NOVO NORDISK,"Moss, Kasey. Acute esophageal necrosis as a complication of diabetic ketoacidosis: A case report. World Journal of Clinical Cases. 2021;9:9571-9576",63.0,YR,,M,Y,94.0,KG,20211210.0,,HP,CA,CA,2021,Q4,Adult
201746671,20174667,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution for injection in pre-filled pen,,2021,Q4,Interstitial lung disease,,2021,Q4,1,I,20200101.0,20211201.0,20211213,20211213,EXP,FR-AFSSAPS-PV20213175,FR-Accord-247207,ACCORD,,73.0,YR,E,M,Y,99.0,KG,20211213.0,,MD,FR,FR,2021,Q4,Elderly
201746671,20174667,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution for injection in pre-filled pen,,2021,Q4,Pulmonary fibrosis,,2021,Q4,1,I,20200101.0,20211201.0,20211213,20211213,EXP,FR-AFSSAPS-PV20213175,FR-Accord-247207,ACCORD,,73.0,YR,E,M,Y,99.0,KG,20211213.0,,MD,FR,FR,2021,Q4,Elderly
201749561,20174956,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,US-Accord-246847,ACCORD,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116 SUPPL:S1192.",66.0,YR,,M,Y,,,20211213.0,,MD,US,US,2021,Q4,Elderly
201749561,20174956,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,US-Accord-246847,ACCORD,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116 SUPPL:S1192.",66.0,YR,,M,Y,,,20211213.0,,MD,US,US,2021,Q4,Elderly
201749561,20174956,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,,2021,Q4,Encephalopathy,,2021,Q4,1,I,,20211201.0,20211213,20211213,EXP,,US-Accord-246847,ACCORD,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. American Journal of Gastroenterology. 2021;116 SUPPL:S1192.",66.0,YR,,M,Y,,,20211213.0,,MD,US,US,2021,Q4,Elderly
201792874,20179287,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw(1 mg, QW(1 milligram every 1 day)  )",,,U,U,,,,1.0,MG,Injection,/WK,2021,Q4,Mesenteric panniculitis,,2021,Q4,4,F,20211001.0,20211223.0,20211214,20211229,EXP,FR-AFSSAPS-AM20212865,FR-MYLANLABS-2021M1091784,MYLAN,,57.0,YR,,F,Y,74.0,KG,20211229.0,,MD,FR,FR,2021,Q4,Adult
201802121,20180212,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,/WK,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211201.0,20211214,20211214,EXP,US-MLMSERVICE-20211125-3239033-1,US-MICRO LABS LIMITED-ML2021-03724,MICRO LABS,,66.0,YR,,M,Y,,,20211214.0,,MD,US,,2021,Q4,Elderly
201802121,20180212,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,/WK,2021,Q4,Drug level increased,,2021,Q4,1,I,,20211201.0,20211214,20211214,EXP,US-MLMSERVICE-20211125-3239033-1,US-MICRO LABS LIMITED-ML2021-03724,MICRO LABS,,66.0,YR,,M,Y,,,20211214.0,,MD,US,,2021,Q4,Elderly
201802121,20180212,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,/WK,2021,Q4,Encephalopathy,,2021,Q4,1,I,,20211201.0,20211214,20211214,EXP,US-MLMSERVICE-20211125-3239033-1,US-MICRO LABS LIMITED-ML2021-03724,MICRO LABS,,66.0,YR,,M,Y,,,20211214.0,,MD,US,,2021,Q4,Elderly
201802121,20180212,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,,,,0.25,MG,,/WK,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,,20211201.0,20211214,20211214,EXP,US-MLMSERVICE-20211125-3239033-1,US-MICRO LABS LIMITED-ML2021-03724,MICRO LABS,,66.0,YR,,M,Y,,,20211214.0,,MD,US,,2021,Q4,Elderly
201931152,20193115,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,,/WK,2021,Q4,Urticaria,,2021,Q4,2,F,,20211216.0,20211216,20211224,EXP,,CH-ROCHE-2981168,ROCHE,,47.0,YR,,M,Y,,,20211224.0,,MD,CH,CH,2021,Q4,Adult
202234411,20223441,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",11.0,MG,Y,N,,,209637.0,1.0,MG,Solution for injection,/WK,2021,Q4,Chronic gastritis,,2021,Q4,1,I,20211130.0,20211213.0,20211223,20211223,EXP,,TW-NOVOPROD-872774,NOVO NORDISK,,49.0,YR,,F,Y,59.0,KG,20211223.0,,MD,TW,TW,2021,Q4,Adult
202234411,20223441,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",11.0,MG,Y,N,,,209637.0,0.5,MG,Solution for injection,/WK,2021,Q4,Chronic gastritis,,2021,Q4,1,I,20211130.0,20211213.0,20211223,20211223,EXP,,TW-NOVOPROD-872774,NOVO NORDISK,,49.0,YR,,F,Y,59.0,KG,20211223.0,,MD,TW,TW,2021,Q4,Adult
202304341,20230434,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 milligram; UNK,,,,,,,,0.5,MG,,,2021,Q4,Reperfusion arrhythmia,,2021,Q4,1,I,20211219.0,20211222.0,20211227,20211227,EXP,GB-MHRA-TPP44631731C8333173YC1639874873888,GB-STRIDES ARCOLAB LIMITED-2021SP031474,STRIDES,,35.0,YR,,F,Y,110.0,KG,20211227.0,,HP,GB,GB,2021,Q4,Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Urine flow decreased,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Myopathy,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Muscle spasms,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Headache,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Body temperature increased,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Serotonin syndrome,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Chills,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Myoglobinuria,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Drug interaction,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Renal failure,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202312061,20231206,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, once a week",,,U,,,,,0.5,MG,,,2021,Q4,Myalgia,,2021,Q4,1,I,,20211215.0,20211227,20211227,EXP,,PL-GLAXOSMITHKLINE-PL2021EME258012,GLAXOSMITHKLINE,Woron J.. Farmakologiczne leczenie otylosci a niebezpieczne dla zdrowia i zycia interakcje lek?w. Medycyna Praktyczna Psychiatria. 2021;6 (83):49-51,29.0,YR,,F,Y,,,20211227.0,,HP,PL,PL,2021,Q4,Young Adult
202322161,20232216,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Unk (1 IE, montags)",,,U,,,,,,,,,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,,20211217.0,20211227,20211227,EXP,,NVSC2021DE290898,NOVARTIS,,72.0,YR,,M,Y,121.0,KG,20211227.0,,MD,DE,DE,2021,Q4,Elderly
202322161,20232216,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Unk (1 IE, montags)",,,U,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211217.0,20211227,20211227,EXP,,NVSC2021DE290898,NOVARTIS,,72.0,YR,,M,Y,121.0,KG,20211227.0,,MD,DE,DE,2021,Q4,Elderly
202322161,20232216,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Unk (1 IE, montags)",,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211217.0,20211227,20211227,EXP,,NVSC2021DE290898,NOVARTIS,,72.0,YR,,M,Y,121.0,KG,20211227.0,,MD,DE,DE,2021,Q4,Elderly
202322161,20232216,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Unk (1 IE, montags)",,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211217.0,20211227,20211227,EXP,,NVSC2021DE290898,NOVARTIS,,72.0,YR,,M,Y,121.0,KG,20211227.0,,MD,DE,DE,2021,Q4,Elderly
202322161,20232216,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Unk (1 IE, montags)",,,U,,,,,,,,,2021,Q4,Cold sweat,,2021,Q4,1,I,,20211217.0,20211227,20211227,EXP,,NVSC2021DE290898,NOVARTIS,,72.0,YR,,M,Y,121.0,KG,20211227.0,,MD,DE,DE,2021,Q4,Elderly
202322161,20232216,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Unk (1 IE, montags)",,,U,,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,,20211217.0,20211227,20211227,EXP,,NVSC2021DE290898,NOVARTIS,,72.0,YR,,M,Y,121.0,KG,20211227.0,,MD,DE,DE,2021,Q4,Elderly
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Asthma,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Depression,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202356401,20235640,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Wheezing,,2021,Q4,1,I,,20211216.0,20211228,20211228,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20211228.0,,HP,CA,CA,2021,Q4,Adult
202357541,20235754,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IE, montags",,,U,,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052734,AUROBINDO,,72.0,YR,,M,Y,121.0,KG,20211228.0,,MD,DE,DE,2021,Q4,Elderly
202357541,20235754,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IE, montags",,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052734,AUROBINDO,,72.0,YR,,M,Y,121.0,KG,20211228.0,,MD,DE,DE,2021,Q4,Elderly
202357541,20235754,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IE, montags",,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052734,AUROBINDO,,72.0,YR,,M,Y,121.0,KG,20211228.0,,MD,DE,DE,2021,Q4,Elderly
202357541,20235754,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IE, montags",,,U,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052734,AUROBINDO,,72.0,YR,,M,Y,121.0,KG,20211228.0,,MD,DE,DE,2021,Q4,Elderly
202357541,20235754,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IE, montags",,,U,,,,,,,,,2021,Q4,Cold sweat,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052734,AUROBINDO,,72.0,YR,,M,Y,121.0,KG,20211228.0,,MD,DE,DE,2021,Q4,Elderly
202357541,20235754,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IE, montags",,,U,,,,,,,,,2021,Q4,Dyspnoea exertional,,2021,Q4,1,I,,20211215.0,20211228,20211228,EXP,,DE-AUROBINDO-AUR-APL-2021-052734,AUROBINDO,,72.0,YR,,M,Y,121.0,KG,20211228.0,,MD,DE,DE,2021,Q4,Elderly
202370001,20237000,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 milligram,,,,,,,,0.5,MG,,,2021,Q4,Reperfusion arrhythmia,,2021,Q4,1,I,20211219.0,20211221.0,20211228,20211228,EXP,GB-MHRA-TPP44631731C8333173YC1639874873888,GB-MYLANLABS-2021M1095414,MYLAN,,35.0,YR,,F,Y,110.0,KG,20211228.0,,HP,GB,GB,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Asthma,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Depression,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Wheezing,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202392551,20239255,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,,,,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20211221.0,20211228,20211228,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20211228.0,,MD,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Depression,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Asthma,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Wheezing,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202440621,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2021,Q4,Hypoacusis,,2021,Q4,1,I,,20211220.0,20211228,20211228,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20211229.0,,CN,CA,CA,2021,Q4,Adult
202446611,20244661,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211222.0,20211229,20211229,EXP,GB-MHRA-EYC 00269726,GB-JNJFOC-20211251895,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20211229.0,,PH,GB,GB,2021,Q4,Elderly
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Asthma,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Urinary incontinence,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Lower respiratory tract infection,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Type 2 diabetes mellitus,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Sleep apnoea syndrome,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Nasal congestion,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Hyperlipidaemia,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Productive cough,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Pharyngitis,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202625861,20262586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2021,Q4,Oropharyngeal pain,,2021,Q4,1,I,,20211220.0,20211231,20211231,EXP,CA- HEALTHCANVIG- E2B_04309799,CA-NOVOPROD-877980,NOVO NORDISK,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202640611,20264061,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg,,,U,,Unk,,,0.5,MG,,,2021,Q4,Reperfusion arrhythmia,,2021,Q4,1,I,20211219.0,20211230.0,20211231,20211231,EXP,GB-MHRA-TPP44631731C8333173YC1639874873888,GB-GLAXOSMITHKLINE-GBCH2021092579,GLAXOSMITHKLINE,,35.0,YR,,F,Y,110.0,KG,20211231.0,,HP,GB,GB,2021,Q4,Adult
202642201,20264220,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2021,Q4,Back pain,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2021,Q4,Infusion related reaction,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2021,Q4,Chest pain,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202642201,20264220,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2021,Q4,Respiratory arrest,,2021,Q4,1,I,20211115.0,20211222.0,20211231,20211231,EXP,,"US-Melinta Therapeutics, LLC-US-MLNT-21-00184",MELINTA THERAPEUTICS,,74.0,YR,,M,Y,122.6,KG,20211231.0,,PH,US,US,2021,Q4,Elderly
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Wheezing,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Asthma,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Depression,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Sleep disorder due to a general medical condition,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Loss of personal independence in daily activities,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Hypoacusis,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
202669071,20266907,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,1,I,,20211227.0,20211231,20211231,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20211231.0,,CN,CA,CA,2021,Q4,Adult
